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ABSTRACT 
Background 
In recent years there has been an explosion of referrals to child and adolescent 
gender identity services. There is a paucity of research on the experiences and 
outcomes of young adults referred from child and adolescent services to adult 
services, and with such large increases in referrals it is vital we understand more 
about the intervention pathways, satisfaction and longer-term outcomes of these 
gender diverse young people. The findings will enable better tailoring of gender 
identity services for young people, and be an important step towards ensuring 
that the support and intervention provided meets the needs of this diverse and 
growing population 
 
Aim 
The aim was to determine the intervention pathways, satisfaction levels and 
longer-term outcomes of the young people who attended the Gender Identity 
Development Service (GIDS), and who were referred on to the Charing Cross 
Adult Gender Identity Clinic (CCGIC).  
 
Method 
All attendees of the GIDS who were referred to the CCGIC between 2011 and 
2016 were sent an invite to participate in an online questionnaire, which asked 
about their emerging gender awareness, prevalence of gender affirming 
interventions, factors influencing intervention decisions, satisfaction with the 
intervention process, feelings about gender identity, body image and wellbeing.  
 
Results 
Of the 365 ex-GIDS clients who were referred to CCGIC, 72 completed the 
questionnaire. Overall, 59% were taking/had taken hormone blockers; 67% 
were/had taken cross-sex hormones and 27% intended to start taking them in the 
future; and 34% had undergone top or bottom surgery, with 56% intending to 
have surgical intervention in the future. Factors influential in the decision-making 
process were identified. Participants were generally satisfied with their 
intervention decisions and the decision-making process. However, areas of 
dissatisfaction were identified and are discussed.  
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Conclusion 
The study shows that a higher number of young adults who are referred from 
child and adolescent services to adult services do pursue (or intend to pursue) 
medical and surgical interventions. Many who do are largely satisfied with the 
intervention process, but there are areas that require improvement.   
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INTRODUCTION 
 
 
1.1. Chapter Overview 
 
In recent years the dimensionality and diversity of gender identity and gender 
identity difficulties has received increasing attention in the research literature, 
popular media and public policy debates (Beek, Cohen-Kettenis, & Kreukels, 
2016; Drescher & Pula, 2014). Heightened public awareness has likely 
contributed to an increase in self-identified gender diversity in children and young 
people, and there has been a corresponding explosion of referrals to speciality 
services for gender diverse youth (de Vries, Kreukels, T’sjoen, Algars, & Mattila, 
2015).This chapter clarifies key terminology and provides an overview of the 
current context surround gender identify. Next it provides a scoping review of 
follow-up studies in adolescents and young adults, followed by the rationale and 
research questions for the current study. 
 
1.2. Terminology 
 
Language and terminology in this area is shifting and evolving, and there is 
currently no consensus on what constitutes the most appropriate terminology 
(Eliason, 2014; Tebbe & Budge, 2016). In this thesis I have endeavoured to use 
terminology that I consider the least pathologising, but recognise that the terms I 
have used may or may not be acceptable to all stakeholders, and may in time 
become obsolete.  
 
1.2.1. Sex 
Sex and gender are terms that are often used interchangeably, but although they 
are inextricably linked, they are quite different. A person’s biological sex is often 
assigned at birth by a medical professional and parents, usually on the basis of 
the external genitals the baby is born with. However, biological sex is determined 
by more than genital appearance alone; it also involves a person’s internal 
genitalia, their chromosomal make-up (XX chromosomes for females and XY for 
males), and secondary sex characteristics (i.e. chest growth/appearance, facial 
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and body hair, voice, muscle mass and fat distribution), which are usually 
regulated by hormones (Barker, 2017). Mounting evidence suggests that, 
contrary to popular belief, sex is not binary in nature (Ainsworth, 2015). 
Approximately 1.7% of people are born with reproductive, chromosomal and/or 
sexual anatomy that do not seem to fit the typical definitions of female or male 
(Hughes, Houk, Ahmed, & Lee, 2006), and are referred to as disorders (or 
differences) of sex development (DSD).    
 
1.2.2. Gender 
Gender, on the other hand, refers to the socially constructed characteristics of 
women and men, such as norms, roles, expression, and the relationships of and 
between groups of women and men (Newman, 2002). These vary from society to 
society and gender can be changed. The majority of people are assigned male or 
female at birth, and are then taught the appropriate norms and behaviours for 
their assigned gender – including how they should interact with others of the 
same or opposite sex within households, communities and work places. When 
individuals or groups do not subscribe to established gender norms they often 
face stigma, discriminatory practices or social exclusion (WHO, 2018).  
 
1.2.3. Identity  
Identity, as a concept, is historically and culturally contingent, and not easy to 
define (Baumeister, 1995). In the west, we tend to frame identity in individual and 
largely intra-psychic terms; and much of our current (western) understanding of 
identity comes from the work of developmental psychologists Erikson (1968) and 
Marcia (1966). A personal identity can be defined as the values, principles and 
roles a person adopts as their own. Identity is thought of as dynamic, in that it 
continues to develop throughout the lifespan, but both Erikson and Marcia cited 
adolescence as a key period for identity formation. As adolescents form their 
identities, they explore and commit to identity-defining roles and values across 
different life domains (e.g. politics, religion, occupation, friendships, intimate 
relationships and gender roles). Adolescents are thought to experience four 
different stages of identity formation (Marcia, Waterman, Matteson, Archer, & 
Orlofsky, 1993), including identity diffusion/confusion, identity foreclosure, identity 
moratorium, and identity achievement. Through these stages adolescents 
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progress from not thinking about these issues, to prematurely forming an opinion 
without any exploration, to searching for meaningful adult roles and values, and 
then achieving their own identity as a result of this process (Kroger, 2008; Marcia 
et al., 1993).  
 
Narrative and social constructionist theorists (Gergen, 1991; McAdams, 1985; 
Potter & Wetherell, 1987) argue that language and context play a key role in 
identity formation. We are thought to develop a sense of who we are through the 
stories we tell (and are told) about ourselves, and that our socio-cultural and 
historical contexts frame and constrain our language and behaviour (Cerulo, 
1997). Identity consists of many integrated aspects of the self, and each person 
may have any number of identities – an ethnic identity, a political identity, a 
religious identity, and a national identity to name a few; all of which are influenced 
by interpersonal relationships, society, and significant events that occur through 
the life course (Kroger, 2008). A fundamental identity is a person’s gender 
identity.  
 
1.2.4. Gender Identity  
Gender identity can be defined as a person’s internal sense of themselves as 
male, female, a combination of both, neither or another gender (APA, 2015a; 
Leibowitz & De Vries, 2016). The sense of one’s gender largely determines how 
people view themselves and forms an important basis for interactions with others 
(Steensma, Kreukels, de Vries, & Cohen-Kettenis, 2013).  
 
1.3. Gender Identity Development: A Biopsychosocial Understanding 
 
The biopsychosocial model was introduced in the late 1970s as an alternative to 
the purely medical model that predominated at the time (Engel, 1977). Engel saw 
the medical model as too reductionist, and felt that a biopsychosocial model 
would provide a more holistic and comprehensive understanding of all the factors 
that play a role in health and disease (Engel, 1977). In the context of gender 
identity, it is a particularly useful model as it facilitates thinking about the complex 
array of biological, psychological and social factors that interact to influence 
gender identity development.  
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Traditionally, studies on gender identity development have fallen into two types; 
those focussed on “normative” or typical development, and those focussed on 
gender diverse development in people with gender dysphoria (see section 1.4 for 
full definition) or DSD. More recently, these lines of research have begun to 
converge, to identify factors associated with variability in gender identity 
development across the entire spectrum (de Vries, Kreukels, Steensma, & 
McGuire, 2014).  
 
1.3.1. Typical Gender Identity Development 
In most cases, a person’s gender identity will develop in line with the gender they 
were assigned at birth, on the basis of their external genitalia. The following is a 
review of the biological, psychological and social factors that are thought to 
influence normative or typical gender identity development.  
 
1.3.1.1. Biological factors: Prenatal exposure to sex hormones is thought to 
influence sex differentiation of the brain and behaviour in a male or female 
direction (de Vries et al., 2014; McCarthy, de Vries, & Forger, 2010). Typically, 
women have more oestrogens in their bodies and men more androgens; most 
commonly testosterone (Stainton Rogers & Stainton Rogers, 2001). While it is 
difficult to study prenatal exposure to sex hormones, evidence suggests that 
exposure to prenatal androgens facilitates interest and engagement in male 
gender-role behaviour (e.g. child toy preferences and adult career choices), and 
spatial ability, but appears to have a lesser influence on gender identity 
(Berenbaum & Beltz, 2016; Cohen-Kettenis & Pfäfflin, 2003; Hines, 2009; 
Steensma et al., 2013). The effects of prenatal exposure to oestrogens is much 
less clear as findings tend to be mixed (Cohen-Kettenis & Pfäfflin, 2003). 
  
1.3.1.2. Psychological factors: Infants as young as 3 months old are capable of 
distinguishing between male and female faces (Quinn, Yahr, Kuhn, Slater, & 
Pascalis, 2002). However, whether they can categorise or label gender is still up 
for debate (de Vries et al., 2014). According to cognitive developmental theory 
(Kohlberg, 1966), gender identity and gender role development are achieved as 
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part of an inherent maturation process. Between the ages of two and twelve, 
children are thought to progress through three stages towards a state of gender 
constancy (i.e. the understanding that they will always be the same sex and that 
identification is based on external genitalia). The specific stages include the 
gender labelling stage (age 2-3 years), where a child is able to recognise their 
own and others’ gender; the gender stability stage (age 3-7 years), where the 
child accepts that gender does not change over time; and the gender consistency 
stage (age 7-12 years), where the child recognises that a person’s gender is fixed 
across situations regardless of changes in appearance or behaviour. Kohlberg’s 
theory suggests that children acquire gender-typical behaviours as a result of 
developing a stable concept of gender. However, this view is contested by some 
as children show gender-typical behaviours well before reaching a state of gender 
constancy (Cohen-Kettenis & Pfäfflin, 2003). 
 
Gender schema theorists (Bem, 1981) posit that during development, children 
learn about their culture’s definitions of femaleness and maleness. In doing so 
they begin to construct cognitive gender schemas (Bem, 1981), which are 
theories about gender-appropriate behaviour that help guide and organise 
information processing and behaviour. From a young age children acquire 
knowledge about gender stereotypical behaviour (i.e. that ‘boys have short hair’ 
and are ‘more aggressive’ and that ‘girls have long hair’ and are ‘more caring’). 
Children are thought to play an active role in gender schema development by 
remembering and attending to gender-consistent information better than gender-
inconsistent information. Children learn to evaluate their own adequacy as a 
person by matching their preferences, attitudes and behaviours to the prototypes 
stored within the schema, and thus begin to conform to cultural definitions of 
femaleness and maleness (Bem, 1981; de Vries et al., 2014). Contemporary 
gender schema theory combines elements of social learning theory and cognitive 
developmental theory (Berk, 2013), and a variety of studies support gender 
schema theory (Cohen-Kettenis & Pfäfflin, 2003). 
 
1.3.1.3. Social factors: Social roles and expectations vary for boys and girls, and 
gendered characteristics are even ascribed pre-birth. For example, babies who 
move around a lot in the womb are often thought to be boys (Montgomery, 2010). 
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According to social learning theory (Bandura, 1977), children learn gender-
appropriate behaviour through a combination of operant conditioning and 
observational learning. Behaviours can be reinforced directly or indirectly by 
observing gender stereotypes. Evidence suggests that boys tend to identify with 
same-gender models more than girls, but this might be related to the fact that 
gender-diverse behaviour is generally more accepted in girls than it is in boys 
(Aitken et al., 2015; Bussey & Bandura, 1999). Critics of social learning theory 
state that it is too simplistic, in that it casts children as too passive, and fails to 
explain how and why gender changes over time (Bem, 1981).  
 
The main criticism of these perspectives is that they each take a partial view. 
Children’s sense of self and identity (i.e. their self-beliefs, cognitions, perceptions, 
emotional responses, and expressions) are influenced by a complex interplay of 
biological, interpersonal, social, cultural and geographic factors, and any coherent 
theory of gender identity will need to integrate them (Bronfenbrenner, 1979; 
Hidalgo et al., 2013).  
 
1.3.2. Gender Diverse Development 
Some children do not follow a typical pattern of gender development, and will 
instead show what can be described as gender diverse development (Steensma 
et al., 2013). Gender diversity refers to the extent to which a person’s gender 
identity, expression, and/or behaviour differs from the cultural norms that are 
prescribed for people of a particular sex (APA, 2015b). For example, in gender 
diverse development, boys may show a preference for stereotypically female-
typed interests and behaviours, and girls a preference for stereotypically male-
typed interests and behaviours (de Vries et al., 2014). The term transgender 
(short: trans) is an adjective used to describe people whose gender identity, 
expression and/or behaviour does not conform to what is typically associated with 
the sex they were assigned at birth (APA, 2015b). Trans people may feel they are 
the other gender (and are sometimes, though not always, referred to as 
transwomen and transmen); but reflecting a non-binary concept of gender, they 
might identify as both male and female, neither, or another gender altogether 
(Grant et al., 2011; Leibowitz & De Vries, 2016). It is important to note however, 
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that people with gender identities and/or expressions that differ from societal 
expectations based on gender assigned at birth are a heterogeneous group, and 
not all gender diverse people will identify as trans.  
 
Gender diversity is not a new (or western) phenomenon. Transgender and non-
binary or third gender identities have been documented throughout history and 
across cultures: The Native American ‘two spirit’ people; the Polynesian Mahu; 
the Hijra, Khushra and Acault of Indian, Pakistani and Myanmar societies; the 
Kathoeys in Thailand; the Muxes in Mexico; and the Xanith of Oman (Bullough & 
Bullough, 1997). The concept of a third gender is also found in queer theories and 
in community based studies in North America, but has been explored less in 
clinical studies (de Vries et al., 2014)  
 
In the remainder of this thesis I will use the terms trans, trans-identified, gender 
diverse, and gender diversity as umbrella terms to describe people whose gender 
identity does not align with the gender they were assigned at birth on the basis of 
their biological sex; and I will use cis or cisgender to describe people whose 
gender does align with the gender they were assigned at birth. The following 
section reviews the biological, psychological and social factors that are thought to 
influence gender diverse identity development.  
 
1.3.2.1. Biological factors: Biological theories highlight three possible pathways to 
gender diverse development: prenatal exposure to hormones, anatomic brain 
differences, and genetic influences. Studies indicate that prenatal exposure to 
testosterone in people with disorders (or differences) in sex development (DSD) 
may affect male gender identity (de Vries, Doreleijers, & Cohen-Kettenis, 2007; 
Dessens, Slijper, & Drop, 2005), but findings are inconsistent. For example, while 
gender dysphoria occurs more in females with congenital adrenal hyperplasia 
(CAH; an enzyme deficiency that causes prenatal exposure to high levels of 
testosterone) than females without CAH, not all foetuses with CAH develop a 
male gender identity (de Vries et al., 2014). Therefore, from these studies, it is not 
clear how, and to what extent, prenatal androgens affect gender identity 
development and the possible influence of later cross-sex hormone treatment 
cannot be ruled out (de Vries et al., 2014).  
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Post-mortem studies have found differences in the brains of male-to-female trans 
people, such that some sex-specific characteristics of the brain are more similar 
to female brains than male brains (Garcia-Falgueras & Swaab, 2008; Taziaux, 
Swaab, & Bakker, 2012; Zhou, Hofman, Gooren, & Swaab, 1995). However, the 
studies were small, conducted by the same research group, and have yet to be 
replicated. Therefore, the extent to which brain differences may play a role in 
gender diverse development is still unclear (de Vries et al., 2014). 
 
Heritability studies suggest that genes may play a role in gender diverse 
development (de Vries, et al., 2014). Heritability estimates for gender dysphoria 
vary between 0.22 and 0.77; although population studies are more likely to be 
measuring gender variance than gender dysphoria (de Vries et al., 2014; Veale, 
Clarke, & Lomax, 2010). However, it is worth noting that the psychosocial 
environments monozygotic twins are raised in are likely to be more similar than 
those of dizygotic twins.  
 
Some studies have found polymorphisms (genetic variations) in sex steroid-
related genes of people who are transgender; CYP17 in female to male 
transgender persons (Bentz et al., 2008) and AR in male to female transgender 
persons (Hare et al., 2009; Henningsson et al., 2005) but others have failed to 
replicate these findings (Bentz et al., 2007; Ujike et al., 2009). No strong 
candidate gene has emerged that explains the development of gender variance 
or dysphoria. While studies of gene-environment interactions have not yet been 
undertaken in this area (de Vries et al., 2014), due to the complexity of gender 
identity development, it is likely that individual behavioural differences are the 
result of a complex interplay between genes and the social and psychological 
environments (Lenroot & Giedd, 2011).  
 
1.3.2.2. Psychological factors: In early studies of gender-variant development, 
gender diversity/dysphoria was thought to be part of a more pervasive 
psychological disturbance (Coates & Person, 1985). It has been hypothesised 
that attachment problems (Marantz & Coates, 1991) or an anxious temperament 
interacting with parental factors (Bradley & Zucker, 1990) can lead to gender 
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dysphoria, but these theories have not been empirically supported. And while 
some studies show a high prevalence of separation anxiety traits (Zucker, 
Bradley, & Lowry Sullivan, 1996) and other internalizing symptoms in children 
with gender dysphoria (Cohen-Kettenis, Owen, Kaijser, Bradley, & Zucker, 2003), 
the direction of causality cannot be determined (de Vries et al., 2014).  
 
1.3.2.3. Social factors: A variety of social factors have been hypothesised to 
impact gender diverse development, including maternal depression, or 
enmeshment with the mother and absence of the father (Stoller, 1968); early 
childhood loss of an attachment figure (Bleiberg, Jackson, & Ross, 1986); and 
parental reinforcement patterns (Green, 1987). However, many of these theories 
have not been empirically tested, and those that have were limited to specific 
aspects of the theory and produced mixed results (Cohen-Kettenis & Pfäfflin, 
2003). It is also worth noting that these theories are all based on binary notions of 
gender, in which gender identity and expression is classified as either female or 
male and normal or abnormal. In reality, there is vast overlap in female and male 
behaviour, and what are considered appropriate attitudes or behaviour for a 
particular gender will vary within and between families and cultures (Wilson, 
Griffin, & Wren, 2002). 
 
In early follow-up studies with people with DSD (Money, Hampson, & Hampson, 
1955) the importance of biological factors were acknowledged, but researchers 
believed that gender identity aligned with that of rearing, and nurture was thought 
to overrule nature. As such, gender reassignment surgery was performed on 
babies with DSD to create sex-compatible external genitalia, with the idea that 
children would label themselves a girl or a boy, and develop a corresponding self-
image (Blizzard, 2002; Money et al., 1955). However, later research found that 
children with DSD who were operated on and raised in this way sometimes 
developed gender identity problems, which suggests that biological factors play a 
greater part than previously thought. However, a more recent review of gender 
identity outcomes in people with DSD (de Vries et al., 2007), after a 
chromosomally opposite gender assignment, gender change only occurred in 
42% of people; and the initial gender assignment remained the best predictor of 
gender identity in adulthood. Taken together these findings suggest that gender 
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identity is influenced by a combination of gender assignment and concomitant 
social and psychological factors (de Vries et al., 2007, 2014). 
 
In order to make sense of the different biological, psychological and social factors 
involved in gender diverse identity development, it is important to keep in mind 
that there is considerable variability in gender diverse development, in terms of 
age of onset, sexual orientation, presence/absence of comorbid conditions (e.g. 
autism), gender expression and behaviour, presence/absence of dysphoria (and 
intensity of dysphoria), desire (or not) for gender affirming intervention etc. – all of 
which may reflect different causal pathways (de Vries, Noens, Cohen-Kettenis, 
Van Berckelaer-Onnes, & Doreleijers, 2010). At present, it is unclear whether 
these represent distinct groups or are part of a gender diverse continuum. 
Increasingly, gender diversity is considered part of nature’s diversity (Ehrensaft, 
2016). However, while many people are content with a gender diverse identity; a 
minority of people are distressed by it.   
 
1.4 . Gender Dysphoria 
 
Gender dysphoria refers to the clinical distress that some people experience as a 
result of the discrepancy between their experienced gender or gender idenitity 
and the gender they were assigned at birth (Steensma et al., 2013). Gender 
dysphoria replaced the previous diagnostic category (gender identity disorder) to 
avoid pathologising identity. Nonetheless, gender dysphoria is still considered a 
diagnosable mental disorder, and although highly controversial, is still listed in the 
most recent DSM 5 (American Psychiatric Association, 2013).  
 
In children, the DSM 5 (American Psychiatric Association, 2013) describes 
Gender Dysphoria as a strong desire to be of the other gender/insistence that 
he/she is the other gender (or another gender). Plus at least five of the following: 
1. A (strong) preference for cross-dressing; 2. Cross-gender roles in make-
believe play; 3. A preference for toys/games of the other gender; 4. Playmates of 
the other gender; 5. Rejection of gender typical play; 6. Dislike of sexual anatomy; 
7. Desire for primary and/or secondary sex characteristics that match one’s 
experienced gender. 
21 
 
In adolescence/adulthood, Gender Dysphoria is described as a marked 
incongruence between a person’s experienced/expressed gender and their 
assigned gender (usually assigned at birth) for at least 6 months duration, as 
manifested by two or more of the following: 1. A marked incongruence between 
one’s experienced/expressed gender and primary and/or secondary sex 
characteristics. 2. A strong desire to be rid of one’s primary and/or secondary sex 
characteristics because of marked incongruence with one’s 
experienced/expressed gender. 3. A strong desire for the primary and/or 
secondary sex characteristics of the other gender. 4. A strong desire to be of the 
other gender (or some alternative gender different from one’s assigned gender). 
5. A strong desire to be treated as the other gender (or some alternative gender 
different from one’s assigned gender). 6. A strong conviction that one has the 
typical feelings and reactions of the other gender (or some alternative gender 
different from one’s assigned gender). Gender dysphoria is associated with 
clinically significant distress or impairment in social, occupational, or other 
important areas of functioning, or with a significantly increased risk of suffering, 
such as distress or disability (American Psychiatric Association, 2013). It is 
important to note that not all gender diverse people experience gender dysphoria, 
and for those that do it does not necessarily persist throughout the person’s life 
(Coleman et al., 2012).  
 
Studies show that in children assigned male at birth, 73-98% of gender identity 
difficulties starting in childhood do not continue past adolescence/early adulthood, 
and in children assigned female at birth, they do not continue in 50-88% of cases 
(Ristori & Steensma, 2016; Wallien & Cohen-Kettenis, 2008). Childhood gender 
dysphoria is strongly associated with a lesbian, gay or bisexual identity around or 
after puberty, and this can account for some of the desistance post puberty 
(Ristori & Steensma, 2016). However, other explanations for the variability 
include variation in intensity of the gender dysphoria across studies (i.e. some 
studies have used clinically referred samples whereas others have not); cultural 
variation in referrals (e.g. in some countries boys are referred more than girls, and 
if this is due to gender diverse behaviour been seen as more problematic in boys 
than girls then this could lead to higher rates of boys with less severe gender 
dysphoria than in other countries); and time at follow-up (Ristori & Steensma, 
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2016). Not much is known about the factors associated with persistence. Studies 
suggest that, on a group level, persistence is closely associated with the intensity 
of the gender dysphoria and the amount of cross-gendered behaviours shown, 
but the predictive value of these factors on an individual level are less clear, and 
thus have little clinical utility (Drummond, Bradley, Peterson-Badali, & Zucker, 
2008).  
 
Some children express a desire to socially transition to their experienced gender 
role in early childhood, long before reaching puberty. Social transitions in early 
childhood are controversial, with divergent views held by healthcare professionals 
(Coleman et al., 2012). The current evidence base is limited and insufficient in 
terms of being able to predict the long-term outcomes of social transitions in early 
childhood (Coleman et al., 2012). Furthermore, the current literature on social 
transitions is often based on a binary model of gender (Newman, 2002). 
Increasingly young people identify in a diversity of ways and many have begun to 
question and reject more traditional assumptions and roles associated with 
gender identities (NHS England, 2015).   
 
Conversely, gender dysphoria that starts in or continues through adolescence, is 
much more likely to continue into adulthood (de Vries, et al., 2014). Over the last 
decade, the age at which adolescents start socially transitioning has decreased 
(NHS England, 2015). The evidence base regarding physical interventions is 
limited and still developing. Not all people with gender dysphoria choose physical 
intervention, but little is known about those that do (NHS England, 2015). 
Findings on regret after physical intervention are mixed, with some studies 
reporting regret rates between 0.3% and 2.2% (Dhejne, Öberg, Arver, & Landén, 
2014; Wiepjes et al., 2018) and others finding little or no evidence of regret 
(Imbimbo et al., 2009).  
 
It is important to note, however, that the notion of desistance and persistence is 
problematic as it serves to perpetuate an unhelpful binary model of gender 
(Newman, 2002; Wiseman & Davidson, 2012). In western contexts, gender 
expression is considered binary and prescriptive, such that females and males 
are expected to behave in feminine and masculine ways. The conflation of 
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biological terms and the use of feminine and masculine language positions 
gender expression as a natural phenomenon, rather than a socially constructed 
one. This naturalistic discourse perpetuates the unhelpful binary model of gender, 
in which gender diverse behaviour is seen as pathological (Newman, 2002; 
Wiseman & Davidson, 2012).  
 
1.5. Prevalence of Gender Diversity 
 
The exact prevalence of people with gender dysphoria or who identify as trans is 
unknown, but several studies have provided estimates (Achenbach & Rescorla, 
2003; Arcelus et al., 2015; Clark et al., 2014; Shields et al., 2013).  
 
1.5.1. Children and Adolescents 
To date, no epidemiological studies have been conducted on the prevalence of 
Gender Dysphoria in children or adolescents (Zucker, 2017). Using the 1999 
standardisation sample for the Child Behavior Checklist (CBCL) for children ages 
6-18 (n = 1822) who had and had not been referred to gender identity services, 
Achenbach and Rescorla (2003) found that less than 1% of non-referred boys 
and 1.2% of non-referred girls endorsed the item ‘Wishes to be of opposite sex’. 
Estimates were higher for referred boys (2.7%) and girls (4.7%). In terms of self-
identification, a random sample of 2730 adolescents in the US found that 1.3% 
identified as transgender (Shields et al., 2013); and similarly, in New Zealand, a 
nationally representative youth survey on the prevalence of transgenderism in 
adolescents (n = 8166) found that 1.2% identified as transgender and 2.5% were 
not sure about their gender (Clark et al., 2014). More recently, in a sample of 
81,885 US high school students, 3.6% of birth-assigned females and 1.7% of 
birth-assigned males responded ‘yes’ to the question ‘Do you consider yourself 
transgender, genderqueer, genderfluid or unsure about your gender identity?’.  
 
1.5.2. Adults 
In a national probability sample study in the US (n = 151,456), the proportion of 
adults who identified as transgender was estimated at 0.5% (Crissman, Berger, 
Graham, & Dalton, 2017). In a recent systematic review of 21 prevalence studies 
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of transsexualism (term used by authors) conducted primarily in adult clinic 
populations around the world, the prevalence of transsexualism varied from 0.45 
to 23.6 per 100,000 people. The meta-analytical prevalence (including 12 
prevalence studies) was 4.6 in 100,000 people (1 in every 21,739); 6.8 for trans-
women (1 in every 14,705) and 2.6 for trans-men (1 in every 38,461). Time 
analysis demonstrated that reported prevalence has increased over the last 50 
years (Arcelus et al., 2015). It is unclear whether the increase in prevalence 
reflect an actual increase or whether it simply reflects that people feel more 
comfortable coming out due to increased social acceptance, decreased 
pathologisation, and greater awareness of therapeutic options available, such as 
psychological support and gender-affirming medical intervention (Zucker, 2017). 
The majority of the studies included in the review were conducted in Western 
European countries, which may reflect a combination of greater socio-cultural 
acceptance of trans people, greater availability of trans-related services, an 
academic interest in trans healthcare, and the presence of legislation relating to 
trans-rights (Arcelus et al., 2015). However, it is worth noting that the notion of 
tolerance in this context is potentially misleading, as there is a reported increase 
in trans people in countries where being gay is unacceptable or illegal.  
 
There are a number of possible reasons for the variability in prevalence 
estimates, including changes to diagnostic criteria and corresponding 
language/terminology (e.g. gender identity disorder, transsexualism and gender 
dysphoria), variability in who/what is being measured (e.g. people with gender 
dysphoria versus people who identify as trans), variability in the type of 
prevalence recorded (e.g. point prevalence versus period prevalence), 
differences in study population (e.g. community versus clinical), and variability in 
awareness/cultural norms (across cultures and time) that allow trans people to be 
more or less visible and able to access services (Arcelus et al., 2015). Due to a 
combination of these factors, prevalence studies often focus on more easily 
identifiable clinical populations (Zucker & Lawrence, 2009), which has led to an 
overrepresentation of prevalence studies from western countries – despite the 
presence and acceptance of gender diverse people and communities in countries 
such as Thailand, India and Pakistan. Notwithstanding the difficulties associated 
with obtaining accurate prevalence estimates, the aforementioned studies 
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demonstrate a global, and increasing presence of people with gender dysphoria 
or who identify as trans.  
 
1.6. Substantial Increase in Referrals to Gender Identity Services 
 
In recent years, there has been a dramatic increase in the number of referrals to 
both child/adolescent and adult clinics in Europe and North America (Aitken et al., 
2015; Butler, De Graaf, Wren, & Carmichael, 2018; Chen et al., 2016; de Vries & 
Cohen-Kettenis, 2012; Kaltiala-Heino, Bergman, Työläjärvi, & Frisén, 2018). 
Factors thought to explain this increase include a lowered threshold for 
helpseeking due increased knowledge and decreased stigmatisation of gender 
diversity; increased awareness of the medical and surgical interventions 
available; increased service provision; and sociocultural features relating to what 
identities are available for whom, as well as sex-related differences in pressure to 
conform (Aitken et al., 2015; Kaltiala-Heino et al., 2018). The large increases in 
the number of referrals has put considerable pressure on existing services. Wait 
times to access services continue to rise, along with the distress levels of those 
waiting for support and intervention (Davies et al., 2013; Ellis, Bailey, & McNeil, 
2015).  
 
Alongside the increase in referrals, have been changes in the profile of young 
people presenting to services. Over the last decade, adolescent clinics around 
the world have observed a shift in the sex ratio of the young people who present 
to the clinics with gender dysphoria – from a previously observed larger 
proportion of assigned males, to a now seen larger proportion of assigned 
females (Aitken et al., 2015; Butler et al., 2018; Kaltiala-Heino, Sumia, Työläjärvi, 
& Lindberg, 2015). The reason for this inverted sex-ratio remains unclear, but it 
has been suggested that it might be easier for assigned females to come out as 
trans than assigned males because although trans identities are becoming more 
accepted, there is still more stigmatisation of cross-gender behaviour in boys than 
in girls (Aitken et al., 2015). Another possibility, in a world where the gender 
equality gap is widening rather than narrowing, it could be that male status is still 
preferable (Butler et al., 2018).  
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Other changes in profile include an increase in young people presenting in their 
mid-teens with no prior history of gender dysphoria, young people (particularly 
assigned females) with increased clinical risk and complexity, greater prevalence 
of marked ASD features (particularly in assigned females), and a greater variety 
of different identities, such as non-binary or gender queer identities (De Vries et 
al., 2010; Kaltiala-Heino, Bergman, Työläjärvi, & Frisén, 2018; Kaltiala-Heino, 
Sumia, Työläjärvi, & Lindberg, 2015; Zucker et al., 2016). 
 
1.7. Intervention and Support 
 
The provision of medical intervention to children and adolescents is an area of 
considerable debate and contention. Adolescence is a period of rapid and 
dramatic physical, psychological and sexual development, and with regards to 
gender identity, there can be considerable fluidity and variability in outcomes, 
particularly in pre-pubertal children (Coleman et al., 2012). The inability to predict 
people’s gender identity trajectories makes intervention decisions complex. 
 
Although it is generally agreed that intervention with children and adolescents 
should involve a comprehensive multi-disciplinary approach, due to a lack of long-
term follow-up studies, there is currently no consensus as to which approach to 
clinical care constitutes best practice (Chen et al., 2016; Coleman et al., 2012; 
Hembree, 2011). However, from a psychological perspective, it is agreed that 
intervention (via individual, group or family therapy) should focus on exploring 
gender identity, role and expression; reducing the young person’s distress 
regarding the gender dysphoria; addressing any other psychological difficulties; 
enhancing social and peer support; and optimizing the person’s psychological 
adjustment, resilience and wellbeing (Byne et al., 2012; Coleman et al., 2012).  
 
1.7.1. Medical Intervention 
With regards to physical intervention with young people in the UK, the number 
and type of interventions a person receives, and the order in which they take 
place will vary from person to person; but broadly, a staged approach is followed 
whereby reversible interventions precede irreversible interventions, in 
combination with ongoing psychological support – sometimes referred to as “the 
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Dutch model” (Coleman et al., 2012; Delemarre-van de Waal & Cohen-Kettenis, 
2006; Hembree et al., 2009, 2017). After a comprehensive psychological 
evaluation, the first stage of physical intervention may involve administering 
hormone blockers (gonadotropin-releasing hormone antagonists or GnRH) to 
adolescents who experience profound and persistent gender dysphoria. Hormone 
blockers suppress puberty, the aim of which is to relieve immediate distress by 
preventing the development of unwanted secondary sexual characteristics, and to 
allow more time for the young person to explore their gender identity (GIRES, 
2014; Wylie et al., 2014); this intervention is considered fully reversible (Wylie et 
al., 2014), but the potential long-term effects on brain and cognitive development 
are unclear (Sadjadi, 2013). The onset of puberty marks a critical diagnostic 
stage for gender dysphoria. In many pre-pubertal children gender dysphoria does 
not continue post-puberty, whereas gender dysphoria in adolescence is much 
more likely to continue into adulthood (de Vries, Steensma, Doreleijers, & Cohen-
Kettenis, 2011; Steensma, Biemond, De Boer, & Cohen-Kettenis, 2011). 
Hormone blockers are generally only started after a person has entered the early 
stages of puberty (i.e. Tanner stages 2-3) – and only if the person has a history of 
gender dysphoria, there are no psychosocial problems that would interfere with 
assessment or intervention, they have adequate social support, and a good 
understanding of the impact of medical interventions (Cohen-Kettenis, Steensma, 
& de Vries, 2011). In adolescents with gender dysphoria, both psychological 
support and puberty suppression have been shown to improve global 
psychosocial functioning and wellbeing (Costa et al., 2015; de Vries et al., 2011, 
2014).   
 
If a young person’s gender dysphoria persists and further criteria are met (i.e. 
self-harm is not escalating, the person has capacity to consent, fertility 
preservation has been explored etc.) the next intervention offered would be cross-
sex hormones, which masculinise or feminise the body; this intervention is 
partially-reversible (but does lead to infertility if fertility preservation is not sought 
beforehand) and typically offered to people aged 16 and over. Research suggests 
that cross-sex hormone therapy reduces symptoms of anxiety and dissociation, 
lowers perceived and social distress, and improves quality of life and self-esteem 
in both assigned females and assigned males (Costa & Colizzi, 2016). The third 
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interventions offered would be surgeries, which are largely irreversible and 
typically offered to those aged 18 and over (Coleman et al., 2012). The majority of 
longitudinal studies investigating people pre- and post-surgery (between 2-13 
years post-surgery) show results that point towards the benefits of gender 
affirming surgery (Dhejne, Van Vlerken, Heylens, & Arcelus, 2016), with levels of 
psychopathology and gender dysphoria in participants similar to normative data 
(De Cuypere et al., 2006; Johansson, Sundbom, Hojerback, & Bodlund, 2010; 
Pimenoff & Pfäfflin, 2011; Ruppin & Pfäfflin, 2015; Smith, Van Goozen, Kuiper, & 
Cohen-Kettenis, 2005). 
 
1.7.2. Ethical Dilemmas Surrounding Medical Intervention with Adolescents 
Adults are offered similar physical interventions to adolescents, but there are key 
differences and dilemmas in the approaches to assessment and intervention 
between adults and adolescents. Adults are seen to be competent to make 
decisions about physical interventions, and the current challenges in adult care 
relate to moving gender identity away from psychiatry and an association with 
mental health, towards a consent based model of care (Bockting, 2009). When 
considering physical interventions for young people, the concerns are related to 
age and capacity (Byne et al., 2012; Vrouenraets, Fredriks, Hannema, Cohen-
Kettenis, & de Vries, 2015). Physical maturation and psychological maturity 
associated with age are key determinants of eligibility and readiness for physical 
interventions, and it is the gap between these that characterises the potential 
dilemmas associated with assessment and intervention in adolescents.  
 
There has been a gradual trend towards providing physical interventions earlier, 
but this is trend is hotly debated (Cohen-Kettenis, Delemarre-van De Waal, & 
Gooren, 2008; Delemarre-van de Waal & Cohen-Kettenis, 2006; Ehrensaft, 2016; 
Hidalgo et al., 2013; Vrouenraets et al., 2015; Wren, 2000). Arguments in favour 
of earlier intervention point to the profound distress (including depression, 
suicidality and self-harm) experienced by many adolescents with gender 
dysphoria; distress that can increase at the onset of puberty due to the 
development of secondary sex characteristics and the increasing social divisions 
between genders; distress that can be exacerbated by the delayed wait for 
physical intervention (Costa, Carmichael, & Colizzi, 2016; Giordano, 2008; 
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Kreukels & Cohen-Kettenis, 2011; Vrouenraets et al., 2015). Preliminary evidence 
suggests early transitions can lead to positive outcomes (McNeil, Bailey, Ellis, 
Morton, & Regan, 2012), including a physical appearance that reportedly makes it 
easier to be accepted as a member of a particular gender compared with people 
who began physical intervention in adulthood (Kreukels & Cohen-Kettenis, 2011).  
 
Arguments against earlier intervention include concerns that gender identity is still 
developing in adolescence and may fluctuate/change in the long-term; that early 
intervention may inhibit spontaneous formation of a stable gender identity, which 
can develop through a crisis of gender; potential negative implications for 
physical, reproductive and CNS development, and psychological and 
psychosexual functioning; impact on sexuality (i.e. blocking hormones may 
prevent age-appropriate socio-sexual experiences and exploration of sexual 
orientation); the importance of social context in the shaping how a person 
experiences their gender diversity; and the question as to who is able to give 
informed consent (Hembree et al., 2009; Kaltiala-Heino et al., 2018; Kreukels & 
Cohen-Kettenis, 2011; Vrouenraets et al., 2015; Wylie et al., 2014) 
 
Adolescence is a time of significant developmental change. It is a process of 
complex adjustment to major physical and emotional changes, as well as 
increased responsibility and societal expectations in relation to gender. This 
developmental period is associated with vulnerability to risk taking, poor impulse 
control, black and white thinking, and a hyper-responsive reward system 
(Ausubel, 2002). Research also suggests that decision-making in adolescence 
may be influenced by emotion and social factors, particularly in peer and ‘hot’ 
contexts (Blakemore & Robbins, 2012). In the face of these complexities, the 
degree to which a minor can consent to medical interventions that will have long-
term, potentially irreversible consequences, will vary greatly from person to 
person. 
 
The narrative about the importance of earlier medical intervention is a powerful 
one – one that is currently playing a significant role in shaping public opinion, and 
the direction of the field. Trans people who did not receive medical intervention in 
adolescence are often portrayed as inherently damaged because of it; this 
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narrative locates the cause of the suffering within the body/person, as a result of 
puberty, and what tends to be missing from these debates and narratives are the 
social conditions (i.e. increasing gender differentiation among friendships groups; 
institutional and social discrimination, marginalisation, bullying, transphobia, being 
mis-gendered etc.) in which the suffering (i.e. distress, self-harm, worries about 
‘passing’ or others finding out etc.) has developed (Hendricks & Testa, 2012). As 
Wren states (2014), ‘Is this the medicalising of psychological and social ills or are 
young trans people the ultimate authority on their gender and their relationship to 
their body?’. The debate will not be settled anytime soon, but nevertheless, the 
de-contextualizing of young trans people’s experience may lead clinicians to miss 
key causal factors of distress; it also runs the risk of positioning puberty 
suppression as a ‘magic bullet’, and may make potential harms of intervention 
more difficult to ascertain (Sadjadi, 2013).  
 
Another contextual factor that requires more thought and attention, are the ways 
in which the binary gender discourse is bound up with medical and surgical 
intervention (Newman, 2002; Wiseman & Davidson, 2012). As mentioned 
previously, binary notions of gender underpin the pathologising of gender 
diversity (Newman, 2002; Wiseman & Davidson, 2012). With the changing profile 
of young people’s gender identities, the predicted trajectories are less clear. 
Some people who experience difficulties with their gender identity may not 
necessarily experience a complete cross-gender identity, and with the diverse 
ways people are now identifying (i.e. non-binary, gender queer, gender fluid etc.) 
not all will seek intervention. In those that do, some may opt for only part of the 
‘gender reassignment package’. For example, taking cross-sex hormones but not 
having any surgery, or electing to have top surgery but not bottom (Steensma et 
al., 2013).  
 
While a small body of literature exists on the outcomes of gender-affirming 
interventions in adults, very little is known about the longer-term outcomes in 
adolescents and young adults who have received intervention. As long as there 
are limited long-term data in support of current guidelines, the above dilemmas 
will continue to exist, and consensus on intervention is not likely to be reached 
(Vrouenraets et al., 2015).   
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1.8. Scoping Review of Follow-Up Studies of Gender Diverse Adolescents 
and Young Adults  
 
Scoping reviews are a particularly useful way of determining the range of 
evidence that informs practice in a field and how the research has been 
conducted, as well as clarifying key concepts, and identifying gaps in the 
research literature (Arksey & O’Malley, 2005; Peters et al., 2015).  
 
1.8.1. Objective 
The objective of the scoping review was to explore the current literature on 
longer-term outcomes of adolescents and young adults who had received some 
form of gender affirming intervention.  
 
1.8.2. Inclusion Criteria 
The scope of the review was developed by defining inclusion criteria for 
participants, interventions, study design and outcomes (Peters et al., 2015). Due 
to resource limitations papers not written in English were excluded.  
 
1.8.2.1. Participants. Studies that included gender diverse adolescents or young 
adults who had received some form of gender-affirming intervention.  
 
1.8.2.2. Interventions. Gender-affirming interventions, including hormone 
blockers, cross-sex hormones, surgery and psychological support.   
 
1.8.2.3. Study Design. All quantitative and qualitative designs. 
 
1.8.2.4. Outcomes. Outcomes of interest included intervention pathways chosen, 
satisfaction (with chosen interventions, body, gender identity, and services), 
decision-making processes, psychological functioning and mental health, global 
functioning, quality of life and wellbeing. 
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1.8.3. Search Strategy 
The overall search strategy was performed in three stages. First, a limited search 
in several databases was performed to determine the relevant terms and index 
terms used. Second, using the identified keywords and index terms published 
work was searched for in 6 electronic databases. Third, reference lists of the 
identified papers were searched to identify any further relevant work. All 
databases were searched from their start date to April 2018 with no language 
restrictions.  
 
The search strategy consisted of two overlapping concepts that were searched 
together using the Boolean operators ‘or’ and ‘and’ (MESH headings were also 
added in databases that contained them). 
 
1. Gender terms (transgender or transsexual or ‘gender varian*’ or ‘gender in-
congruen*’ or ‘gender incongruen*’ or ‘gender dysphori*’ or ‘gender 
divers*’) 
 
AND 
 
2. Time/treatment terms (treatment pathway* or ‘treatment decision*’ or 
‘treatment choice’ or longitudinal or ‘long term effect’ or ‘long term 
outcome*’ or ‘long term follow up’ or ‘long term follow-up’ or prospective or 
retrospective or ‘cross section*’ or ‘follow up’ or’ follow-up’) 
 
 
1.8.4. Databases 
The 6 databases searched included Academic search complete, CINAHL, PEP 
archive, PsychINFO, PubMed, and Scopus.  
 
1.8.5. Validation of Search Strategies 
The search strategy was validated by choosing five known papers from a 
previously conducted (unpublished) review in the area, and seeing if the search 
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strategy picked these known papers up. All five papers were picked up by the 
search.  
 
1.8.6. Extracting and Charting the Results 
All citations identified by the searches were downloaded using Mendeley 
reference management software, and the duplicates removed. The titles and 
abstracts were screened for relevance and potential inclusion in the review using 
the inclusion and exclusion criteria. Full texts were obtained for any potentially 
relevant papers.   
 
1.8.7. Data Extraction and Management 
The data extraction form was developed using scoping review guidelines (Peters 
et al., 2015). Data extracted included information about participants, the 
interventions, study design and outcomes relevant to the review.  
 
1.8.8. Results 
After importing all citations to Mendeley and removing duplicates, 4858 records 
had been identified. After inspecting titles and abstracts, 4785 irrelevant papers 
were removed, and full texts were retrieved for the remaining 73 papers. A further 
two papers were added through hand searching (n = 75). After excluding 70 
irrelevant papers using the inclusion/exclusion criteria, five studies remained in 
the final review (see Appendix A for flow chart, including reasons for exclusion).  
 
The included studies (N = 5) were all published between 1997 and 2018. Based 
on country of lead author, studies were conducted in four countries: UK (1), 
Netherlands (3), and USA (1). The range of mean ages of the participants in the 
included studies was 15.0 to 22.0, and all had received one or more of the 
following interventions: psychological support (1 study), hormone blockers (4 
studies), cross-sex hormones (2 studies), and surgeries (2 studies). Outcomes 
assessed by the studies were gender dysphoria (4 studies), psychological 
functioning (4 studies), global/psychosocial functioning (3 studies) depression (1), 
anxiety (1 study), anger (1 study), psychopathology (1 study), wellbeing (1 study), 
quality of life (1 study), satisfaction with surgery (1 study), regret (2 studies), and 
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body-satisfaction (3 studies). The study designs were all observational 
longitudinal cohort studies. Brief summaries of each study (N = 5) are provided 
below.  
 
Study 1 (Cohen-Kettenis & Goozen, 1997): Cohen-Kettenis and colleagues 
followed-up 19 young people (mean age = 22.0 years), with a diagnosis of 
transsexualism, between one and five years after undergoing a gender affirming 
surgery. Post-surgery, the group were no longer gender-dysphoric, and scored in 
the normal range on a number of different psychological function measures. 
Assigned females reported varying levels of satisfaction in their top surgery 
results (40% satisfied; 50% moderately satisfied; and 10% dissatisfied), and 60% 
were satisfied with their body image. All of the assigned males were satisfied with 
their body image, and 60% were satisfied with the results of their vaginoplasty 
surgery. No-one reported regretting having surgery. Limitations of the study 
include its small sample size.  
 
Study 2 (deVries, Steensma, Doreleijers & Cohen-Kettenis, 2011): deVries and 
colleagues followed up 70 young people (mean age = 16.6 years), on average, 2 
years after they had received hormone blockers, but before starting cross-sex 
hormones. At follow-up, general functioning had improved, and behavioural, 
emotional and depressive symptoms had decreased. No change was observed in 
participants’ gender dysphoria, body satisfaction, levels of anxiety or anger. 
Limitations of the study include a relatively small sample, and, in terms of 
generalisability, the use of a highly select dysphoric sample (i.e. well-adjusted, 
with few comorbidities).   
 
Study 3 (deVries et al., 2014): This study was a longer-term evaluation of study 2 
above, in which deVries and colleagues followed up 55 young people at three 
time points: Before starting hormone blockers (mean age = 13.6 years), when 
starting cross-sex hormones (mean age = 16.7 years), and at least one year after 
receiving gender affirming surgery (mean age = 20.7 years). The results indicated 
that gender dysphoria and body image difficulties persisted during puberty 
suppression, but remitted after taking cross-sex hormones and undergoing 
gender affirming surgery. Over time, assigned females showed reduced anger, 
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anxiety and externalising symptoms, whereas assigned males showed stable or 
slightly more symptomology on these measures. Through the course of the study, 
psychological functioning steadily improved, and these improvements correlated 
with post-surgical subjective wellbeing. No-one reported regretting receiving any 
of the interventions. Limitations of the study included a relatively small sample 
from a single clinic, and the highly select dysphoric, but well-adjusted sample who 
had few comorbidities (i.e. the sample was not representative of the full spectrum 
of gender diverse individuals).   
 
Study 4 (Costa et al., 2015): Costa and colleagues followed up 201 young people 
with gender dysphoria at four time points: Baseline (mean age = 15.5 years); 6 
months from baseline (mean age = 16.5 years) after 6 months of psychological 
support; 12 months from baseline, after 12 months of psychological support and 6 
months of puberty suppression; 18 months from baseline, after 18 months of 
psychological support and 12 months of puberty suppression. Psychological 
support and puberty suppression were both associated with improvements in 
global functioning. Limitations of the study included only focussing on 
psychosocial functioning as an outcome and a question as to the clinical 
significance of the significant findings.  
 
Study 5 (Mathews, Kuper & Lau, 2018): Mathews and colleagues followed up 31 
adolescents (mean age = 16.0 years), one year after taking cross-sex hormones 
(n = 28) or hormone blockers (n = 3). At follow-up, 63% of the sample retained 
clinically elevated competency issues and 19% reported internalizing difficulties. 
Mothers of the participants reported significantly fewer externalizing and total 
problems. No statistically significant improvements were reported by the young 
people themselves, or by fathers.  
 
Overall, these longitudinal follow-up studies suggest that gender dysphoria and 
body difficulties tend to remit after intervention involving cross sex hormones or 
surgery, but not hormone blockers. The majority of people report feeling satisfied 
with surgical outcomes (although this was only assessed in one study). The 
impact of different interventions on psychological and global functioning is less 
36 
 
clear, as it appears to vary within and between studies. The observed variation 
may be partially explained by differing severity of symptoms at baseline, baseline 
differences in comorbidities, and/or differing levels of support (social and 
psychological).  
 
1.9. Rationale and Clinical Relevance 
 
The current evidence-base is of limited utility in the contemporary UK context – 
the number of follow-up studies of adolescents into young adulthood is small, and 
much of the research that does exist has been conducted with small samples, in 
primarily non-UK populations, and focussing on a limited number of outcomes. To 
date, although a few studies have looked at the prevalence of gender affirming 
intervention in adults (Eyssel, Koehler, Dekker, Sehner, & Nieder, 2017; Kailas, 
Lu, Rothman, & Safer, 2017), no-one has done so in adolescents or young adults. 
And although one study has looked at satisfaction with surgical outcomes in 
young adults (Cohen-Kettenis & Van Goozen, 1997), no studies have looked at 
satisfaction with the process more broadly (i.e. satisfaction with decisions made 
about interventions, level of involvement in decision-making, information/advice 
received, timings and length of process etc.). Shared decision-making is seen as 
an ethical imperative by health professional regulatory bodies, and the principal 
mechanism for ensuring patients get the care they want and need (Coulter & 
Collins, 2011); and there are some key drivers for shared decision-making within 
the National Health Service (NHS) policy (NHS England, 2014, 2017). 
Furthermore, satisfaction with the process and involvement in decision-making  
have been cited as key indicators of quality and success in trans healthcare, and 
ones that are integral to evolving relationships between service users and 
clinicians (Eyssel et al., 2017). Measurement of patient experiences of trans-
healthcare, provides the opportunity for reflection and improvement of care and 
patient outcomes, and this has not yet been conducted in young trans people who 
attended a child and adolescent gender identity clinic and who were referred 
onwards to an adult clinic.    
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1.9.1. The Gender Identity Development Service (GIDS)  
The Gender Identity Development Service (GIDS) is the site of the current study. 
The GIDS is one of the largest child and adolescent services in Europe. Based at 
the Tavistock Centre in London, the service offers assessment and intervention 
for children and young people (up to the age of 18), who are experiencing 
difficulties with their gender identity development. The multidisciplinary team 
consists of clinical psychologists, psychiatrists, social workers, child 
psychotherapists, and paediatric and adolescent endocrinologists. The GIDS was 
nationally commissioned by NHS England in 2009; its main bases are in London 
and Leeds, but outreach clinics are located in other areas of the England and 
Wales (Butler et al., 2018; Carmichael & Davidson, 2009). The intervention and 
support provided at GIDS is informed by the World Professional Association for 
Transgender Health (Coleman et al.,  2012) and recent guidelines from the 
Endocrine Society (Hembree et al., 2009). In line with other services in Europe 
and North America, the GIDS has experienced a dramatic increase in the number 
of referrals it receives, and a change in profile of the young people who attend the 
service (Butler et al., 2018). Little is currently known about the longer-term 
outcomes of the young people who attended the GIDS (Butler et al., 2018; Costa 
et al., 2015). These factors, in combination with the GIDS’ influence and reach in 
the UK, places the GIDS as an ideal location for the current study.  
 
1.9.2. Population of Interest within GIDS 
GIDS is a gender identity development service, and, as such, the young people 
who attend GIDS are a diverse population. Not all people who attend GIDS 
experience gender dysphoria, and for those that do, it does not necessarily 
persist (Coleman et al., 2012). Furthermore, not everyone who attends GIDS will 
experience a complete cross-gender identification and many will identify as non-
binary or gender fluid (or another identity). Only a proportion of those who attend 
GIDS will go on to pursue medical and surgical intervention, and currently very 
little is known about those that do (NHS England, 2015). Therefore, the current 
study focusses on a cohort of ex-GIDS attendees who were referred (at age 18) 
from GIDS to the Charing Cross adult gender identity clinic (CCGIC) where 
medical and surgical interventions could be obtained. Consequently, the findings 
38 
 
and implications of the current study are applicable to this population only and not 
to the broader GIDS population.   
 
To my knowledge, this is the first ever follow-up study of a cohort of gender 
diverse young adults who previously attended a child and adolescent gender 
identity clinic (the GIDS) and who were referred, at age18, to an adult gender 
identity clinic (CCGIC). It is also the first study to investigate the prevalence of 
different gender affirming interventions in a UK clinic-based sample of gender 
diverse young adults; the first to characterise the nature of the interventions by 
assigned gender; and the first to investigate satisfaction levels with the process 
and involvement in decision-making. With such large increases in referrals to 
child and adolescent gender identity clinics, the changing profile of clinic 
attendees, and increasing pressure to intervene earlier, it is vital that we 
understand more about the intervention pathways, satisfaction levels, and longer-
term outcomes of gender diverse young people who go on to pursue further 
intervention after leaving the child and adolescent clinic. The findings will enable 
better tailoring of gender identity services for young people, and be an important 
step towards ensuring that the support and intervention provided meets the needs 
of this diverse and growing population 
 
1.10. Research Aim and Research Questions 
 
The aim of the research was to determine the intervention pathways, satisfaction 
levels with the process, and longer-term outcomes of the young people who 
attended the GIDS, and who were referred on to the CCGIC.   
 
The research questions are as follows: 
1. Which intervention pathways did people follow after being referred to the adult 
clinic?  
2. What factors influenced people’s intervention decisions? 
3. Were people satisfied with the intervention process? 
4. What are the longer-term outcomes for the former GIDS attendees? 
5. What impact do gender affirming interventions have on body image and 
wellbeing? 
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METHOD 
 
2.1. Chapter Overview 
 
This chapter describes the epistemological position taken in conceptualising, 
designing and conducting the research; the rationale for the chosen methodology; 
and the methods used to collect and analyse the data.  
 
2.2. Epistemological Position 
 
Ontology is the branch of philosophy concerned with the nature of reality and how 
we can understand it (Burr, 2015). Epistemology is the branch of philosophy 
concerned with what constitutes knowledge (e.g. ‘facts’, relationships, causality 
etc.) in addition to how we can make claims of knowing (Burr, 2015).  
 
When thinking about psychiatric diagnoses (e.g. Gender Dysphoria), from a 
positivist position, the ontological assumption would be that ‘mental illness’ exists 
in the world, and awaits verification by expert observers; and the epistemological 
assumption would be that these naturally occurring phenomena are inherently 
pathological (Pilgrim, 2007, 2009). From a constructivist position, the ontological 
assumption would be that reality is socially constructed; and the epistemological 
assumption would be that we can only know about the world through the ways we 
represent it, and that knowledge constitutes accounts and discourses that are 
situated or contingent (Pilgrim, 2007, 2009). 
 
In research, the epistemological position of the researcher states their view on 
what constitutes acceptable knowledge, and is used to frame the research design 
(Darlaston-Jones, 2007). In the current study I take a critical realist position 
(Bhaskar, 2008). Critical realism was developed in response to the limitations of 
both positivism and constructivism (Bhaskar, 2008). The ontological premise 
combines the positivist’s search for evidence of a reality that is independent of 
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human consciousness with the idea that the meaning made of this reality is 
socially constructed (Oliver, 2011); that is to say it is shaped by the cultural, 
historical, political, and social norms that operate within a particular context and 
time (Clark, MacIntyre, & Cruickshank, 2007; Darlaston-Jones, 2007). Critical 
realism accepts our social constructions as the reality of our social worlds (Oliver, 
2011). The epistemological consequence is that knowledge must be approached 
sceptically or critically because our attempts to describe and explain the world 
around us are imperfect, and the ways we order our world, into categories and 
relationships between categories, could never be justified absolutely, and so 
remain open to critique (Scott, 2013).  
 
A critical realist position is particularly relevant to the study of gender identity, as it 
is not possible to conceptualise and account for the experiences of people who 
identify as transgender or non-binary, without acknowledging both the material 
reality of the body (i.e. how it links to gender assignment and expression etc.) and 
the social processes that frame and constrain a person’s gender identity and 
expression (e.g. gender norms that dictate acceptable/unacceptable behaviour 
according to gender, and laws that prohibit self-identification; Brickell, 2006; 
Lorber & Farrell, 1991).   
 
2.3. Methodology 
 
Methodology refers to the tools we use to help us know about the reality we seek 
to explore (i.e. how we generate and analyse data; Green & Thorogood, 2014). 
Quantitative methods are arguably the most appropriate methods to determine 
the frequency of occurrence of particular outcomes and experiences, therefore, a 
cross-sectional survey design was used to determine the intervention pathways 
and longer-term outcomes of young adults who had previously attended GIDS 
and who were referred to the CCGIC. Qualitative methods aim to make sense of 
phenomena, in terms of exploring the meaning people make of their experiences 
(Greenhalgh & Taylor, 1997), and therefore participants were provided with 
comment boxes throughout the questionnaire, and invited to use them to expand 
on and provide context to their quantitative answers. The qualitative data were 
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organised into codes and themes by question, and used to provide context or to 
elucidate specific issues identified by the quantitative data of the question.   
 
2.4. Study Design 
 
The study used a cross-sectional survey design. 
 
2.5. Ethical Considerations 
 
2.5.1. Ethical Approval 
Ethical approval was obtained from the London Riverside National Health Service 
research ethics committee (REC reference number 17/LO/1674; see Appendix B) 
and sponsorship and indemnity was provided by the University of East London 
(see Appendix C).   
 
2.5.2. Informed Consent  
An information sheet was provided at the start of the questionnaire (Appendix D), 
and potential participants were encouraged to discuss the study with their friends 
and family before agreeing to participate. After reading the information sheet, 
participants were required to sign an online consent form (Appendix E) before 
proceeding with the questionnaire.  
 
2.5.3. Confidentiality and Anonymity 
No personally identifiable data was collected during the course of the study, 
except for the email addresses of the participants who wished to be entered into 
the prize draw to win £100 worth of Amazon vouchers and those who wished to 
be sent the results at the end of the study. Any email addresses provided were 
held separately from the questionnaire data and not linked in any way. All 
participant data was treated confidentially and in accordance with the Data 
Protection Act 1998. All participant data was stored on a password-protected 
computer. Unique participant identification numbers were used on the 
databases/programmes used for analysis. 
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2.5.4. Protecting Vulnerable participants 
For multiple reasons gender diverse individuals sometimes change their identity 
and relocate. To minimise the risk of sending potentially sensitive written material 
to the wrong person, most recent addresses were obtained from the CCGIC client 
records. Furthermore, the invitation letter that was sent in the mail did not contain 
any information or references to gender identity or gender identity clinics.  
 
Reflecting on one’s views and experiences in this area has the potential to be an 
informative and empowering experience. However, it is a potentially sensitive 
topic, as many people will have experienced significant distress, challenges, 
victimisation and stigma with regards to their gender identity/expression. At the 
end of the questionnaire, all participants were provided with a list of support 
services and encouraged to use them if they felt they needed additional support 
at any time. 
 
2.6 Population and Sample  
 
The population of interest were the 365 people who were discharged, at age 18, 
from GIDS and referred to the CCGIC between 2011 and 2016 (mean age = 19.9 
years; SD 1.79; 95% CI 19.9 to 20.1%). Of this population, 64.7% were assigned 
female (AF) at birth (n = 236; mean age 19.7 years; SD 1.79; 95% CI 19.5 to 
19.9%) and 34.8% were assigned male (AM) at birth (n = 127; mean age = 20.2 
years; SD = 1.79; 95% CI 19.8 to 20.5%). Details of ages and gender assigned at 
birth were unavailable for two of the 365 referred. Of this group, one person was 
deceased and one did not have a postal address. Invites to participate in the 
online questionnaire were sent out via post to the remaining 363 people.   
 
2.7. Procedure 
 
2.7.1. Inclusion/Exclusion Criteria  
Clinic attendees referred to the CCGIC before 2011 were not invited to participate 
in the study, as clinic records prior to 2011 were reportedly unreliable. Clinic 
attendees referred to the CCGIC after 2016 were also not considered, as, due to 
waitlist times at the CCGIC, it was unlikely that many of these people would have 
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had any surgical interventions by the start date of data collection. Due to limited 
resources, non-English speakers were excluded from the study. People under the 
age of 18 were also excluded from participating.  
 
2.7.2. Participant Identification Process.  
All eligible participants were identified using the GIDS patient database. Names 
and postal addresses of clinic attendees were obtained from the GIDS and 
CCGIC databases.   
 
2.7.3. Recruitment Process 
Letters inviting people to participate (Appendix F) were sent via mail to all eligible 
participants (N = 363). To minimise the risk of disclosing the person’s identity, 
should any of the letters have been opened by someone other than the intended 
recipient, the invitation letters contained very basic information about the study, 
on university letterhead, and without mention of gender identity. The letter 
included instructions on how to access more detailed information on the study, 
where to direct questions, how to access the online questionnaire and information 
about entering a prize draw to win a £100 Amazon voucher.  
When participants accessed the online questionnaire they were first directed to 
an information sheet (Appendix D), then an online consent form (Appendix E), 
and then to the questionnaire (Appendix G). At the end of the questionnaire 
participants were provided with a list of resources (Appendix H). Participant IP 
addresses were checked to prevent repeated participation.  
To maximise the participant response rate, leaflets advertising the study 
(Appendix I) were placed in the CCGIC waiting room, and given to clinic staff to 
distribute to ex-GIDS clients. CCGIC clinicians were also emailed on a bi-weekly 
basis reminders of which ex-GIDS clients they were due to see that week. Data 
collection for the current study took place during the spring of 2018, but the 
survey will remain open and online until the end of 2018. 
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2.8. Materials 
 
The questionnaire was developed in accordance with good practice guidelines on 
the conducting and reporting of survey research (Kelley, Clark, Brown, & Sitzia, 
2003), and used a participatory approach by involving young trans people in the 
questionnaire development and piloting (N = 2). Information and outcomes of 
interest gathered via the questionnaire are outlined below. All questions were in a 
forced-response format, such that participants could not proceed without 
providing an answer to a question, but an ‘I prefer not to answer’ option was 
provided for each question. Comment boxes were also provided after each 
question. Skip patterns/logic was used to ensure that participants only viewed, 
and could answer, questions that were relevant to them.  
 
2.8.1. Sociodemographic Information 
Age, gender identity, gender assigned at birth, ethnicity, relationship status, and 
employment status.  
 
2.8.2. Emerging Gender Awareness 
This included the age the person first became aware of a difference between the 
gender they were assigned at birth and their expressed/experienced gender; the 
age they were first referred to GIDS; and the age they started socially 
transitioning. Responses were given in text and then re-coded into numbers. 
Answers such as ‘since I was very little’ or ‘as long as I can remember’ were 
recoded into a 5 years and younger category.  
 
2.8.3. Intervention Pathways Chosen 
Interventions of interest included hormone blockers, cross-sex hormones, top 
surgery (a common umbrella term in the literature to define breast and/or chest 
surgery) and bottom surgery (a common umbrella term in the literature to define 
genital surgery), psychological support (individual therapy, group session and/or 
family work), and speech and language therapy. Other information gathered 
included age person received the intervention, and plans (if any) for future 
intervention (same options as above). 
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2.8.4. Factors Influencing Decisions about Interventions 
Participants were asked ‘To what extent did the following factors influence the 
decisions you made regarding your treatment choices?’ Answer options included 
1. Information provided by staff at GIDS, 2. Information provided by staff at an 
adult gender identity clinic, 3. Information provided by staff at another NHS 
service, 4. Information from charity/third sector organisations, 4. Opinions/advice 
from family members, 5. Opinions/advice from friends, 6. Opinions/advice from 
partner, 7. Information on the internet (participants were invited to expand on this 
answer in a comments box), 8. Weighing up the risks and benefits of 
interventions, and 9. Other (participants were invited to expand on this answer in 
a comments box). Participants rated the extent to which each factor had 
influenced their decisions on a scale of 0 (not at all) to 10 (greatly).   
 
2.8.5. Satisfaction with the Intervention Process 
Satisfaction refers to the person’s subjective evaluation of their experience 
(Bockting, Robinson, Benner, & Scheltema, 2004). Participant satisfaction with 
the intervention process was operationalised using the different measures 
described below.   
 
2.8.5.1. Decision-making around interventions. To assess satisfaction with the 
process, participants were asked to rate their levels of agreement with the 
following statements for each intervention type (i.e. hormone blockers, cross-sex 
hormones, top surgery, bottom surgery, and speech and language therapy): 1. I 
am satisfied with my decision to take/have (intervention), 2. I felt involved in the 
decision-making process about whether or not to take/have (intervention), 3. The 
information/advice I received about (intervention) from the clinic(s) I attended 
helped me make a decision about (intervention). Response options were on a 5-
level Likert scale (strongly agree, agree, neither agree or disagree, disagree, 
strongly disagree, and not applicable).  
  
The question format for psychological support, differed from the above format, in 
that participants were asked to rate their level of agreement with a single 
statement about each type of psychological support (e.g. individual therapy, 
group sessions and family work), in each type of service (e.g. 
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GIDS/adult/private/another service). For example, Attending 
(individual/group/family) counselling and therapy at (GIDS/adultGIC/private/ 
another service) helped me to make decisions about my transition process. 
Response options were on a 5-level Likert scale (strongly agree, agree, neither 
agree or disagree, disagree, strongly disagree, and not applicable).  
 
2.8.5.2. Previous decisions about interventions. Participants were asked ‘If you 
were making decisions about interventions today, would any of your past 
decisions about interventions be different?’ Answer options (for each intervention 
type) included yes, no, not sure and not applicable. Two new variables were 
created to obtain percentages and counts of those who answered ‘yes’ or ‘not 
sure’ to decisions about one or more interventions. 
 
2.8.5.3. Intervention timings and length of process. Satisfaction with intervention 
timings and length of the process (for each of the intervention types) was 
assessed by asking participants 1. ‘What did you think about the length of the 
process (from the point you were referred to the point when you received the 
intervention)?’ Answer options included too short, about right, too long, not sure, 
and not applicable; and 2. ‘What did you think about the timings of when you had 
the interventions?’ Answer options included too soon, about right, too long, not 
sure, and not applicable.  
 
2.8.6. Satisfaction with Gender Identity and Body Image  
Satisfaction with gender identity and body image were assessed by asking 
participants ‘In general, how do you feel about the following aspects of 
yourself? 1. Your gender identity, and 2. Your body in relation to your gender 
identity. Response options were on a 5-level Likert-type scale (very satisfied, 
satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied, and I 
prefer not to say). Participants were invited to provide more detail in a comment 
box.  
 
2.8.7. Psychological Wellbeing  
Psychological wellbeing was measured using the Warwick-Edinburgh Mental 
Well-being Scale (WEMWBS; Tennant et al., 2007), which is a14 item scale 
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designed to monitor mental wellbeing in the general population. The items are 
worded positively (e.g. ‘I’ve been feeling optimistic about the future’) and cover 
both the emotional and functioning aspects of mental wellbeing. There are 5 
response categories (none of the time – 1 point; rarely – 2 points; some of the 
time – 3 points; often – 4 points; all of the time – 5 points), which are summed to 
provide a single score ranging from 14-70. Scores of 0-32 points indicate very low 
wellbeing; 32-40 below average; 40-59 average; 59-70 above average. The 
internal consistency in the validation sample was high (α = .91).  
 
2.9. Analysis 
 
Data were analysed using SPSS version 23. The quantitative responses were 
primarily analysed using descriptive statistics (frequency tables and t-tests). 
ANOVAs were used to establish associations between different intervention types 
and continuous outcomes of interest. A priori sample size calculations were 
generated for the t-tests and ANOVAs. Data were analysed by assigned gender 
as previous research suggests they are different populations and thus need to be 
thought as separately (Costa et al., 2015). To increase the cell sizes and/or ease 
interpretation of the results some categorical variables were transformed into new 
variables (e.g. different forms of psychological support, types of hormone 
treatments, and types of surgeries); some categorical variables were transformed 
into fewer categories (e.g. by grouping strongly agree and agree, and strongly 
disagree and agree on Likert scale responses); and some categorical variables 
were dichotomised (e.g. to create yes/no variables).  
 
The qualitative responses to each question (i.e. the comment box data at the end 
of a question) were collated and analysed inductively by reading through the 
responses to a particular question and coding them to identify recurrent themes. 
The codes and themes relating to a particular question were then used to provide 
context or to elucidate specific issues identified by the quantitative data for that 
question.  
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RESULTS 
 
3.1. Chapter Overview 
This chapter first describes the sociodemographic characteristics of the sample 
and explores key ages in emerging gender awareness. Next, the prevalence of 
gender affirming interventions and factors influencing intervention decisions are 
outlined. Satisfaction with the transition process and outcomes are presented, 
before ending the chapter with a look at how different interventions impact body 
image and wellbeing. 
 
3.2. Sociodemographic Characteristics 
 
Of the 365 people who were referred from the GIDS to the CCGIC from 2011 to 
2016, one person was deceased and one had no postal address. Of the 363 
invitation letters sent out, 12 were returned to sender, leaving 351 people who 
were sent an invite to participate in the study. Of these, 82 people responded, 
giving an overall response rate of 24.0% (82/351). Of the 82 responders, 9 
dropped out after signing the consent form and one person was under 18, thus all 
10 were excluded from the analyses. The following analyses are based on the 
remaining 72 participants. 
 
The mean age of the sample (N = 72) was 20.0 years old (SD 1.70; CI 19.6 to 
20.4), with a range of 18 to 24 years (see Tables 1 and 3). Of the sample, 79.2% 
(n = 57) were AF, and 19.4% (n = 14) were AM. An independent samples t-test 
revealed a statistically significant difference between the mean ages of AFs and 
AMs, with AFs being significantly younger (M = 19.6 years; SD 1.53; 95% CI 19.2 
to 20.1) than AMs (M 21.2 years; SD 1.85; 95% CI 20.2 to 22.3), t(67) = 3.30, p = 
.002; d = 0.81. According to Cohen’s conventions (Cohen, 1988) this constitutes a 
large effect size. An apriori sample size calculation, on the basis of a 2-tailed test, 
with a medium effect size, and an alpha of .05, indicated a sample size of 88 was 
need to detect a significant effect, but due to the exploratory nature of the study, 
the t-test was run despite this. However, a post-hoc sample size calculation, on 
the basis of a 2-tailed test, with a large effect size, and an alpha of .05, indicated 
a sample size of 50 was need to detect a significant effect. The majority of the 
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sample self-identified as a men or transmen (72.2%; n = 52); as White British/Irish 
(80.6%; n = 58). Half of sample were in a relationship (50%; n = 36).  
 
Table 1: Sociodemographic characteristics of participants  
Sociodemographic characteristics  N     % 
Age 18 17 23.5% 
19 16 22.2% 
20 15 20.8% 
21   4   5.6% 
22 13 18.1% 
23   3   4.2% 
24   2   2.8% 
Preferred not to answer   2   2.8% 
Gender identity 
 
Man 32  44.4% 
Trans-man 20  27.8% 
Woman   8  11.1% 
Trans-woman   4    5.6% 
Party as a man, partly as a woman   1    1.4% 
Neither as a man or a woman   0    0.0% 
Non-binary/gender fluid or similar    2    2.8% 
Don’t know yet and/or questioning    0    0.0% 
Other*   5    6.9% 
Gender assigned at birth Assigned female at birth (AF) 57 79.2% 
 Assigned male at birth (AM) 14 19.4% 
 Not known   1   1.4% 
Ethnicity  
 
White British/Irish 58 80.5% 
White Other   5   6.9% 
Black/African/Caribbean/Black 
British 
  1   1.4% 
Asian/Asian British   2   2.8% 
Mixed/multiple ethnic group   4   5.6% 
Preferred not to answer   2   2.8% 
Relationship status 
 
Married/civil partnership   1   1.4% 
Living with a partner 10 13.9% 
In a relationship(s) 25 34.7% 
Single 35 48.6% 
Preferred not to answer   1   1.4% 
Employment status** Working (full or part time) 25 34.7% 
At College or University 39 54.2% 
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Sociodemographic characteristics  N     % 
 Unemployed 10 13.9% 
 Volunteering   2   2.8% 
 Disabled   1   1.4% 
 Preferred not to answer   1   1.4% 
*See Appendix J for participants’ explanations of ‘other’ 
** Counts will not sum to 72 as participants could tick more than one category  
 
3.3. Emerging Gender Awareness 
 
On average, people first became aware of a difference between the gender they 
were assigned at birth and their expressed/experienced gender at 10.4 years old 
(SD 3.96; 95% CI 9.5 to 11.4; range 5-17 years; see Table 2). An independent 
samples t-test revealed that there was no statistically significant difference in the 
age people first became aware between those AF (M = 10.6; SD = 3.90) and 
those AM (M = 9.79; SD 4.17), t(69) = -.69, p = .494; d = 0.17. On average, 
people were first referred to GIDS at 14.9 years old (SD 1.69; 95% CI 14.5 to 
15.3; range 9-18 years). An independent samples t-test revealed no significant 
difference in referral age between those AF (M = 14.9; SD = 1.50) and those AM 
(M = 14.8; SD = 2.42), t(69) = -.28, p = .779; d = 0.07 . On average, people 
started socially transitioning at 15.1 years old (SD 1.94; 95% CI 14.6 to 15.5; 
range 7-19). An independent samples t-test revealed a statistically significant 
difference in the age people started socially transitioning, with those AF starting 
earlier (M = 14.7; SD 1.86) than those AM (M = 16.4; SD 1.74), t(67) = 3.12, p = 
.003; d = 0.76. According to Cohen’s conventions (Cohen, 1988) this constitutes a 
large effect size. An apriori sample size calculation, on the basis of a 2-tailed test, 
with a medium effect size, and an alpha of .05, indicated a sample size of 88 was 
need to detect a significant effect in each of these examples, but due to the 
exploratory nature of the study, the t-tests were run despite this. However, a post-
hoc sample size calculation, on the basis of a 2-tailed test, with a large effect 
size, and an alpha of .05, indicated a sample size of 50 was need to detect a 
significant effect.   
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Table 2: Mean ages at different time points during emerging gender awareness 
by gender assigned at birth   
  All 
participants 
(N = 71) 
Assigned 
female (AF) 
(n = 57) 
Assigned 
male (AM) 
(n = 14) 
p-
value 
Age (Yrs.)  first 
became aware of 
difference between 
GAB* + EG* 
Mean (SD) 
Range 
10.50 (3.94) 
5-17yrs** 
10.60 (3.90) 
5-17yrs 
9.79 (4.17) 
5-15yrs 
.494 
Age (Yrs.) first 
referred to GIDS 
Mean (SD) 
Range 
14.92 (1.69) 
9-18yrs 
14.93 (1.50) 
11-17yrs 
14.79 (2.42) 
9-18yrs 
 
.779 
Age (Yrs.) started 
socially transitioning 
Mean (SD) 
Range 
15.07 (1.94) 
7-19yrs 
14.71 (1.86) 
7-18yrs 
16.43 (1.74) 
13-19yrs 
 
.003 
*GAB – Gender assignment at birth; EG – Expressed/experienced gender 
** All ages 5 and below were collapsed into one category ‘Age 5 and under’ 
 
3.4. Prevalence of Gender-Affirming Interventions 
 
3.4.1. Hormone Blockers Prevalence 
Overall, 59.2% (N = 42; AF = 31; AM = 10) of the sample had taken or were 
currently taking hormone blockers; 1.4% (n = 1; AM = 1) intended to start taking 
them in the future; and 11.1% (n = 8; AF = 5; AM = 3) were undecided as to 
whether or not they would start taking hormone blockers in the future (see Table 
3). Reasons cited for being undecided were provided by seven of the eight people 
who were undecided, and included not knowing whether blockers provided any 
additional benefit if taken alongside cross-sex hormones (3); only intending to 
take them if distress levels relating to periods worsened (1); unsure whether it 
was ‘too late’ to take them (1); and not knowing whether blockers were offered at 
the adult clinic (2). See Appendix K for full quotes. The average age people 
started taking hormone blockers was 16.4 years old (SD 1.27; range 14-20 
years). 
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Table 3: Prevalence of gender affirming interventions, age at start of 
interventions, and intentions to start/have interventions in the future by gender 
assigned at birth  
                                                                                                                               All
people 
Assigned
Female (AF) 
Assigned
Male (AM) 
Total*  100.0% (72)   78.2% (57)    19.4% (14) 
 
Age, years    
     Mean (SD)    20.0yrs (1.70)   19.6yrs (1.53)    21.2yrs (1.85) 
     Range    18-24yrs                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           18-24yrs    18-24yrs 
Ever taken hormone blockers 
(HB)  
   
     Yes    59.2% (42)   55.4% (31)    71.4% (10) 
          Currently taking    23.9% (17)   21.4% (12)    35.7% (5) 
          No longer taking    35.3% (25)   33.9% (19)    35.7% (5) 
     No    40.8% (29)   44.6% (25)    28.6% (4) 
Mean age first started taking HB 
(SD) 
   16.5yrs (1.27)   16.4yrs (1.17)    16.8yrs (1.62) 
Intention to start HB in the future      1.4% (1)     0.0% (0)      7.7% (1) 
Undecided about starting HB in the 
future 
   11.1% (8)     8.9% (5)    23.1% (3) 
Ever taken cross-sex hormones 
(CSH) 
   
     Yes     67.1% (47)   63.6% (35)    78.6% (11) 
          Currently taking    64.3% (45)   60.0% (33)    78.6% (11) 
          No longer taking      2.8% (2)     3.6% (2)      0.0% (0) 
     No    31.9% (23)   36.4% (20)    21.4 (3) 
Mean age first started taking CSH 
(SD) 
   18.0yrs (1.17)   18.1yrs (1.03)    17.7yrs (1.62) 
Intention to start CSH in the future    27.1% (19)   30.4% (17)    15.4% (2) 
Undecided about starting CSH in 
the future 
     5.7% (4)     7.1% (4)      0.0% (0) 
Ever had top surgery (TS)**    
     Yes    21.1% (15)   26.8% (15)      0.0% (0) 
     No     78.9% (56)   73.2% (41)  100.0% (14) 
Mean age first had TS    19.9yrs (1.34)   19.9yrs (1.35) - 
Intention to have TS in the future    55.7% (39)   60.7% (34)    30.8% (4) 
Undecided about having TS in the 
future 
   11.4% (8)     8.9% (5)    23.1% (3) 
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Ever had bottom surgery (BS)    
     Yes    12.7% (9)     7.1% (4)    35.7% (5) 
     No     87.3% (62)   92.9% (52)    64.3% (9) 
Mean age first had BS    21.1yrs (1.05)   21.3yrs (1.50)    21.0yrs (0.71) 
Intention to have BS in the future    25.7% (18)   25.0% (14)    30.8% (4) 
Undecided about having BS in the 
future 
   37.1% (26)   39.3% (22)    30.8% (4) 
Ever attended individual therapy 
(IT) 
   
     Yes    73.6% (53)    71.9% (41)    78.6% (11) 
     No    26.4% (19)    28.1% (16)    21.4% (3) 
Ever attended group sessions 
(GS) 
   
     Yes    23.9% (17)    21.4% (12)    28.6% (4) 
     No    76.1% (54)    78.6 (44)    71.4% (10) 
Ever attended family therapy (FT)    
     Yes    40.0% (28)    42.9% (24)    30.8% (4) 
     No    60.0% (42)    57.1% (32)    69.2% (9) 
Ever had speech & language 
therapy (SLT) 
   
     Yes      0.0% (0)      0.0% (0)      0.0% (0) 
     No   100.0% (69)  100.0% (55)  100.0% (13) 
Intention to have SLT in the future    12.9% (9)    10.7% (6)    23.1% (3) 
Undecided about having SLT in the 
future 
     8.6% (6)      8.9% (5)      7.7% (1) 
*Some row counts will not sum because gender assigned at birth was missing for one participant  
**Note: Top surgery is only available on the NHS to those assigned female at birth 
 
3.4.2. Cross-Sex Hormones Prevalence 
Overall, 67.1% (n = 47; AF = 35; AM = 11) of the sample had taken or were 
currently taking cross-sex hormones, 27.1% (n = 19; AF = 17; AM = 2) intended 
to start taking them in the future, and 5.7% (n = 4; AF = 4) were undecided as to 
whether or not they would start taking cross-sex hormones in the future. The 
average age people started taking cross-sex hormones was 18.0 years old (SD 
1.17; range 16-20 years).  
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3.4.3. Surgery Prevalence 
Overall, 33.8% (n = 24; AF = 19; AM = 5) of the sample had had either chest or 
genital surgery. 21.1% (n = 15; AF = 15) had undergone chest surgery and 12.7% 
(n = 9; AF = 4; AM = 5) had undergone surgical intervention in the genital area. 
The average age people had chest surgery was 19.9 years old (SD 1.34; range 
17-21) and genital surgery 21.1 years old (SD 1.05; range 19-22).   
 
With regards to plans for surgical intervention in the future, 55.7% (n = 39; AF = 
34; AM = 4) intended to have chest surgery, and 11.4% (n = 8; AF =5; AM = 3) 
were still undecided. Of the eight people that were undecided, three people cited 
the reason for being undecided was that they were going to wait and see how 
they felt after starting/observing the effects of taking cross-sex hormones. Overall, 
25.7% of the sample (n = 18; AF = 14; AM = 4) intended to have genital surgery, 
and 37.1% (n = 26; AF = 22; AM = 4) were undecided. Of the 26 people who were 
undecided about genital surgery, 18 people cited a reason for this, which included 
not feeling satisfied with current surgical methods and results, and hoping for 
future advances in this area (6); still in the process of weighing up the risks and 
benefits of genital surgery (5); too soon to make a decision (3); not feeling 
dysphoric about their genitals or currently not feeling the need for genital surgery 
but not ruling it out in the future (2); not knowing enough about genital surgeries 
(2); concerns about the pain involved (1); and wanting to wait and see how they 
felt after the effects of cross-sex hormones and/or chest surgery (1; see Appendix 
L for full quotes). We do not know the specific types of chest or genital surgeries 
the participants desired.  
 
3.4.4. Psychological Support Prevalence 
Overall, 73.6% (n = 53; AF = 41; AM = 11) of the sample had attended individual 
counselling or therapy in relation to their gender identity; 23.9% (n = 17; AF = 12; 
AM = 4) had attended group sessions; and 40.0% (n = 28; AF = 24; AM = 4) had 
attended family therapy.  
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3.4.5. Speech and Language Therapy Prevalence 
None of the sample had attended speech and language therapy (SLT), and only 
17.4% (n = 12) had been offered it. Of the sample, 12.9% (n = 9; AF = 6; AM = 3) 
intended to start SLT in the future, and 8.6% (n = 6; AF = 5; AM = 1) were 
undecided. Reasons for being undecided were provided by all six participants, 
and included not being aware SLT was an option (2); unsure if it will be 
needed/waiting to see the effect of hormones first (2); not been offered it yet (1); 
and considering obtaining it privately (1). It is worth noting here that SLT is no 
offered at GIDS, but is offered at adult services.  
 
3.5. Factors Influencing Decisions about Interventions 
  
Overall, the three factors cited as being most influential on people’s intervention 
decisions were 1. Weighing up the risks and benefits of the different interventions 
(M = 6.58; SD 3.42; 95%CI 5.77 to 7.39; range 0-10), 2. Information found online 
(M = 5.87; SD 3.24; 95%CI 5.11 to 6.64; range 0-10), and 3. Information provided 
by staff at the GIDS (M = 5.34; SD 3.49; 95%CI 4.51 to 6.16; range; 1-10). See 
Figure 1. Participants who rated information found online as being influential, 
were invited to provide more detail in a comments box, where the following 
sources were cited: websites (e.g. www.reddit.com,  www.transbucket.com), 
bulletin boards (e.g. www.4chan.org), blogs (e.g. www.tumblr.com), videos 
(www.youtube.com), talking to others on forums/group chats (e.g. 
www.susans.org), NHS websites, and websites of surgeons and patient reviews.  
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Figure 1: Factors influencing participants’ decisions about intervention, as 
measured by mean influence ratings (N = 72) 
 
When analysed separately by gender assigned at birth, the above patterns 
remained for AFs, such that the factors cited as most influential on people’s 
intervention decisions were weighing up the risks and benefits of the different 
interventions (M = 6.66; SD 3.29), followed by information found online (M = 6.00; 
SD 3.01), and then information provided by staff at the GIDS (M = 5.07; SD 3.45). 
However, a different pattern emerged for AMs, whereby the most influential factor 
cited was information provided by staff at the GIDS (M = 6.29; SD 3.71), followed 
by weighing up the risks and benefits of the different interventions (M = 6.00; SD 
3.98), and then opinions/advice from friends (M = 6.07; SD 4.20).  
 
3.6. Satisfaction with the Intervention Process 
 
3.6.1. Hormone Blockers  
Of the people who had taken or were taking hormone blockers (N = 42), 83.3% (n 
= 35; AF = 25; AM = 9) either ‘agreed’ or ‘strongly agreed’ that they were satisfied 
with their decision to take hormone blockers (see Figure 2); 83.3% (n = 35; AF = 
26; AM = 8) also ‘agreed’ or ‘strongly agreed’ that they felt involved in the 
decision-making process about whether or not to take hormone blockers; and 
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71.4% (n = 30; AF = 23; AM = 6) ‘agreed’ or ‘strongly agreed’ that the 
information/advice they received from the clinic(s) they attended helped them to 
make a decision about hormone blockers.   
 
 
Figure 2: Satisfaction and involvement with the process in people who had taken 
or were taking hormone blockers (N = 42) 
 
Of the people who had never taken hormone blockers (N = 29), 27.5% (n = 8; AF 
= 7; AM = 1) either ‘agreed’ or ‘strongly agreed’ that they were satisfied with their 
decision not to take hormone blockers; 24.1% (n = 7; AF = 7; AM = 0) ‘agreed’ or 
‘strongly agreed’ that they felt involved in the decision-making process about 
whether or not to take hormone blockers; and 31.0% (n = 9; AF = 8; AM = 1) 
‘agreed’ or ‘strongly agreed’ that the information/advice they received from the 
clinic(s) they attended helped them to make a decision about hormone blockers 
(see Figure 3).  
 
69.0%
71.4%
73.8%
11.9%
9.5%
14.3%
9.5%
11.9%
11.9%
0% 20% 40% 60% 80% 100%
Info/advice helped me
make a decision about
blockers
Felt involved in the
decision-making process
Satisfied with decision
to take blockers
Percentage of participants in each rating category (N = 42) 
Sa
ti
sf
ac
ti
o
n
 w
it
h
 t
h
e
 p
ro
ce
ss
Strongly
agree
Agree
Neither
agree nor
disagree
Disagree
58 
 
 
Figure 3: Satisfaction with the process in people who had never taken hormone 
blockers (N = 29) 
 
Of the 29 people who had never taken hormone blockers, 20 provided context to 
their answers in a comment box. By the time they reached services, over half 
thought (or were told) that it was too late to take hormone blockers (12), and one 
third of people felt the decision was made for them by clinicians/services (7). A 
minority of people pointed to unhelpful information/advice from clinicians or GP as 
the reason they had not taken hormone blockers (2), and a minority had felt 
pressured by clinicians to take blockers but had not (2). One person reported 
being dissuaded by their family from taking blockers, and one person had 
obtained testosterone privately, so did not need/want to take blockers (see 
Appendix M for full quotes). 
  
3.6.2. Cross-Sex Hormones 
Of the people who had taken or were taking cross-sex hormones (N = 47), 97.9% 
(n = 46; AF = 35; AM = 10) either ‘agreed’ or ‘strongly agreed’ that they were 
satisfied with their decision to take cross-sex hormones (see Figure 4); 93.7% (n 
= 44; AF = 34; AM = 9) ‘agreed’ or ‘strongly agreed’ that they felt involved in the 
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82.9% (n = 39; AF = 31; AM = 7) ‘agreed’ or ‘strongly agreed’ that the 
information/advice they received from the clinic(s) they attended helped them to 
make a decision about cross-sex hormones.  
 
 
 
Figure 4: Satisfaction with the process in people who had taken or were taking 
cross-sex hormones (N = 47) 
 
3.6.3. Surgeries 
3.6.3.1 Top surgery. Of the people who had undergone top surgery (N = 15), 
100% (n = 15; all AF) had either ‘agreed’ or ‘strongly agreed’ that they were 
satisfied with their decision to have the surgery (see Figure 5); 100% (n = 15; all 
AF) ‘agreed’ or ‘strongly agreed’ that they felt involved in the decision-making 
process about whether or not to have top surgery; and 80.0% (n = 12; all AF) 
‘agreed’ or ‘strongly agreed’ that the information/advice they received from the 
clinic(s) they attended had helped them to make a decision about top surgery. 
Just under half (46.7%; n = 7; all AF) ‘agreed’ or ‘strongly agreed’ that they were 
satisfied with the post-operative hormone advice they had received.  
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Figure 5: Satisfaction with the process in people who had undergone top surgery 
(N = 15) 
 
3.6.3.1 Bottom surgery. Of the people who had undergone bottom surgery (N = 
9), 100% (n = 9; AF = 4; AM = 5) either ‘agreed’ or ‘strongly agreed’ that they 
were satisfied with their decision to have the surgery (see Figure 6); 88.9% (n = 8; 
AF = 4; AM = 4) ‘agreed’ or ‘strongly agreed’ that they felt involved in the 
decision-making process about whether or not to have the surgery; 77.8% (n = 7; 
AF = 4; AM = 3) ‘agreed’ or ‘strongly agreed’ that the information/advice they 
received from the clinic(s) they attended had helped them to make a decision 
about bottom surgery; and 88.8% (n = 8; AF = 3; AM = 5) ‘agreed’ or ‘strongly 
agreed’ that they were satisfied with the post-operative hormone advice they had 
received.  
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Figure 6: Satisfaction with process in people who had undergone bottom surgery 
(N = 9) 
 
3.6.4. Psychological Support 
3.6.4.1. Psychological support at GIDS. Participants who had attended individual 
therapy, group sessions and/or family therapy at GIDS were asked to rate the 
extent to which each psychological support (individual therapy/group 
sessions/family therapy) had helped them to make decisions about their transition 
process. Of those who attended individual therapy (N = 38), 57.8% (n = 22; AF = 
19; AM = 2) strongly agreed or agreed that it helped them to make decisions 
about their transition process. Of those who attended group sessions (N = 14), 
50.0% (n = 7; AF = 6; AM = 1) strongly agreed or agreed that it helped them to 
make decisions about their transition process. Of those who attended family 
therapy (N = 20), 40.0% (n = 8; all AF) strongly agreed or agreed that it helped 
them to make decisions about their transition process (see Figure 7).  
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Figure 7: Participant perceptions on whether the psychological support at GIDS 
helped them make decisions about their transition process, by type of support  
 
3.6.4.2. Psychological support at CCGIC. Participants who had attended 
individual therapy at CCGIC were asked to rate the extent to which attending 
individual therapy had helped them to make decisions about their transition 
process. Of those who attended (N = 19), 63.2% (n = 12; AF = 10; AM = 2) 
strongly agreed or agreed that it helped them to make decisions about their 
transition process (see Figure 8).  
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3.6.4.3. Private psychological support.  Participants who had attended private 
individual therapy were asked to rate the extent to which attending individual 
therapy had helped them to make decisions about their transition process. Of 
those who attended (N = 17), 64.7% (n = 11; AF = 8; AM = 3) strongly agreed or 
agreed that it helped them to make decisions about their transition process (see 
Figure 9).  
 
 
 
Figure 9: Participant perceptions on whether the private individual therapy they 
attended helped them make decisions about their transition process  
 
3.6.4.4. Psychological support across services. Participant ratings of the extent to 
which attending individual therapy had helped them to make decisions about their 
transition process were compared across services. Broadly the same pattern 
emerged across services, in that a majority of participants agreed or strongly 
agreed (GIDS 57.5%; n = 22; CCGIC 63.2%; n = 12; Private 64.7%; n = 11) that 
therapy had helped them to make decisions about their transition process (see 
Figure 10).  
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Figure 10: Participant perceptions on whether the individual therapy they 
attended helped them make decisions about their transition process, by service  
 
3.6.5. Current Reflections on Previous Decisions about Interventions  
 
When asked the question ‘If you were making decisions about interventions 
today, would any of your past decisions about [counselling/therapy, blockers, 
cross-sex hormones, top surgery, bottom surgery, speech and language therapy] 
be different?’ Overall, 40.0% (n = 28; AF = 24; AM = 3) answered ‘yes’ to at least 
one intervention, and 15.7% (n = 11; AF = 10; AM = 1) answered ‘not sure’ to at 
least one intervention. When broken down by intervention, the majority of 
participants responded no (see Figure 11). The two interventions with the highest 
number of ‘yes’ responses, were hormone blockers and top surgery.  
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Figure 11:  Percentages of participants who would/would not have made different 
decisions about interventions if they were making them today 
 
Of the 28 people who answered yes in reference to at least one previous decision 
being different, 24 people expanded on their responses in a text box (see 
Appendix N for full quotes). Over half of the people who expanded on their 
responses (n= 16) described a wish to have started interventions sooner; 
particularly hormone blockers, but also cross-sex hormones, surgery and 
counselling/therapy.  
 
‘Would seek counselling sooner. Would want blockers & T [testosterone] 
much sooner to help prevent the last stages of puberty that I had to go 
through while waiting. Would have had chest surgery 2 years ago’. 
 Participant self-identified as a man (20 years old) 
 
People had varying opinions on hormone blockers: Several people felt the 
requirement to take hormone blockers before cross-sex hormones was 
unnecessary (n = 2). One person would now consider hormone blockers as a 
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negative side effects of hormone blockers, and stated that they would have taken 
birth control instead.  
 
‘I would have taken birth control instead of hormone blockers to stop my 
menses. Some aspects of hormone blockers are wonderful - there's no 
fluctuations in my masculinity and femininity like I used to have due to my 
cycle, and it feels great to feel simply neutral, but the cost has been quite 
high. I know depression is a common side effect and it's difficult to tell 
whether I've experienced it as a result or whether my mental health has 
struggled because I've been so tired that I've felt like I have no future’. 
Participant self-identified as a transman (18 years old)  
 
One person would have liked to have accessed speech and language therapy 
had it been available in their area. Two people felt that counselling/therapy was a 
‘waste of time’ or ‘detrimental’, but others would have liked to have accessed it 
earlier (n = 4) and had it continue during the transition between services (n = 1). 
One person said they no longer want bottom surgery, and two people spoke 
about their understanding of gender becoming more nuanced and less binary 
over time, and cited this being the reason why some of their decisions would be 
different.  
 
‘I saw transitioning as going from one extreme to the other. Like I knew I 
was never gonna be a ‘manly man’ but I never thought about potentially 
being gender queer or trans masc…I didn’t have sex until I was 20, and I 
think that helped me come to realise I’m more transmasculine than just a 
man. Now I’m here, I think I could reconsider chest surgery, but I don’t 
regret it. I can’t wait to have my first summer where I can take my top off, 
and where a binder won’t rub me and suffocate me’. 
Participant self-identified as a transman (22 years old)  
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‘I’ve somewhat de-transitioned now, medically speaking (not socially). I 
would now put more emphasis on the emotional support I could get from 
therapy. I would consider hormone blockers as a long-term treatment, 
rather than a precursor to hormones. I would not be on cross-sex 
hormones. But I would still have wanted top-surgery’. 
Participant self-identified as partly a man, partly a woman (age 
unknown) 
 
3.6.6. Timing and length of process 
3.6.6.1. Timing of interventions. With regards to medical interventions, almost two 
thirds of those who took or were taking hormone blockers (n = 30) and just over 
half of those taking cross-sex hormones (n = 28) felt the timing of these 
interventions was too late (see Figure 12). With regards to surgeries, almost half 
of those who had undergone top surgery felt the timing was too late (n = 12), and 
the majority of those who had undergone genital surgery felt the timing was either 
too late (n = 7) or were not sure about the timing (n = 3). A majority of participants 
(n = 33) felt the timing of psychological support was about right.  
 
Figure 12: Participants’ perceptions of the timings of each intervention 
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3.6.6.2. Length of process. Across all interventions, the majority of people (55.9% 
to 76.8%; n = 33 to 43) felt that the length of the process was too long (see Figure 
13).  
 
 
 
Figure 13: Participants’ perceptions of the length of process of each interventions  
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my second appointment will likely be 6 months after the first. Once I'm on 
hormones, I'll likely have to wait another year before I can get top surgery’. 
 Participant self-identified as a transman (18 years old) 
 
People cited various barriers to accessing services or receiving interventions, 
including a general lack of services (n = 2); appointments being rescheduled or 
referrals being delayed due to staff leaving or administrative errors (n = 10); 
mental health difficulties that required attention first (n = 1); not being offered 
certain interventions (n = 1); and waiting for clinician’s signatures (n = 1).  
 
‘I am still yet to receive top surgery, I was on a waiting list from nearly a 
year but have been taken of it due to the surgeon being unable to now do 
the surgery as he has moved. I'm now unaware of when I will be getting 
surgery’. 
Participant self-identified as a man (20 years old) 
 
With regards to the impact of long waiting times, some people felt that certain 
steps in the process were unnecessary and delayed intervention (n = 6).   
 
‘I would have liked to have received hormones earlier rather than having to 
attend appointments at adult services to assess whether I was "ready" to 
take them, and being required to change my legal name before I could 
even get a recommendation’. 
Participant self-identified mostly as a transman, but sometimes 
genderless (20 years old) 
 
‘A potentially more troubling issue is the barriers one faces when trying to 
get treatment, it is categorically insufficient to truthfully explain your 
struggles. My experience was being interrogated about the way I present, 
being told I have to 'be a woman all of the time, not just some of the time'. 
The criteria for being judged as correctly transgender seem very specific, 
and god help me if I didn't figure out the rough criteria and start lying’. 
Participant self-identified as a woman (19 years old) 
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‘I can't speak for trans feminine people, but the fact that trans masculine 
people are denied referrals for top surgery until they've been on HRT for a 
certain amount of time is cruel and ridiculous. Binding is painful, 
unpleasant, and can be traumatising. Many people can't pass as 
masculine because of their chest, meaning that physical changes they may 
experience from HRT (esp. facial hair) make it even more dangerous to 
exist as a trans person due to how visible discrepancies from gender 
norms are received’. 
 Participant self-identified as a man (20 years old) 
 
The long wait and delays to intervention were experienced as particularly 
distressing by some of the participants (n = 14). 
 
‘I was due to start testosterone treatment mid-2015, however due to my 
GP repeatedly refusing the first injection due to supposed complications 
despite telling him I wasn't allergic to anything, I wasn't able to start the 
treatment until June 2016. The injection was done by a local hospital and 
only then was I allowed to have the continuing injections done at the 
surgery. The year wait before I was able to start testosterone caused me 
to become suicidal and depressed’. 
Participant self-identified as a man (21 years old) 
 
‘My waiting for hormones was very long, and resulted in multiple suicide 
attempts’. 
 Participant self-identified as a man (20 years old) 
 
‘I'll reiterate how imperative, I believe it is for the service to be 
understanding and caring toward transgender individuals in relation to their 
body or their identity. It comes across as very disrespectful when doctors, 
psychiatrists or other staff are referring to body-parts or other such things 
with the incorrect terms, or just not taking their time to use gender neutral 
one. By doing so they're impacting mental health of the individual. I know I 
dread going to the GICs, I always have and always will. However, if I 
71 
 
thought I wouldn't have to encounter words that make me want to cut 
myself up I could deal with the process that bit easier’. 
 Participant self-identified as a man (22 years old) 
 
Due to wait times, some participants turned to private services to obtain 
intervention (n = 4), and one person felt that the delays to intervention 
(specifically hormone blockers) meant that top surgery became necessary.  
 
‘If I had had hormone blockers before I hit puberty, I would not have 
needed top surgery. However, specifically for me, this would not have 
been possible, as I hit puberty around age 8-9, before I had words to 
describe my gender identity’. 
Participant self-identified as a man and a transman (20 years old) 
 
3.7. Feelings about Gender Identity and Body Image  
The mean satisfaction rating for gender identity was 4.1 (SD 1.1; 95% CI 3.8 to 
4.4; n = 70), which indicates an average rating of ‘satisfied’; and the mean 
satisfaction rating with body (in relation to gender identity) was 2.5 (SD 1.5; 95% 
CI 2.2 to 2.9; n = 70), which indicates an average rating at the mid-point between 
‘dissatisfied’ and ‘neither satisfied nor dissatisfied’ (see Figure 14).    
 
Figure 14: Satisfaction ratings for body image (in relation to gender identity) and 
gender identity  
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The body image and gender identity satisfaction ratings were analysed by gender 
assigned at birth. An independent samples t-test revealed that there was a 
statistically significant difference in the mean body satisfaction ratings with AMs 
(M = 2.77; SD 1.88; n = 13) reporting greater satisfaction with their body (in 
relation to their gender) than AFs (M = 2.48; SD 1.45; n = 56), t(67) = .61, p = 
.033; d = 0.15. According to Cohen’s conventions this constitutes a small effect 
size. An independent samples t-test revealed that there was no statistically 
significant difference in the mean gender identity satisfaction ratings between 
those AM (M = 4.00; SD 1.23; n = 13) and those AF (M = 4.11; SD 1.09; n = 56), 
t(67) = -.31, p = .767; d = 0.08. An apriori sample size calculation, on the basis of 
a 2-tailed test, with a medium effect size, and an alpha of .05, indicated a sample 
size of 88 was need to detect a significant effect in both these tests, but due to 
the exploratory nature of the study the t-tests were run despite this. Caution 
should be taken in interpreting these results.  
 
3.8. Psychological Wellbeing  
The mean wellbeing score Warwick-Edinburgh Mental Well-being Scale 
(WEMWBS) was 46.5 (SD 12.55; CI 43.5-49.5; range 14-68), which falls in the 
average range of the measure. Of the sample, 17.1% (n = 12) were classified as 
having above average wellbeing, 50.0% (n = 35) as average, 17.1% (n = 12) as 
below average, and 15.7% (n = 11) as having very low wellbeing (see Figure 15). 
The internal consistency for the current sample was high (α = .95).  
 
 
 
Figure 15: Psychological wellbeing scores 
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3.9. The Impact of Interventions on Wellbeing and Body Satisfaction 
3.9.1. Body Image 
A two-way between-groups analysis of variance (ANOVA) was conducted to 
compare the main effects of medical interventions (2 levels: yes/no) and surgical 
interventions (2 levels: yes/no), and interaction effects between interventions on 
body image. There was a statistically significant difference at the p<.05 for the 
intervention groups: F (2,67) = 15.17, ƞ = .312, p = .000, which indicated a 
statistically significant difference in body image scores between the medical 
intervention group (M = 2.85; SD = 1.50), and surgical intervention group (M = 
3.84; SD = 1.30). According to Cohen’s conventions (Cohen, 1988), this 
constitutes a small to medium effect size. The main effect of medical intervention 
F (1,67) = 3.45, ƞ = .049, p = .068, was not statistically significant, but the main 
effect of surgical intervention F (1,67) = 17.84, ƞ = .210, p = .000 was statistically 
significant, which suggested that people who had received surgical intervention 
had significantly higher body image scores than those who had not received 
surgical intervention. However, the effect size was small (Cohen, 1988). An 
apriori sample size calculation, using fixed effects for main effects and 
interactions, with a medium effect size, and an alpha of .05, indicated a sample 
size of 400 was needed to detect a significant effect, but due to the exploratory 
nature of the study, the ANOVA was run despite this. Furthermore, it was not 
possible to determine whether there were any interaction effects because there 
were no people in the sample who had received surgery, but not taken cross-sex 
hormones. Therefore, caution should be taken in interpreting these results.  
 
 
3.9.2. Psychological Wellbeing  
A two-way between-groups analysis of variance (ANOVA) was conducted to 
compare the main effects of medical interventions (2 levels: yes/no) and surgical 
interventions (2 levels: yes/no), and interaction effects between interventions on 
wellbeing. There was a statistically significant difference at the p<.05 for 
intervention on wellbeing: F (2, 67) = 4.32, ƞ = .114, p = .017, which indicated a 
statistically significant difference in wellbeing scores between medical intervention 
group (M = 47.22; SD = 12.62), and surgical intervention group (M = 53.37; SD = 
9.70). According to Cohen’s conventions (Cohen, 1988), this constitutes a small 
74 
 
effect size. The main effect of medical intervention F (1, 67) = 0.01, ƞ = .000, p = 
.926, was not statistically significant, but the main effect for surgical intervention F 
(1, 67) = 7.78, ƞ = .104, p = .007 was statistically significant, which suggests that 
people who had received surgical intervention had significantly higher wellbeing 
scores than those who had not received surgical intervention. However, the effect 
size was small (Cohen, 1988). An apriori sample size calculation, using fixed 
effects for main effects and interactions, with a medium effect size, and an alpha 
of .05, indicated a sample size of 400 was needed to detect a significant effect, 
but due to the exploratory nature of the study, the ANOVA was run despite this. 
Furthermore, it was not possible to determine whether there were any interaction 
effects because there were no people in the sample who had received surgery, 
but not taken cross-sex hormones. Therefore, caution should be taken in 
interpreting these results.  
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DISCUSSION 
4.1. Chapter Overview 
 
This chapter will restate the background and aims of the thesis, provide a brief 
summary of the key study findings, and discuss the findings in relation to the 
research questions and existing literature. Next, methodological strengths and 
limitations of the research will be discussed, followed by some personal 
reflections on the process. The implications of the findings for clinical practice and 
research will be discussed, before ending the chapter with conclusions.  
 
4.2. Background to the Thesis 
 
In recent years there has been an explosion of referrals to speciality services for 
gender diverse youth. There is a paucity of research on the experiences and 
outcomes of young adults referred from child and adolescent gender identity 
services to adult services, and with such large increases in referrals it is vital we 
understand more about the intervention pathways, satisfaction, and longer-term 
outcomes of these gender diverse young people. The findings will enable better 
tailoring of gender identity services for young people, and be an important step 
towards ensuring that the support and intervention provided meets the needs of 
this diverse and growing population 
 
4.3 Aims and Objectives of the Thesis 
 
To my knowledge, this was the first ever cross-sectional follow-up study of a 
cohort of gender diverse young adults who previously attended a child and 
adolescent gender identity clinic and who were referred, at age18, to an adult 
gender identity clinic. The overall aim of the study was to address current gaps in 
the literature by determining the intervention pathways, satisfaction levels and 
longer-term outcomes of the young people who attended the GIDS, and who 
were referred on to the CCGIC.  
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4.4 Summary of Main Findings 
 
In this sample of gender diverse young adults, a high proportion were taking 
cross-sex hormones, and the majority were largely satisfied with their decision to 
take cross-sex hormones, and with the decision-making processes/support 
involved. A much smaller proportion of the sample had undergone surgical 
intervention, but all were satisfied with their decisions and the decision-making 
processes/support involved. This finding may reflect the cross-sectional nature of 
the study, the age of the sample, and the fact that many people were in the 
middle of their intervention journeys. Supporting this idea, a substantial number of 
the sample intended to have top surgery, and to a lesser extent bottom surgery, 
in the future. Despite relatively high satisfaction ratings with intervention 
processes, areas of dissatisfaction were identified and these represent targets for 
improvement; they include the timings and length of process of interventions, 
access to hormone blockers, psychological support and post-op hormone advice 
after top surgery. The factors cited as most influential in people’s intervention 
decisions varied by gender assigned at birth, and included weighing up the risks 
and benefits of different interventions, information found online, information 
provided by staff at the GIDS, and opinions/advice from friends. The majority of 
the sample reported average levels of wellbeing, which are comparable people of 
a similar age in the general population. While the majority were satisfied with their 
gender identity, the majority were dissatisfied or neutral about their body image.  
 
4.4.1. Sample Recruited 
The study sample was comparable to the population sample with regards to age 
(i.e. the average age in the study sample was 20.0 years, compared to 19.9 years 
in the population of young people who were referred from GIDS to CCGIC). 
Although the sample had a greater proportion of assigned females to males, than 
in the population (i.e. 78.2% vs 64.7%), it was broadly comparable. The higher 
proportion of assigned females seen in this sample of young adults (referred to an 
adult service between 2011 and 2016), supports the temporal shift in sex ratio 
found in previous studies of adolescent clinic populations (Aitken et al., 2015).  
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The assigned females in the study were significantly younger than the assigned 
males, which is in line previous findings (Olson, Schrager, Belzer, Simons, & 
Clark, 2015). As Aitken and colleagues suggested (2015), it might be easier for 
AFs to come out as trans than AMs, because although trans identities are 
becoming more accepted, there is still more stigmatisation of cross-gender 
behaviour in boys/men than in girls/women – potentially explaining the observed 
age differences.  
 
The average age at which the sample were referred to the GIDS (14.9 years old) 
supports the recent observed increase in young people in their mid-teens 
presenting to services for the first time (de Vries et al., 2010; Kaltiala-Heino et al., 
2018; Zucker et al., 2016). Four participants identified as non-binary, 
genderqueer or genderless, which reflects the diversity of ways in which young 
people are now identifying. Addressing the medical and mental health needs of 
these young people will present additional challenges to health professional in 
trans-related healthcare (Olson et al., 2015; Steensma et al., 2013). With 
increased diversity comes increased fluidity, and services will need to develop 
more nuanced and tailored ways of intervening than more traditional binary-
focussed pathways.  
 
4.4.2. Research Question 1: Which Intervention Pathways Did People Follow 
After Being Referred to the Adult Clinic?  
Almost two thirds of the sample had taken or were taking hormone blockers. 
There are no previous studies with which to compare these findings, but one 
might expect the number to be higher, given that hormone blockers are available 
in the UK to people once they have entered the early stages of puberty (i.e. 
Tanner stages 2-3), and that the average age of the sample was 20.0 years old. 
However, the average age at which people were first referred to services (i.e. 
post-puberty), long wait times to be seen at the clinics, and possible presence of 
comorbidities (that can delay access to medical intervention) may help to explain 
these findings.  
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The vast majority of the sample were either taking cross-sex hormones or 
intended to take them in the future (91.4%), and only a minority of the sample had 
undergone top/chest surgery (21.1%) or bottom/genital surgery (12.7%).  
While there are no previous studies in adolescents/young adults with which to 
compare these findings, the figures do align with similar research conducted in 
adult samples (Kailas et al., 2017). In this adult sample (N = 99), 97.0% were 
taking cross-sex hormones, 25.0% had undergone top/chest surgery, and 13.0% 
had undergone bottom/genital surgery. At first glance, these findings are perhaps 
surprising, considering the how much younger the current sample was (20.0 
years old) compared to the sample in the adult study (42.3 years old). One might 
conclude that those who present to adult services want physical interventions 
(and those who do not do not); and that prevalence of medical and surgical 
interventions in clinic populations is fairly stable, regardless of the age people 
start medical transitions. However, caution should be taken when drawing 
conclusions on the basis of these comparisons. The study that looked at the 
prevalence of gender affirming interventions in a clinic-sample was a US study 
that did so prior to state expansion of insurance cover for gender affirming 
surgery (Kailas et al., 2017). Thus, the relatively low prevalence of surgical 
intervention in this adult study could be partially explained by the lack of 
insurance coverage/funds to cover the surgeries at the time. A study conducted in 
a non-clinical sample of trans-identified individuals (N = 415) in Germany, where 
gender affirming intervention is government funded, found similar prevalence (to 
the current study) of taking cross-sex hormones (AF = 81.4%; AM = 88.5%), but a 
higher prevalence of surgical interventions (top surgery AF = 62.4%; AM = 21.2%; 
and hysterectomy/ovary removal (AF) = 36.0%; genital reconstruction surgery 
(AM) = 44.9% (Eyssel et al., 2017). These differences may, to some extent, 
reflect differing cultures within the medical professionals in different countries, 
regarding what constitutes support and their willingness to perform surgeries.  
 
If one compares desire for (more) surgery then a slightly different picture 
emerges. In the current sample, 55.7% intended to have top/chest surgery 
(11.4% were undecided) and 25.7% intended to have bottom/genital surgery 
(37.1% were undecided). These figures are much higher than in the US adult 
sample (Kailas et al., 2017), in which 22.0% desired top/chest surgery and 4.0% 
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desired bottom/genital surgery. These differences may reflect generational and 
cultural differences, differences in approach to intervention, or issues relating to 
funding.  
 
On average, the current sample started interventions 1.5 to 2 years later than 
adolescents and young adults in previous studies (de Vries, McGuire, et al., 
2014). The current sample started puberty suppression at 16.4 years (compared 
to 14.8 years in the Dutch sample); cross-sex hormones at 18.0 years (compared 
to 16.7 years); and gender affirming surgery at 21.2 years (compared to 19.2 
years). The age of starting interventions in the Dutch sample are more closely 
aligned with current age-related guidelines (Coleman et al., 2012; Delemarre-van 
de Waal & Cohen-Kettenis, 2006; Hembree et al., 2009, 2017). However, drawing 
comparisons with the Dutch study is problematic, because the Dutch study was 
an evaluation of an early intervention sample, whereas the current sample was a 
cross-sectional look at an older (non-early intervention) sample, and therefore we 
would expect the Dutch sample to have accessed interventions earlier. 
Furthermore, there are multiple reasons why the current sample might have 
started interventions at the ages they did, including presenting to services later 
and the possible presence of comorbidities that might have required attention 
first. 
 
When thinking about prevalence of interventions, and comparing findings to 
previous research, it’s important to remember that the current study is not an 
outcome study. Rather, it is a cross-sectional snap shot in time, where some 
participants had completed their intervention journey, and others were still in the 
middle of it. Thus, making direct comparisons with outcome studies, in which 
participants had completed their intervention journey, is potentially problematic.  
 
4.4.3. Research Question 2: What Factors Influenced People’s Intervention 
Decisions? 
The factors cited as being most influential on people’s intervention decisions 
varied by gender assigned at birth. The top three factors cited as most influential 
for AFs were 1. Weighing up the risks and benefits of different interventions, 2. 
Information found online, and 3. Information provided by staff at the GIDS. The 
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top three factors cited at being most influential for AMs were 1. Information 
provided by staff at the GIDS, 2. Weighing up the risks and benefits of different 
interventions, and 3. Opinions/advice from friends. There are no previous studies 
with which to compare these findings. 
 
Effectively communicating risk to clients/patients is a key part of insuring that 
consent is informed (Paling, 2003). Unfortunately, we do not know how the 
participants assessed the risks and benefits of gender affirming interventions, or 
what sources they used to make these evaluations. Studies indicate that when 
making decisions about surgery, people tend to extract the gist of any 
information, rather than the details (Lloyd, Hayes, Bell, & Naylor, 2001), and risk 
assessments are often driven by emotions rather than facts (Ropeik & Clay, 
2002). Almost every doctor involved in gender affirming healthcare has to 
communicate information on risk, yet many doctors do not have adequate training 
in risk communication (Paling, 2003). Furthermore, the nature and understanding 
of risk, in this area, is something that is rapidly changing. Future qualitative 
research is needed to thoroughly explore that ways in which gender diverse 
people evaluate the risks associated with medical and surgical intervention, and 
the role that others play in the evaluation process, so that this information can be 
considered and incorporated into any written materials, online information 
sources, and risk communication training for doctors.   
 
Increasingly, we are exposed to a huge amount of health information online, and 
therefore it is important that this information is accurate and trustworthy 
(Morahan-Martin, 2004). However, people often report finding it difficult to know 
which internet sources to trust (Morahan-Martin, 2004). The current study showed 
that websites are an important source of information (regarding decision-making) 
for gender diverse young people. Although some participants cited NHS websites 
as being influential sources of information when making decisions about 
interventions, the other online sources of information cited were websites that are 
largely unregulated (i.e. blogs, photo and video sharing websites, social 
networking sites, bulletins boards etc.). While these sites are ideal places to 
obtain information about people’s experiences of transitioning, due to their lack of 
regulation, they are not necessarily the best places to obtain accurate and reliable 
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health information (e.g. side effects or long-term impact of hormone treatments, 
or risks associated with surgery). Future qualitative research exploring the 
content, design and usage patterns of these websites would provide useful 
information for those involved in developing and managing websites containing 
health information for gender diverse people (in terms of maximising their utility 
as information sources). 
The fact that the information provided by staff at the GIDS was cited as being 
highly influential in people’s intervention decisions is interesting, as it appears to 
contravene the narrative in the media about trans people having poor 
relationships with gender identity services. These findings put individual 
complaints in perspective, and demonstrate, that despite the challenges inherent 
in providing trans-related healthcare, it appears that many are satisfied.  Future 
qualitative research exploring what people found helpful and why would be useful 
in terms of achieving and maintaining high levels of client satisfaction in this area.  
 
4.4.4. Research Question 3: Were People Satisfied with the Intervention 
Process? 
 
4.4.4.1. Levels of satisfaction/dissatisfaction with interventions. The majority of 
participants were satisfied with the intervention process regarding hormone 
blockers, cross-sex hormones, and surgeries (i.e. satisfied with their decisions, 
felt involved in the decision-making process, and perceived the information/advice 
they received from the clinics as helpful). Previous studies with adolescents or 
young adults after receiving gender affirming interventions have tended to look at 
satisfaction with outcomes, such as body/appearance and surgery (Cohen-
Kettenis & Van Goozen, 1997; de Vries, McGuire, et al., 2014; de Vries, 
Steensma, Doreleijers, & Cohen-Kettenis, 2011), rather than satisfaction with the 
process, so there are no previous findings with which to compare these findings.  
 
The majority of satisfaction studies conducted in adult populations also tend to 
privilege outcomes over process, but some have looked at satisfaction with 
gender identity services (Bockting et al., 2004; Davies et al., 2013; Ellis, Bailey, & 
McNeil, 2015; Eyssel et al., 2017; Wylie, Fitter, & Bragg, 2009). Unfortunately, the 
process questions in most of the studies did not map onto those asked in the 
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current study, and so are not directly comparable. An exception to this was 
Davies and colleagues, who reported overall satisfaction rates of 60% (Davies et 
al., 2013). The lack of attention in the literature to satisfaction with the intervention 
process and decision-making is surprising. Particularly in the UK, where NHS 
commissioning bodies increasingly expect patient satisfaction to be considered as 
a service performance indicator, and the fact that shared decision-making is a 
principal mechanism for ensuring people get the care they need and want 
(Coulter & Collins, 2011). 
 
The age criteria for hormone blockers and cross-sex hormones are currently 
under debate (Cohen-Kettenis et al., 2008; Delemarre-van de Waal & Cohen-
Kettenis, 2006; Ehrensaft, 2016; Hidalgo et al., 2013; Vrouenraets et al., 2015; 
Wren, 2000). Although they appear to have worked well for the majority of the 
young adults in this sample, continued research is needed to determine factors 
(identifiable pre-puberty) that would predict the continuation of a gender diverse 
identity into adulthood (Steensma et al., 2011). What is much needed, but absent 
from the current literature, are longitudinal prospective studies looking at a 
diversity of pathways, and exploring individual experiences, choices, gender 
identities and expression.  
 
The fact that most AFs were satisfied with top surgery, and not many intended to 
have bottom surgery potentially supports the idea that passing/public perception 
is a priority (Kailas et al., 2017). However, looking at the reasons people cited for 
being undecided about genital surgery, the picture is more complex. While some 
people did comment on not feeling dysphoric about their genitals, the main 
reasons people gave for being undecided linked to dissatisfaction with current 
surgical methods and outcomes, and concern about potential complications and 
pain. Other reasons cited related to people still being in the middle of their 
medical transition process, and, as such, people were still weighing up the risks 
and benefits, learning about different surgical options, and waiting to see how 
they felt after starting cross-sex hormones. These findings highlight the 
complexities of how people reconcile their gender identity with their physical 
body, and may reflect the developmental stages and processes they were going 
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through (i.e. connected to evolving social, physical, emotional and relational 
experiences and understandings).  
 
Lower satisfaction ratings were related to psychological support, timings and 
length of process, post-surgery hormone advice, and in people who had not taken 
hormone blockers. When looking at psychological support it is firstly important to 
note that the numbers of participants who had received the different types of 
support were very small. Secondly, psychological support varies widely across 
intervention type and service, in terms of its focus, content, frequency and length. 
For example, decision-making about interventions is not the focus of the group 
sessions at GIDS. In group sessions they use cognitive behavioural techniques 
and systemic approaches to manage mood and relationships; and (post-
assessment) in individual therapy at GIDS, people are only seen quarterly; 
whereas at CCGIC individual therapy could be more frequent and focussed on a 
range of factors; and private therapy could be weekly or even more frequent than 
that. With this information in mind, caution should be taken in interpreting these 
findings. 
 
While the satisfaction ratings for psychological support were not low per-se (40-
58% of participants strongly agreed or agreed that psychological support helped 
them to make decisions about their transition process), these satisfaction ratings 
were lower than those for other interventions. These findings are similar to those 
found in previous studies (Costa et al., 2015). Clinical psychologists are often 
seen as arbiters of who has access to gender affirming intervention and when 
(Bockting et al., 2004; Davies et al., 2013). Many of the people in this sample 
reported feeling clear about what they wanted (in terms of medical and surgical 
intervention) and may have seen the requirement to meet with a clinical 
psychologist as a barrier to this.  
 
The aim of psychological support at GIDS is to provide a non-judgemental 
therapeutic environment in which to support young people to ameliorate any 
behavioural, emotional, and relationship difficulties associated with their gender 
identity difficulties. Support, problem solving, communication and acceptance, 
from therapists and parents/carers, can enhance a young person’s understanding 
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of their identity; help them to fully consider the choices available to them; and 
allow time for exploration and self-acceptance of any number of authentic 
gendered selves – in identity and/or expression (Costa et al., 2015; Hidalgo et al., 
2013). But psychologists are also required to write letters of referral to 
endocrinologists and surgeons; and the ‘gatekeeping’ role of psychologists may 
make it difficult to establish a trusting therapeutic relationship between therapist 
and client, which constitutes a barrier to client satisfaction (Bockting et al., 2004). 
The gatekeeper role may also prevent clients from feeling able to fully disclose 
the full range of their experiences, fears and wishes. For example, they may 
believe that presenting as non-binary, more curious, or more gender fluid may 
mean they will not be put forward for medical intervention as quickly as if they 
would if they presented in a binary way (Eyssel et al., 2017). Importantly, this may 
prevent young people from fully engaging in support that could be extremely 
valuable (i.e. not with a goal of dissuading people from physical intervention, but 
to support them through the process, and help them fully engage in a process of 
understanding and exploring the complexities involved).  
 
As gender identity and expression continues to evolve in a non-binary way 
(Eyssel et al., 2017), and in a world that largely still views gender as binary, there 
could be an even greater role for clinical psychologists to play in assisting young 
people to explore their gender identity, navigate their coming out process, and 
consider complex decisions about physical interventions. With so many more 
trajectories possible (within a non-binary view of gender), it is important to reduce 
the barriers to engagement with psychological support wherever possible, and 
client satisfaction in this area should be continually assessed (Bockting et al., 
2004).  
 
The highest levels of dissatisfaction with the intervention process were with 
regards to the timings and length of process of interventions, with a large majority 
of participants stating that the process took too long and that interventions were 
accessed too late. There are no previous studies in adolescents or young adults 
with which to compare these findings. An earlier  
earlier UK study on satisfaction with two adult gender identity clinics found higher 
satisfaction rates, with 52% of clients being pleased or very pleased with the wait 
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time for the first appointment (Davies et al., 2013), but a lot has changed in the 
past 5-6 years since this data was collected (in terms of increasing numbers of 
referrals), and frustration with waiting times is now well known and documented in 
gender identity services in the UK and overseas (Ellis et al., 2015; Eyssel et al., 
2017). 
 
The Standards of Care for the Health of Transsexual, Transgender, and Gender 
Nonconforming People (Coleman et al., 2012) state that adolescents are eligible 
for puberty suppressing hormones once pubertal changes have begun; for cross-
sex hormones at age 16 (although increasingly the start depends on the duration 
the person has been taking hormone blockers and the psychological wellbeing of 
the adolescent; Cohen-Kettenis & Klink, 2015); and for genital surgery at 18 (if 
person has lived continuously for 12 months or more in the gender role congruent 
with their gender identity). However, the age at which the young people in the 
sample obtained these interventions were much later than this (i.e. 16.5 years for 
hormone blockers, 18.0 years for cross-sex hormones, 20.0 years for top surgery, 
and 21.0 years for bottom surgery). We do not know definitively why; but the 
current sample highlighted multiple barriers to accessing services (and physical 
intervention), many of which are supported by the literature; these include a 
general lack of services, the rising numbers of referrals to existing services 
(increasing wait times), appointments being rescheduled or referrals being 
delayed due to staff leaving or administrative errors, and a lack of specialists in 
the field (Davies et al., 2013). The current waiting time for the GIDS is 14 months, 
and for the CCGIC it is also 14 months. The findings in the current study suggest 
that the long waiting times and delays to intervention due to waiting times were 
experienced as particularly distressing to some. More resources and specialists in 
the field, and greater awareness of gender diversity (within schools, communities, 
and organisations), are much needed.   
 
People who had not taken hormone blockers were largely dissatisfied with their 
decision not to take hormone blockers, their level of involvement with the 
decision, and with the information/advice received from clinics. Much of the 
dissatisfaction related to the long waiting times and delays to accessing 
intervention. By the time they reached services, many (incorrectly) thought or 
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were told it was too late for them to take hormone blockers. Adolescents who 
have matured physically, but who are not ready to make a decision about cross-
sex hormones can use hormone blockers to inhibit unwanted physical functions, 
such as menses in assigned females and erections in assigned males (Cohen-
Kettenis & Klink, 2015). Furthermore, hormone blockers can also be used to 
induce a hypogonadal state prior to starting cross-sex hormones, which means 
cross-sex hormones can be given in lower doses than ordinarily needed to 
suppress endogenous sex steroid production (Cohen-Kettenis & Klink, 2015). It 
seems prudent that young people have access to this information while they are 
on the waiting list for GIDS, but not necessary for those waiting for the CCGIC as 
adult services do not titrate cross-sex hormones the way paediatric services do.  
    
With regards to post-surgical hormone advice, the vast majority of people (almost 
90%) who had undergone bottom surgery agreed or strongly agreed they were 
satisfied with the post-operative hormone advice they had received. However, 
less than half of those who underwent top surgery (all AFs) agreed or strongly 
agreed that they were satisfied with the post-operative hormone advice they 
received. The lower satisfaction rates in those who underwent top surgery could 
reflect the diversity of the professionals involved, and perhaps it is not well 
coordinated. However, the numbers of people who had surgical intervention are 
small and so caution must be taken in interpreting the findings.  
 
Due to the differing socio-cultural contexts young trans people grow up in, the 
findings from the current study can only be generalised to young British trans 
people. It would be beneficial to replicate the study in other countries to see if the 
patterns and observations are similar.   
 
4.4.4.2. Reflections on previous decisions.    
When asked if any previous decisions would be different a minority (14.7-32.8%) 
across the interventions, said yes. A majority of those who said yes made 
reference to wishing to have started interventions sooner, particularly hormone 
blockers, but also cross-sex hormones, surgery and counselling/therapy. As 
mentioned previously, delays to interventions can arise for many different 
reasons, and this is a useful area to focus on in future research. Two people 
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spoke about how their understanding of gender changed over time, and cited this 
as the reason why some of their decisions about interventions might be different. 
Regret is not a word they used, nor would it be an accurate way to describe their 
reflections. These findings support the emergence of a more nuanced and less 
binary conceptualisation of gender identity, and point to the complexities of how 
people reconcile their gender identity with their physical body (Steensma et al., 
2011).    
 
4.4.5. Research Question 4: What are the Longer-Term Outcomes for the Former 
GIDS attendees?  
4.4.5.1 Gender identity and body image. The majority of the sample were 
satisfied with their gender identity, and majority were somewhere between 
dissatisfied and neutral with their body image. Previous studies in a cohort of 
Dutch young adults found that body image difficulties persisted through puberty 
suppression, but remitted after taking cross-sex hormones and undergoing 
gender affirming surgery (de Vries et al., 2014). However, the Dutch study was a 
prospective follow-up study of young adults at particular times post-intervention; 
and thus it is difficult to draw direct comparisons with the finding of the current 
study, which may have been an artefact of the cross-sectional nature of the study 
(i.e. in that many participants were only part way through their intervention 
journeys). Nevertheless, the pattern of responses do appear to bear on the semi-
disjunction between the social-cognitive framing of gender, and the material 
reality of an embodied experience (e.g. a transman may be happy with his 
masculine gender identity, yet feel that his body is a poor match to an ideal he 
happens to hold). This is a potentially interesting area for further research. 
Furthermore, AMs reported greater satisfaction with their body (in relation to their 
gender) than AFs, but the effect size was small so the clinical relevance of this is 
questionable, and the numbers/sample size are also small so interpretation 
warrants caution.  
 
4.4.5.2 Psychological wellbeing. The majority of the sample reported average 
levels of wellbeing. Compared to the average scores of the validation sample 
(population sample median = 51; student sample median = 50; Tennant et al., 
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2007b), the current sample was only slightly lower in wellbeing (median = 48) but 
samples from both studies were all in the average range (40-59). While the 
measure was useful in providing a broad measure of wellbeing in the current 
sample, it is generic. Development of a trans-specific wellbeing measure could be 
warranted given the unique factors that have the potential to contribute to 
wellbeing in this population.  
  
4.4.6. Research Question 5: What Impact do Interventions Have on body image 
and wellbeing? 
I originally intended to look at the impact of the different interventions on 
wellbeing and body satisfaction, as this would have been useful in determining 
whether some interventions, or combination of interventions, had a greater impact 
on body image and wellbeing than others. Unfortunately there were not enough 
numbers in the sample to do this. Initially I decided to combine individual therapy, 
group sessions and family therapy to make a ‘psychological intervention’ variable; 
combine hormone blockers and cross-sex hormones to make a ‘medical 
intervention’ variable; and combine top and bottom surgery to make a ‘surgical 
intervention’ variable. However, after considering the conceptual variation within 
the psychological intervention category, I decided against this. The focus, 
content, frequency and length of sessions vary widely across intervention type 
and service, so conceptually, it did not feel appropriate to create and analyse the 
impact of a combined psychological intervention category.  
 
The positive association between surgical intervention and body image and 
wellbeing is congruent with previous research in adults (Owen-Smith et al., 2018). 
However, there are a number of factors to consider that mean caution should be 
taken when interpreting these findings. First, it was not possible to calculate the 
interactions between medical and surgical intervention as no-one in the sample 
had undergone surgical intervention but not taken cross-sex hormones. This 
finding makes sense in light of the staged approach to intervention taken at the 
GIDS, whereby reversible treatments are provided before irreversible treatments 
(Coleman et al., 2012; Delemarre-van de Waal & Cohen-Kettenis, 2006; 
Hembree et al., 2009, 2017). However, as illustrated by one of the participants 
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(who self-identified as partly a man, partly a woman), due to increased variation in 
the ways people identify, intervention pathways may not always follow this linear, 
staged approach (i.e. this participant wanted to consider hormone blockers as a 
long-term treatment, not cross-sex hormones, but still wanted to have top 
surgery). Not being able to determine whether there were any interaction effects, 
means caution must be taken when interpreting the main effects of medical and 
surgical interventions on body image and wellbeing.  
Second, the sample size calculations suggested there was not enough people in 
the groups to detect a significant effect (should one exist to detect), providing 
another reason for being tentative when interpreting the observed effects. Third, 
the effect sizes and differences in body image and wellbeing between groups 
were small, and all still within average range, and thus may not be clinically 
relevant. Future longitudinal studies, with much larger sample sizes and with 
people who have completed their intervention journeys, are needed in order to 
draw more definitive inferences about how interventions impact body image and 
wellbeing, 
 
4.2. Strengths and Limitations of the Research 
 
The use of an online questionnaire represents a strength of the current study as it 
potentially reduced interviewer bias, item non-response/missing data due to 
skipping errors, minimized data transcription and transfer errors, and offered a 
high degree of privacy and anonymity, which likely led to increased self-
disclosure and less social desirability bias (De Leeuw, Hox, & Kef, 2003). The 
questionnaire format relies on self-report data, which can be subject to bias due 
to systematic misreporting (e.g. over reporting of normative behaviour and under 
reporting of stigmatized behaviour due to social desirability) or forgetting. 
However, various techniques have been shown to reduce socially desirable 
responding, including self-administration and assurances of anonymity and 
confidentiality (Tourangeau & Yan, 2007). Due to the steps taken to reduce 
socially desirable responding, it is unlikely that misreporting made a substantial 
contribution to the results.  
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The use of a quantitative online questionnaire was appropriate as facilitated the 
collection of data that answered the research questions. However, without 
context, much information is missing. For example, we do not know about 
experiences prior to referral, the existence of comorbidities, experiences at school 
and at home, levels of parental support etc., all of which are critical in providing a 
comprehensive picture of young people’s experiences. The inclusion of comment 
boxes, and text that encouraged people to provide context to their answers was a 
strength of this questionnaire as it provided valuable contextual information to the 
quantitative data. While people often skip past comment boxes in questionnaires, 
the high response rate in the text boxes of this study suggests that people wanted 
to be heard and had a lot to say.  
 
As with all cross-sectional data, it was not possible to make causal inferences 
from the data (e.g. with respect to associations between stage/type of gender 
affirming intervention and body image satisfaction or wellbeing). However, the 
main aim of the study was to determine the intervention pathways chosen by the 
ex-GIDS clients and their satisfaction with the intervention process, and the 
current questionnaire was well-suited for these purposes.  
 
The response rate (24%) was on the lower (but acceptable) end for survey 
research (Hess, Rossi Neto, Panic, Rübben, & Senf, 2014). However, in the 
context of the population of interest, the response rate was considered an 
achievement. Historically, trans-identified people have had a difficult relationship 
with psychology/psychologists, due to the historic (and ongoing) pathologising of 
gender identity; and studies indicate that trans individuals can be distrusting of 
trans-related research in that it may result in reinforcing pathological perspectives 
on trans identities (Eyssel et al., 2017; Richards, Barker, Lenihan, & Iantaffi, 
2014; Tebbe & Budge, 2016); and some people may have had unresolved issues 
with services due to long waitlists and delayed access to intervention (Davies et 
al., 2013). None of the population of interest had any ongoing contact with GIDS 
and many would have had no further contact with the CCGIC either; after 
transitioning it is common for people to move away from the area to avoid people 
who had known them in their gender assigned at birth (Khoosal, Grover, & Terry, 
2011).  
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Multiple efforts were made to maximise the response rate, including piloting the 
questionnaire for length and language acceptability, offering an incentive to 
participate, ensuring anonymity, informing participants of the approximate 
completion time, including a progress bar, using skip logic to cut down the 
completion time, offering to send a summary of the results to participants, and 
extending the duration of the survey’s availability. Nevertheless, the lower 
response rate may have introduced non-response bias, which is variation 
between the responses of people who were sent survey invites and the 
responses of the actual respondents. This type of bias is usually created by 
refusals to participate and/or an inability to reach potential respondents. 
Unfortunately one cannot know about that which one does not know, and that is a 
limitation of any research where there are non-responders. The sample was 
broadly representative of the population in terms of age and assigned gender, but 
caution should be taken in interpreting the findings due to not knowing anything 
about those that did not respond. The recruitment is set to continue to the end of 
2018, which should increase the response rate; and the study may also be 
opened up to ex-GIDS clients who were referred to other adult clinics throughout 
England, which will likely increase the sample size considerably.   
 
Participants were asked to estimate the age they first became aware of a 
difference between the gender they were assigned at birth and their 
expressed/experienced gender. In recognition that this might be a difficult 
question to answer, a text answer format was provided. During the analysis of the 
data it because apparent that people seemed to want to answer the question in 
two ways – 1. When they first became aware of a difference themselves, and 2. 
When they first had the language to be able to talk about it with others. Future 
research should consider this. Furthermore, data collected about early childhood 
thoughts, feelings and behaviours are subject to potential recall bias, which is 
why it is important for future studies to explore these factors in prospective 
longitudinal studies.  
Satisfaction with gender identity and body image were measured using a single 
item question – ‘In general, how do you feel about the following aspects of 
yourself? 1. Your gender identity, and 2. Your body in relation to your gender 
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identity. Participants could answer with ‘very satisfied’, ‘satisfied’, ‘neither satisfied 
nor dissatisfied’, ‘dissatisfied’, ‘very dissatisfied’, and ‘I prefer not to say’. It might 
have been preferable to use standardised measures of gender dysphoria and 
body image, such as the 12-item Utrecht Gender Dysphoria Scale (UGDS), and 
the 30-item Body Image Scale (BIS). However, using these standardised 
measures was prohibitive, because they would have added considerable length 
to a questionnaire that was already quite long, and doing so may have increased 
the participant drop-out rate (which was quite low in the current study). Also, the 
findings involving gender identity and body image in the current study, 
approximated findings found in previous studies that had used more 
comprehensive, standardised measures. The current study is not an outcome 
study; it is a cross-sectional snap-shot with the primary aim of capturing the 
intervention pathways of young people referred to an adult gender identity clinic. 
With that in mind, the use of a single item measure about gender identity and 
body image was deemed appropriate to address the broad research questions of 
the current study.  
 
The relatively small sample size (N = 72) prevented running inferential statistics 
that would have allowed predictions to be made. However, given that the study 
was the first of its kind, the research was in many ways exploratory, and as such, 
it is prudent to first know what it is you are looking at before you start attempting 
to make predictions. In an attempt to work around the small sample size (and the 
corresponding small numbers in the cells), interventions were combined to make 
intervention types (e.g. hormone blockers and cross-sex hormones were 
combined to create ‘medical interventions’ and top and bottom surgery were 
combined to create ‘surgical interventions’). While analysis of each individual 
intervention (e.g. cross-sex hormones or top surgery) would have been more 
informative in terms of knowing how they impact wellbeing and body image, the 
existing questions were adequate in capturing the extent to which interventions 
(more broadly) impact wellbeing and body image.  
 
The study sample (N = 72) constitutes a select group, within a select group (N = 
365 young people referred from the GIDS to CCGIC), and therefore the findings 
have limited generalisability. These data describe a proportion of young adults 
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who wanted to, and were able to, access services providing support for gender 
dysphoria and gender affirming medical/surgical interventions. These results may 
not generalise to all who access support, or to gender diverse young adults who 
are not receiving trans-related care, and who do not wish to transition with the 
use of cross-sex hormones or surgery.  
 
4.3. Reflections of the Researcher 
 
I was initially drawn to this area of study because of my own experiences, and 
exploration of my gender identity as a pre-pubescent child; and my later coming 
out as a gay woman. At around the age of seven or eight I held a strong desire to 
be a boy (I did not feel I was a boy). For several years, I dressed in boys clothes, 
had a short haircut, sometimes used a boy’s name, and had a clear preference 
for activities stereotypically deemed ‘boy’s activities’ (i.e. playing football, play 
fighting, climbing trees, jumping off ramps on bikes, having mud fights etc.). I 
grew up in a family and community that accepted me as I was, and I do not ever 
recall feeling self-conscious about my ‘cross-gender’ behaviour and preferences. 
Just after puberty, I began to strongly identify as a girl, and disliked being 
mistaken for a boy. I grew my hair long and started wearing ‘girl’s clothes’. Shortly 
after that, I had my first experience of same-sex attraction, and in my early 20s I 
came out as gay. I grew up in the 1970s/80s, and wonder, if I had a grown up 
today, would I have felt as comfortable to explore my gender identity as I did back 
then? Or would people have ‘rushed in’, asked questions about my gender 
identity, and referred me to a gender identity clinic? As a child, I was never 
discouraged from or made to feel ashamed of exploring my gender identity, and 
(as research suggests) I believe this was part of me developing my own identity. 
 
So my interest in this area pertains very much to an interest in how families, 
societies, and cultures frame and constrain people’s experiences and 
expressions of their own gender (across the lifespan). As a (gay) woman, I am 
acutely aware of how societal expectations and sanctions have constrained my 
ability to express my gender identity. Even now, as comfortable as I am with my 
sexuality, my outward expression of my gender identity will, at times, depend on 
where I am and who I am with. So it is with that knowledge and experience that I 
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wonder about the stigmatizing context that society creates, and how it might give 
rise to the dysphoria felt by some gender diverse young people. If families, 
societies and cultures had less rigid gender binaries (i.e. did not sanction people 
so heavily for challenging/subverting gender norms), would people (with and 
without gender identity concerns) feel more able to express their gender in 
whichever way they choose? And in the context of gender affirming intervention, 
would we see fewer requests for intervention?  
 
As the research project began to take shape, I became conscious of language 
and the power it gave me, as the researcher, to frame the research in a particular 
light. I also became aware that I was ‘working’ with a population who have 
(historically) had a difficult relationships with clinical psychology/ psychologists 
due to the historical (and ongoing) pathologising of gender identity; and that many 
had felt let down by previous researchers due to personal and political agendas 
fuelling problematic and potentially damaging writing and research without 
reflecting on how it might impact those being written about (Davies et al., 2013; 
Eyssel et al., 2017; Richards et al., 2014; Tebbe & Budge, 2016).  
 
Although quantitative research is often seen as ‘objective’, in that it deals with 
‘facts’ and figures, the language the author uses can position people/the data in a 
particular light to fulfil a particular agenda. I hoped that by being mindful and 
attentive to language, including as much of the ‘voices’ of the participants as 
possible (albeit from text box data), and using supervision well, and I could 
produce a piece of research that the participants would feel accurately 
represented and benefitted them. However, in future projects, I would prefer to 
work in complete partnership with people from the trans-community; making 
service-users a more integral part of the entire research process (from design and 
data collection to analysis and dissemination). I feel this more strongly than I have 
in previous research projects with cis-gender populations.   
 
4.4. Implications and Recommendations  
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4.4.1. Implications for Clinical Practice 
In a climate where patients/clients are increasingly seen as consumers of 
healthcare, patient/client satisfaction has become a key indicator of quality and 
success, and one that is integral to evolving relationships between services users 
and clinicians (Bockting et al., 2004). Measurement of client experiences and 
satisfaction provides an opportunity for reflection on and improvement of care. 
Timely access to medical and surgical interventions is critical to the wellbeing of 
some trans people, and the palpable frustration regarding waiting times and 
delays to support and intervention found in the current study are already well 
known and documented in gender identity services in the UK and overseas 
(Davies et al., 2013; Ellis et al., 2015; Eyssel et al., 2017). Waiting times have 
risen in recent years (Davies et al., 2013), and are set to continue rising. 
Recommendations and measures that could be implemented to address long wait 
times and reduce associated distress include: 
 
- Increasing funding for existing and new satellite services 
- Increased training of specialists 
- Providing appropriate training to other health professionals (i.e. clinical 
psychologists working in CAMHS, IAPT and school settings, and GPs). A 
large number of gender diverse young people will never desire or seek 
medical intervention, and therefore providing training to other health 
professionals will make support more accessible and free up GI clinic staff 
to support clients with a higher level of need, and those who do wish to 
pursue medical and surgical intervention 
- Providing trans-awareness training more broadly to all professionals who 
work with young people (e.g. teachers, social workers, support/youth 
workers etc.) 
- Incentivise existing professionals to increase retention of current 
specialists 
- Implement routine measures of service quality and client satisfaction 
regarding waiting times 
- Increase the ways in which people on the waiting list can contact the clinic 
(i.e. email, phone, online form etc.). The adult gender identity clinic in 
Nottingham have a support line that is run by Gendered Intelligence (a 
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non-profit community interest company whose aim is to increase public 
understanding of gender diversity), which is a model that could be 
replicated  
- Increase the number of resources available to those on the waiting list (i.e. 
support groups, mentors, information on networks of counsellors and 
therapists with further education and training in gender identity issues etc.) 
- Set up a user-group advisory board to improve partnership with the local 
trans community (Eyssel, 2017) 
 
While the satisfaction levels for psychological support were good for two thirds of 
the sample, there is room for improvement for the remaining third. In line with the 
WPATH Standards of Care (Coleman et al., 2012) a clinical psychologist referral 
is currently needed in order for young people to access medical and surgical 
intervention, which is why clinical psychologists are often seen as arbiters of who 
gets access to medical and surgical intervention and when (Bockting et al., 2004; 
Davies et al., 2013). Many trans people take issue with the perceived need for 
someone other than themselves to decide whether they are eligible medical and 
physical intervention (Bockting et al., 2004); and although it is designed to 
promote quality of care, this gatekeeping role can create an inherent barrier to 
client satisfaction by making it difficult to establish a trusting therapeutic 
relationship between therapist and client; without which it is difficult to set and 
achieve therapeutic goals (Bockting et al., 2004). Furthermore, the gatekeeping 
role might prevent young people from speaking openly and honestly about their 
thoughts, feelings and experiences due to the perceived impact it might have on 
their access to medical and surgical intervention (Ellis et al., 2015). Not only does 
this represent a barrier to satisfaction, but importantly, it represents a barrier to 
people fully engaging in a process of understanding and exploring all the 
complexities involved, and of receiving much needed support throughout the 
transition process. Recommendations and measures that could be implemented 
to improve client experience of, and satisfaction with, psychological support could 
include: 
 
97 
 
- Separating assessment from support (i.e. providing psychological support 
that is not linked to assessment and referral for medical and surgical 
intervention) 
- Setting up a trans community advisory board (involving former clients who 
have experienced the process) to inform young people, early in the 
process, about what to expect from psychological support (Bockting et al., 
2004) 
- Providing continuing professional development (CPD) training to deepen 
clinicians’ knowledge of non-binary gender identities (and how to work 
effectively with this population in the context of medical and surgical 
intervention) 
- Implementing ongoing quality improvement measures to explore the 
gatekeeping role and assess how it can be managed within therapy to 
facilitate a positive therapeutic outcome 
- Providing high quality supervision where clinicians can reflect on the 
complexities of, and how to balance (personally and professionally), the 
dual roles of ‘gatekeeper’ and therapist 
- Exploring with service-users what people want from psychological support, 
in terms of timing, content, frequency and duration 
- Implementing a formal mechanism by which clients can provide feedback 
about psychological support that will be actively responded to and 
monitored over time (Bockting et al., 2004) 
 
4.4.2. Implications for Research  
The study identified the weighing of risks and benefits of medical and surgical 
intervention as a key factor that influenced people’s decisions about interventions. 
Unfortunately, we do not know how participants assessed the risks and benefits 
of gender affirming interventions, or what sources they used to make these 
evaluations. Studies suggest that risk assessments are often driven by emotions 
rather than facts (Ropeik & Clay, 2002). Effectively communicating risk to patients 
is a key part of insuring that consent is informed (Paling, 2003), but many doctors 
do not have adequate training in how to effectively communicate risk information 
to patients (Paling, 2003). Further qualitative research is needed to thoroughly 
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explore that ways in which gender diverse people evaluate the risks associated 
with medical and surgical intervention, and the ways in which health professionals 
involved in trans-related healthcare communicate risk information to patients. This 
information could be usefully incorporated into written materials, online 
information sources, and risk-communication training for professionals. Questions 
for future research might include: 
 
- How do gender diverse people conceptualise and evaluate the risks, 
challenges and benefits of medical and surgical interventions? 
- What sources of information do people use to make these evaluations? 
- When is the optimum time for people to receive risk information? 
- How do different professionals involved in trans-related healthcare 
conceptualise the risks involved in medical and surgical intervention? 
- When and how do different professionals involved in trans-related 
communicate risk information to clients? 
 
The study identified online sources of information as another a key factor that 
influenced people’s decisions about gender affirming interventions. Although 
some NHS websites were cited as being influential online sources of information 
when making decisions about interventions, the majority of online sources cited 
were largely unregulated websites (i.e. blogs, photo and video sharing websites, 
social networking sites, bulletins boards etc.). While these websites might be 
ideal sources of information on people’s transition experiences, due to being 
unregulated, they may not contain accurate and reliable health information. 
Increasingly, we are exposed to a huge amount of health information online 
(Morahan-Martin, 2004), but people often report finding it difficult to know which 
internet sources to trust (Morahan-Martin, 2004). Further qualitative research is 
needed to thoroughly explore the nature and content of trans-related health 
information online. Questions for future research might include: 
 
- Why do people look online for information about gender affirming 
interventions and related issues? 
- What online sources of information about interventions and related issues 
do people find most helpful and why? 
99 
 
- What types of information can be found on the websites people cite as 
most helpful? 
- What are people’s perceptions of the information they find and how to they 
make assessments about the quality, authority and trustworthiness of the 
information they find? 
 
Our understanding of experiences and outcomes in adolescent and young adult 
clinic populations is based on a small number of retrospective and prospective 
studies, with small sample sizes and short follow-up periods. The current study 
adds to this small body of literature by exploring intervention pathways and 
satisfaction with the intervention process. However, due to the aforementioned 
limitations of the current study, larger scale, prospective, longitudinal studies are 
much needed as they will facilitate inferences and enable us to draw more 
definitive conclusions in this population.  
 
 
4.5. Conclusion  
 
The thesis findings provide a unique contribution to the small body of existing 
literature on gender diverse adolescents and young adults, and have succeeded 
in filling some gaps in the literature in this area. The study shows that a higher 
number of young adults who are referred from child and adolescent services to 
adult services do pursue (or intend to pursue) the different stages of medical and 
surgical intervention, and many of those that do are largely satisfied with the 
intervention process. Despite the various limitations of the thesis, the findings 
help provide a clearer picture of the intervention pathways and satisfaction of with 
the process of these young adults; and areas requiring improvement have been 
highlighted. Taken together, these findings will enable better tailoring of gender 
identity services for young people, and are an important step towards ensuring 
that the support and intervention provided meets the needs of this diverse and 
growing population. 
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APPENDICES 
Appendix A. Flow chart for literature search  
 
 
 
 
 
 
Reasons for exclusion (n = 70): 
 58 = >25 at follow-up  
 10 = no gender affirming intervention received  
 1 = not trans population (mixed population who underwent vaginoplasty) 
 1 = not published in English (published in French) 
  
Records Identified through database searching 
(n = 4858) & other sources (n = 2)
Records screened - title & abstract (n = 4860)
Full-text articles assessed for elligibility (n = 
75)
Full-text articles excluded (n = 70). Reasons 
for exclusion listed below. 
Articles remaining in the review (n = 5) 
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Appendix B. NHS ethical approval letter (first page) 
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Appendix C. Sponsorship and indemnity letter (first page) 
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Appendix D. Information sheet 
 
Information Sheet  
  
  
Title of Project: What Happens to Gender Diverse Young People who are 
Referred to an Adult Gender Identity Service from a Child and Adolescent 
Service? A Cross-Sectional Look at Treatment Choices and Outcomes 
  
This study has been approved by the NHS Research Ethics Committee.         
Project ID Number:   225974 
Protocol reference number: Version 2; Date 10.11.2017 
  
 We would like to invite you to take part in our research study. 
 Before you decide whether to take part we would like you to understand 
why the research is being done and what it would involve for you 
 Part 1: Tells you about the study and what will happen if you choose to take 
part 
 Part 2: Gives you more detail about the conduct of the study 
 Please ask if there is anything that is not clear (by sending email to 
u1534920@uel.ac.uk) 
  
Part 1 
Why are we doing the study? 
There has been a substantial increase in the number of people seeking 
assessment, support and treatment from gender identity services for children and 
young people. However, there has been very little research in the UK on the 
longer-term outcomes and journeys of gender diverse young people. In order to 
adequately meet the needs of young people in this area, it is important to explore 
these longer-term outcomes. 
  
Why have I been chosen? 
We have written to everyone who was discharged from the Gender Identity 
Development Service (GIDS) between 2011 and 2016 and referred to Charing 
Cross adult gender identity clinic, and invited them to take part in the study by 
filling out a questionnaire about their treatment choices and longer-term outcomes 
since leaving GIDS. 
  
Do I have to take part? 
No. It’s up to you to decide whether or not to participate in the research. Your 
usual health care will not be affected by whether you choose to take part or not as 
your participation will be completely anonymous. Take as long as you need to 
reach a decision, and please do talk to others about the study if you wish. If you 
do decide to take part, you will be asked to sign an online consent form. 
  
What will happen to me if I take part? 
If you decide to take part in the questionnaire study you will be directed to an 
online questionnaire that will ask you about the decisions and choices you’ve 
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made and outcomes since leaving the Gender Identity Development Service 
(GIDS). 
  
Will I benefit from taking part? 
Reflecting back on your experiences can be an informative and thought provoking 
experience, and as a thank you for your input in the study, each participant who 
completes a questionnaire will be invited to enter a prize draw to win a £100 
Amazon voucher. Entry into the draw is completely optional. 
  
Are there any risks involved? 
We hope that you will find reflecting on your experiences an informative and 
thought provoking experience. However, you may find this process difficult, or 
upsetting and so will be provided with a list of support services you can contact 
should you feel you need some support extra support. 
  
What happens when the study ends? 
The results of this study will be written up and submitted for publication in 
academic journals and presented at conferences. We hope the findings will lead 
to improved services for children and young people. 
  
Will my GP and/or clinic care team know I am in the study? 
No (only if you choose to tell them yourself). 
  
Will the information I give in the study be kept confidential? 
Yes. We will follow all ethical and legal guidelines, and all information about you 
will be handled in confidence. Detailed information on this is given in Part 2. 
  
Can I withdraw from the study once I’m in it? 
Yes. You can withdraw from the study at any before the data has been analysed. 
  
Part 2: Detailed information about the conduct of the study 
What will happen to the information I provide? 
All information about you will be treated confidentially and in accordance with the 
Data Protection Act 1998. We will keep any personally identifying information 
(e.g. your email address if you decide to go into the prize draw or wish for a 
summary of the study results to be sent to you) separate from the rest of the 
study information about you. Your study data will only be identifiable by a unique 
participant identification number. All anonymised data will be kept on a password 
protected file on a password protected computer. Only authorised persons (the 
research team and the regulatory bodies that monitor researchers in the UK) will 
have access to your personal data. The information you provide will not be 
shared with your care team or GP. 
  
What if there is a problem or what if something goes wrong? 
If you wish to complain, or have any concerns about any aspect of the way you 
have been approached or treated by members of staff due to your participation in 
the research, National Health Service or UEL complaints procedures are 
available to you. Please contact the researcher if you would like more information 
on this. In the unlikely event that you are harmed by taking part in this study, 
compensation may be available. If you suspect that the harm is the result of the 
117 
 
Sponsor’s (University of East London) negligence then you may be able to claim 
compensation. After discussing with the researcher, please make the claim in 
writing to Lorna Hobbs who is the Chief Investigator for the research and who is 
based at UEL: School of Psychology, The University of East London, Stratford 
Campus, London E15 4LZ. The Chief Investigator will then pass the claim to the 
Sponsor’s Insurers, via the Sponsor’s office. You may have to bear the costs of 
the legal action initially, and you should consult a lawyer about this. 
  
What will happen to the results of this study? 
The results of this study will be written up as a Clinical Psychology Doctoral 
thesis, and will also be submitted for publication in academic journals and 
presented at conferences. We hope the findings will lead to improved services for 
children and young people. We would be happy to send you a summary of the 
results – if you would like us to do so please enter your emails address in the 
appropriate box on the consent form. 
  
Who is organising and funding the study? 
The study is being run by The University of East London. It is funded by the NHS 
as part of a Clinical Psychology Doctorate thesis. It is sponsored by The 
University of East London. The research team are: Dr Lorna Hobbs (Trainee 
Clinical Psychologist); Dr Kenneth Gannon (Educational Supervisor); and Dr 
Sarah Davidson (Clinical Psychologist). 
  
Who has reviewed the study? 
To protect the interests of participants, all research in the NHS is looked at by an 
independent group of people, called a Research Ethics Committee. This study 
has been reviewed and given a favourable opinion by the London Riverside 
Research Ethics Committee (REC reference: 17/LO/1674. IRAS project ID: 
225974). 
  
Is there an independent contact point where I can get general advice about 
taking part in research? 
Yes. INVOLVE is a national advisory group that supports greater public 
involvement in NHS, public health and social care research. They provide advice 
and information on public involvement in research. You can find more information 
on their website: www.invo.org.uk or you can contact them at: INVOLVE, Wessex 
House, Upper Market Street, Eastleigh, Hampshire, SO50 9FD or Telephone: 023 
8065 1088. 
  
Is there a contact point where I can find out further details about the study? 
Yes. If you have any questions or would like more information please contact 
Lorna Hobbs at ___________________ 
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Appendix E. Consent form  
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Appendix F. Invitation letter to participate in the study 
 
     
            
 
 
 
           
[Enter date] 
 
Hello,  
 
My name is Lorna Hobbs and I am a Clinical Psychology Doctoral Researcher at 
the University of East London. In recent years you were discharged from an NHS 
child and adolescent clinic in North London. I am writing to you to invite you to 
participate in a research survey I am conducting. The aim of the survey is to 
follow-up previous young people who attended the clinic to see if the advice, 
treatment, and decisions they made have been helpful in the longer-term.  
 
I would be extremely grateful for your help and participation in the survey. Little is 
currently known about the longer-term outcomes of the young people who 
attended the clinic. With your input we will gain a better understanding of these 
longer-term outcomes and this will enable the service to better tailor support for 
the increasing number and diversity of young people seen at the clinic.  
 
If you would like to participate please follow this link to find out more and to 
access the online questionnaire [web address]. The questionnaire will take 
approximately 10-15 minutes to fill out. You responses will be completely 
University of East London 
Water Lane, Stratford,  
London, E15 4LZ 
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anonymous (as no identifying information is collected), and any clinicians you see 
will be unaware of your participation in this research (unless you speak to them 
about it yourself). As a thank you for participating, you will be entered into a prize 
draw to win £100 worth of Amazon vouchers. Your participation is very much 
appreciated and valued.  
 
If you have any questions at all please do not hesitate to contact me via email at 
___________________.  
 
Kind regards,  
 
Lorna Hobbs 
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Appendix G. Questionnaire  
 
On the electronic version of the questionnaire the option ‘I do not wish to answer’ 
was available for each question. Note: The actual format differed in the online 
questionnaire as there were skip patterns embedded into the questionnaire to 
avoid people having to read information/questions that were not relevant to them.  
 
1. Age__________ 
2. What was your assigned gender at birth? 
_______________________________ 
3. Age you first became aware of a difference between your assigned gender 
and your gender/gender identity___________   
4. Age you were first referred to the Gender Identity Development Service 
(GIDS)___________ 
5. Age you started socially transitioning ___________  
6. How would you describe your gender identity? 
a. I identify as a man 
b. I identify as a woman 
c. I identify as a trans-man 
d. I identify as a trans-woman 
e. I identify partly as a man, and partly as a woman 
f. I identify neither as a man or a woman 
g. I identify as non-binary/gender fluid or similar 
h. I don’t know what my gender identity is (yet) or I am questioning my 
gender identity 
i. Other (please 
specify)_______________________________________________ 
7. Ethnicity  
 White British/Irish 
 White other 
 Black/African/Caribbean/Black British 
 Asian/Asian British 
 Mixed/multiple ethnic groups 
 Other (please describe) 
_________________________________________________ 
 Rather not say 
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8. Relationship status  
 Married/civil partnership 
 Living with partner 
 In a relationship(s) 
 Single 
 Divorced 
 Widowed 
 Other (please describe) 
_________________________________________________ 
 Rather not say 
 
9. Employment status (tick any/all that apply) 
 Working (full or part-time) 
 At College or University 
 In training 
 Unemployed 
 Retired 
 Other (please specify) 
____________________________________________________ 
 Rather not say 
 
10. Have you ever received any of the following in relation to your gender 
diversity?  
 
Counselling/therapy (tick all that apply) 
 
Individual counselling/therapy sessions  
Where did you attend the individual counselling/therapy sessions? 
 GIDS 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Adult Gender Identity Clinic 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Other NHS service 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
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 Private 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Other ____________________________________________ 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
Comments____________________________________________ 
      
Group sessions  
Where did you attend the group sessions (tick all that apply) 
 GIDS 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Adult Gender Identity Clinic 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Other NHS service 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 
 Private 
Approximate number of sessions: 1-6   6-12  12-18  19+  
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Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Other ____________________________________________ 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
Comments____________________________________________ 
 
Family sessions  
Where did you attend the family sessions (tick all that apply) 
 GIDS 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Adult Gender Identity Clinic 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Other NHS service 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Private 
Approximate number of sessions: 1-6   6-12  12-18  19+  
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Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
 Other ____________________________________________ 
Approximate number of sessions: 1-6   6-12  12-18  19+  
Attending this type of counselling/therapy helped me to make 
decisions about my transition process (strongly agree, agree, 
neither agree/disagree, disagree, strongly disagree) 
 
Comments___________________________________________ 
 
Hormone blockers 
a. Yes (currently taking them)/Yes (but no longer taking them)/No 
b. If no:  
I am satisfied with my decision not to take hormone blockers 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments_____________________________________________
____________ 
c. If yes or no:  
I felt involved in the decision-making process about whether or not 
to take hormone blockers 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments_____________________________________________
____________ 
 
The information/advice I received about hormone blockers from the 
clinic(s) I attended helped me make a decision about hormone 
blockers 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments____________________________________________ 
d. If yes:  
 
Age you first started hormone blockers______ 
 
Where did/do you obtain hormone blockers? (tick all that apply) 
 Child/adolescent gender identity clinic 
 Adult gender identity clinic 
 GP 
 Private clinic 
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 Online 
 Overseas 
 Other 
___________________________________________________ 
 
Comments 
___________________________________________________ 
 
I am satisfied with my decision to take hormone blockers 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments__________________________________________ 
 
e. If yes (but no longer taking them): 
 
Age you stopped hormone blockers ___________ 
 
I am satisfied with my decision to stop taking hormone blockers 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments____________________________________________ 
 
Cross sex hormones  
a. Yes (currently taking them)/Yes (but no longer taking them)/No 
b. If no:  
I am satisfied with my decision not to take cross-sex hormones 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments____________________________________________ 
c. If yes or no:  
I felt involved in the decision-making process about whether or not 
to take cross-sex hormones 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments____________________________________________ 
 
The information/advice I received about cross-sex hormones from 
the clinic(s) I attended helped me make a decision about cross-sex 
hormones 
Strongly agree(1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments____________________________________________ 
d. If yes: 
 
Age you started cross-sex hormones__________ 
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Where did/do you obtain cross-sex hormones? (tick all that apply) 
 Child/adolescent gender identity clinic 
 Adult gender identity clinic 
 GP 
 Private clinic 
 Online 
 Overseas 
 Other_____________________________________________ 
 
Comments 
___________________________________________________ 
I am satisfied with my decision to take cross-sex hormones  
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
____________________________________________________ 
e. If yes (but no longer taking them): 
 
Age you stopped taking cross-sex hormones___________ 
 
I am satisfied with my decision to stop taking cross-sex hormones 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments____________________________________________ 
 
Surgery 
a. yes/no 
b. If no:  
I am satisfied with my decision not to have any surgery(s) 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
___________________________________________________ 
 
c. If yes or no:  
I felt involved in the decision-making process about whether or not 
to have any surgery(s) 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
___________________________________________________ 
 
The information/advice I received about surgeries from the clinic(s) 
I attended helped me make a decision about surgery 
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Strongly agree(1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
___________________________________________________ 
 
a. If yes: 
 
What surgery(s) have you had? 
 
1. Top/chest surgery(s)  
Age you had this/these surgery(s)?__________ 
Where did you have this/these 
surgery(s)?_______________________ 
 
I am satisfied with my decision to have this/these surgery(s)  
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
I am satisfied with the quality of the post-op hormone advice I 
received? Strongly agree (1), Agree (2), Neither agree nor 
disagree (3), Disagree (4), Strongly disagree (5), NA (I didn’t 
receive any post-op hormone advice). 
 
Comments 
_________________________________________________ 
 
 
2. Bottom/genital surgery(s) 
Age you had this/these surgery(s)? 
Where did you have this/these 
surgery(s)?______________________________ 
 
I am satisfied with my decision to have this/these surgery(s) 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
I am satisfied with the quality of the post-op hormone advice I 
received? Strongly agree (1), Agree (2), Neither agree nor 
disagree (3), Disagree (4), Strongly disagree (5), NA (I didn’t 
receive any post-op hormone advice). 
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Speech and Language therapy 
a. Were you offered Speech and Language therapy? yes/no 
b. If no:  
Would you like to have been offered Speech and Language 
therapy? yes/no 
c. If yes: Did you have Speech and Language therapy? yes/no 
d. If no: 
I am satisfied with my decision not to have speech & language 
therapy 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
____________________________________________________ 
 
e. If yes or no:  
I felt involved in the decision-making process about whether or not 
to have speech and language therapy 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
____________________________________________________ 
 
The information/advice I received about speech & language therapy 
from the clinic(s) I attended helped me make a decision about 
speech & language therapy  
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
____________________________________________________ 
 
 
f. If yes:  
Age you started speech & language therapy ________ 
How long did you attend speech & language therapy?__________ 
 
I am satisfied with my decision to have speech & language therapy 
Strongly agree (1), Agree (2), Neither agree nor disagree (3), 
Disagree (4), Strongly disagree (5), NA 
Comments 
____________________________________________________ 
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11. To what extent did the following factors influence the decisions you made 
regarding your treatment choices? Rating scale 0 (not at all) to 10 
(influenced greatly)  
a. Information provided by staff at the Gender Identity Development 
Service 
0 1 2 3 4 5 6 7 8 9 10  
b. Information provided by staff at an adult gender identity clinic 
0 1 2 3 4 5 6 7 8 9 10 
c. Information provided by staff at another NHS service (which one?) 
0 1 2 3 4 5 6 7 8 9 10 
d. Information from third sector organisations 
0 1 2 3 4 5 6 7 8 9 10 
e. Opinions/advice of family members  
0 1 2 3 4 5 6 7 8 9 10 
f. Opinions/advice of significant others 
0 1 2 3 4 5 6 7 8 9 10 
g. Information on the internet (which sites?) 
0 1 2 3 4 5 6 7 8 9 10 
h. Thinking about the risks and benefits of taking hormones and/or 
having surgeries 
0 1 2 3 4 5 6 7 8 9 10 
i. Other (please 
specify)_____________________________________________ 
 
12. What did you think of the timings of the interventions you had? 
a. Counselling/therapy/groups (n/a, too soon, about right, too late, not 
sure, other) 
b. Hormone blockers (n/a, too soon, about right, too late, not sure, 
other) 
c. Cross sex hormones (n/a, too soon, about right, too late, not sure, 
other) 
d. Chest surgery (n/a, too soon, about right, too late, not sure, other) 
e. Genital surgery (n/a, too soon, about right, too late, not sure, other) 
f. Other surgery (please 
specify_________________________________________) 
(n/a, too soon, about right, too late, not sure, other) 
g. Speech & language therapy (n/a, too soon, about right, too late, not 
sure, other) 
Comments 
______________________________________________________ 
 
13. What did you think about the length of the process (from the point you 
were referred)? 
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a. Counselling/therapy/groups (n/a, too short, about right, too long, not 
sure, other) 
b. Hormone blockers (n/a, too short, about right, too long, not sure, 
other) 
c. Cross sex hormones (n/a, too short, about right, too long, not sure, 
other) 
d. Chest surgery (n/a, too short, about right, too long, not sure, other) 
e. Genital surgery (n/a, too short, about right, too long, not sure, other) 
f. Other surgery (please 
specify_________________________________________) 
(n/a, too short, about right, too long, not sure, other) 
g. Speech & language therapy (n/a, too short, about right, too long,  
not sure, other) 
Comments 
_______________________________________________________ 
 
14. Which interventions (if any) do you intend to have in the future? 
Counselling/therapy/groups  
a. Yes/no/undecided/NA (already had/having 
counselling/therapy/groups) 
b. If undecided, 
why?______________________________________________ 
If yes,  
c. What age do you intend to have counselling/therapy? _________ 
d. Where do you intend to have 
counselling/therapy?_____________________ 
Comments 
_______________________________________________________ 
Hormone blockers 
Yes/no/undecided/NA (already taken/taking) 
a. If undecided, 
why?________________________________________________ 
If yes: 
b. What age do you intend to start hormone blockers? ______ 
c. Where do you intend to get this intervention? (tick those that you 
are considering) 
 Adult gender identity clinic 
 GP 
 Private clinic 
 Online 
 Overseas 
 
Other________________________________________________ 
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Comments 
______________________________________________________ 
 
Cross sex hormones  
Yes/no/undecided/NA (already taking) 
a. If undecided, 
why?_________________________________________________ 
If yes: 
b. What age do you intend to start cross sex hormones? ____ 
c. Where do you intend to get this intervention? (tick those that you 
are considering) 
 Adult gender identity clinic 
 GP 
 Private clinic 
 Online 
 Overseas 
 Other______________________________________________ 
 
Comments 
______________________________________________________ 
 
Top/Chest surgery  
Yes/no/undecided/NA (already had surgery) 
a. If undecided, 
why?_________________________________________________ 
If yes: 
b. Specify 
type(s)________________________________________________
____ 
c. What age do you intend to have this surgery? _______ 
d. Where do you intend to have the surgery? 
______________________________ 
Comments 
______________________________________________________ 
 
Bottom/Genital surgery  
Yes/no/undecided/NA (already had surgery) 
a. If undecided, 
why?________________________________________________ 
If yes: 
b. Specify 
type(s)________________________________________________
___ 
c. What age do you intend to have this surgery?________ 
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d. Where do you intend to have the 
surgery?______________________________ 
Comments 
______________________________________________________ 
 
Other intervention(s) 
Yes/no/undecided 
e. If undecided, 
why?______________________________________________ 
If yes: 
f. Specify 
type(s)________________________________________________
__ 
g. What age do you intend to have this intervention?________ 
h. Where do you intend to have the 
intervention?____________________________ 
Comments 
_______________________________________________________ 
 
Speech and Language therapy 
Yes/no/undecided/NA (already had/having S&L therapy) 
a. If undecided, 
why?______________________________________________ 
If yes: 
b. What age do you intend to have speech & language therapy? 
____________ 
c. Where do you intend to have speech & language 
therapy?_______________ 
 
Comments 
__________________________________________________________ 
 
 
15. If you were making decisions about interventions now, would any of your 
previous decisions about interventions be different? Tick all that apply and 
please explain how they would be different 
 Hormone blockers – Yes/No/NA 
If Yes, in what way would your decision(s) about Hormone Blockers 
be different? 
____________________________________________________ 
 
 Cross sex hormones – Yes/No/NA 
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If Yes, in what way would your decision(s) about Cross sex 
hormones be different? 
____________________________________________________ 
 
 Top/chest surgery – Yes/No/NA 
If Yes, in what way would your decision(s) about Top/chest surgery 
be different? 
____________________________________________________ 
 
 Bottom/genital surgery – Yes/No/NA 
If Yes, in what way would your decision(s) about Bottom/genital 
surgery be different? 
____________________________________________________ 
 
 Other (please specify – Yes/No/NA 
In what way would your decision(s) be different? 
____________________________________________________ 
 
16. How do you feel now about your gender identity? (Very satisfied, Satisfied, 
Neither satisfied nor dissatisfied, Dissatisfied, Very Dissatisfied) 
Comments_________________________________________________ 
 
17. How do you feel now about your body in relation to your gender identity? 
(Very satisfied, Satisfied, Neither satisfied nor dissatisfied, Dissatisfied, 
Very Dissatisfied) 
Comments_________________________________________________ 
 
18. Below are some statements about feelings and thoughts. Please tick (√) 
the box that best describes your experience of each over the last 2 weeks: 
a. I’ve been feeling optimistic about the future (None of the 
time/Rarely/Some of the time/Often/All of the time)  
b. I’ve been feeling useful (None of the time/Rarely/Some of the 
time/Often/All of the time)  
c. I’ve been feeling relaxed (None of the time/Rarely/Some of the 
time/Often/All of the time)  
d. I’ve been feeling interested in other people (None of the 
time/Rarely/Some of the time/Often/All of the time)  
e. I’ve had energy to spare (None of the time/Rarely/Some of the 
time/Often/All of the time)  
f. I’ve been dealing with problems well (None of the time/Rarely/Some 
of the time/Often/All of the time)  
g. I’ve been thinking clearly (None of the time/Rarely/Some of the 
time/Often/All of the time)  
h. I’ve been feeling good about myself (None of the time/Rarely/Some 
of the time/Often/All of the time)  
i. I’ve been feeling close to other people (None of the 
time/Rarely/Some of the time/Often/All of the time)  
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j. I’ve been feeling confident (None of the time/Rarely/Some of the 
time/Often/All of the time)  
k. I’ve been able to make up my own mind about things (None of the 
time/Rarely/Some of the time/Often/All of the time)  
l. I’ve been feeling loved (None of the time/Rarely/Some of the 
time/Often/All of the time)  
m. I’ve been interested in new things (None of the time/Rarely/Some of 
the time/Often/All of the time)  
n. I’ve been feeling cheerful (None of the time/Rarely/Some of the 
time/Often/All of the time)  
 
19. Is there anything else you would like to say? 
 
 
THANK YOU FOR TAKING THE TIME TO COMPLETE THIS QUESTIONNAIRE 
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Appendix H. List of resources for participants 
 
      
 
List of Resources 
The Beaumont Society – Largest transgender support group in the UK. Offers a 
24/7 information line, who can point you in the direction of the best resources for 
you 
 01582 412220 
 www.beaumontsociety.org.uk/ 
LGBT Helpline – provides listening, support and information via phone or 
instant messaging 
 1890 929 539 (trans-specific shifts are 6-9pm) 
 www.lgbt.ie/our-services/instant-messaging-support-
service?gclid=CI7Qh7z54tICFVIYGwodJkMKlQ 
Mermaids – is a support group for trans-identified people aged 19 and under. 
Their information line is open Monday to Saturday from 3pm till 7pm 
 0208 1234819 
 www.mermaidsuk.org.uk 
Gendered Intelligence – is a not for profit group that works with the trans 
community, and those who impact on trans lives. Gendered intelligence 
specialises in supporting young trans people under the age of 21. 
 www.genderedintelligence.co.uk 
FTM London – is a support group for transmen and anyone who identifies on the 
trans-masculine spectrum.  
 07717 140461 
 www.ftmlondon.net 
The Queer Youth Network – online forums discussing everything LGBT related. 
 www.lgbtyouth.org 
138 
 
The Mix – An online community where you can chat anonymously to other young people 
about how you’re feeling on their message boards. 
 www.themix.org.uk/sex-and-relationships/sexuality/young-and-trans-
5178.html?gclid=CMHkk8b44tICFRATGwodiPcDng 
 Freephone support line 0808 808 4994 
---------------------------------------------------------------------------------------------------------- 
If you are in crisis and need help when other services are closed please 
contact one of the following: 
 The Samaritans on 116 123  
 Your GP 
 Go to A&E 
 Contact the emergency services on 999 
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Appendix I. Study leaflet for adult clinic 
 
   
Did you attend the Gender Identity Development Service (GIDS) at any time 
during the last 6 years? 
We are interested in hearing about your experiences. 
________________________________ 
 We are conducting a short online survey of previous GIDS clients to find 
out whether the advice, treatment and decisions they made have been 
helpful in the longer-term. 
 Your participation is valued, as with your input we will gain a better 
understanding of the longer-term outcomes of people who attended GIDS, 
and this will enable better tailoring of services to the increasing number 
and diversity of young people seen at the clinic. 
 Your responses will be completely anonymous, and any doctors or 
clinicians you see will be unaware of your participation in this research 
(unless you speak to them about it yourself). 
 You will be entered into a draw to win a £100 Amazon voucher 
 If you would like to participate and/or have questions about the survey 
please feel free to contact Dr Lorna Hobbs via email at _______________ 
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Appendix J. Participant explanations of ‘other’ (regarding gender identity) 
 
1. I am a dysphoric female. I don't believe in gender identity  
2. I identify both as a 'man' and as a 'trans man'  
3. Mostly as a trans man, but sometimes genderless  
4. "I am a woman", "I am a trans woman"  
5. I don't identify as any specific gender, I have just overcome insecurities and 
misunderstandings of how I have thought about myself in the past and how 
that might have made me think I had a female brain or whatever the popular 
reason is right now. I know I am male  
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Appendix K. Reasons cited for being undecided about taking hormone 
blockers in the future (full quotes) 
 
UNSURE – BLOCKERS (8) 
1. I am currently taking Oestrogen and will take blockers if it is required to get 
my hormones to the right levels for transition. 
2. Too late for it, as far as I know? Not that any services have been helpful 
3. No comments 
4. I am eligible for them, if my periods begin to distress me again. But at the 
moment I feel I can cope with them. 
5. not sure if I need blockers with HRT 
6. I don't think my adult gic offers them 
7. I'm already taking cross-sex hormones and resources seem to have 
conflicting opinions as to whether or not hormone blockers in addition 
would help 
8. I’d rather be on testosterone if possible but would jump at the chance of 
this too if it was offered at this point 
Themes 
 Unclear if any additional benefit above CS hormones alone (3) 
 Unsure whether it’s too late (i.e. person is too old) (1) 
 If distress levels associated with periods worsen (1) 
 Person not sure if blockers are offered in adult clinic (2) 
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Appendix L. Reasons cited for being undecided about having genital 
surgery in the future (full quotes) 
 
UNSURE – GENITAL SURGERY (26) 
1. No comments 
2. Plan to see how I feel about it after transitioning 
3. No comments  
4. No comments 
5. No comments  
6. I don't think I could mentally or physically handle the pain of either method 
available. There are also various complication risks for the surgeries too 
which severely worry me. 
7. No comments 
8. If technology improves to have a more functional and natural-looking penis 
(without skin transplant) then I would definitely consider it 
9. Do not currently feel the need to however I am not ruling it out as a future 
option. 
10. Really not sure. will need to decide in the future 
11. Currently I feel the results for FtM transsexuals are poor and they wouldn't 
satisfy me. I'd only get surgery if the results improve immensely. 
12. Weighing out the risks and benefits 
13. I am fairly sure I do not want genital surgery. I do not really have bottom 
dysphoria (or any dysphoria these days), I do not want to risk the sexual 
function which I currently have, and I am not very encouraged by the 
current surgical results pictures. I have put 'undecided' here because it is 
an ongoing consideration, maybe in 20 years there will be better 
techniques, or maybe in 5 years I will have dysphoria about it, I can't 
predict the future. 
14. I need to learn more about this to make a decision. 
15. Probably not, but depends on advances in genital surgery as currently I 
find the result unsatisfactory 
16. No comments 
17. not the current surgery options 
18. It depends on the progress of surgical procedures and the aesthetic results 
in the future, right now I am not too fussed over it, but who knows, maybe 
in the future I will want surgery. 
19. No comments 
20. It is likely, but I am not entirely certain as I must do more research on 
procedures. 
21. Right now surgery on my very sensitive, hardly ever seen genitals seems 
like a waste. Also phalloplasty is still very risky so why bother. I don’t want 
to be sterile, either. 
22. The complex surgeries are a lot to think about. 
23. Unsure about which surgery. Have other priorities like chest surgery so I 
haven’t thought of it as a real possibility yet. 
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24. I haven't spoken to my counsellors much about bottom surgery as it's so 
far away. I do get bottom dysphoria, but I use packers which really helps it. 
25. Unsure which surgeries would be ideal 
26. No comments 
Themes 
 Weighing risks and benefits (5) 
 Pain (1) 
 Outcomes (results poor/not good enough/results unsatisfactory) – methods 
may improve future advances in surgical methods and results (6) 
 Waiting until results of  transitioning – focussed on current 
surgery/transition  (1) 
 Too soon to make a decision (3) 
 Not needed/not dysphoric (2) 
 Don’t know enough about it – need to do more research – complex (2) 
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Appendix M. Reasons cited/contextual information for why people had not 
taken hormone blockers (full quotes) 
Satisfaction with the process in people who have never taken hormone blockers – 
comments (20) 
Unhelpful information/advice (2) 
Decision made by clinicians/service (7) 
Too late (12) 
Felt pressured to take them by clinicians/services (2) 
Family dissuaded (1) 
Went private to get T (1) 
Wanted to take them (11) 
1. When attending [service] the information was unhelpful, confusing and 
inaccurate. 
2. There was no option given to make hormone blockers available to me 
whatsoever, despite my clearly expressed desire to pursue medical 
transition as soon as possible 
3. No comment 
4. No comment 
5. No comment 
6. It was too late for me to take hormone blockers by the time I was referred 
to [service], but I wish I had taken them earlier so they could've made a 
difference. 
7. As I was already past puberty I wasn't allowed to go on hormone blockers. 
8. I had been referred for hormones blockers and was about to start before 
being discharged despite being told I would not be discharged as I was 
under [hospital]. 
9. I asked [service] for hormone blockers and they refused to because 'It 
wasn't worth it' me personally It would have been like a starting point to 
Transition and could have made me feel better about the situation i was in, 
It could have made me feel better about myself. 
10. No comment 
11. In hindsight it would have been great to have been on hormone blockers 
so that I didn't develop breasts, however, it was too late for them by the 
time I got to the children's services 
12. No comment 
13. When I tried to bring up the subject I felt as though I wasn't able to ask any 
questions about them or their effects, as the doctors I saw expected me to 
already know everything about them. Eventually I was promised hormone 
blockers while under [service], but this was then redacted and I was later 
told I wouldn't be given them due to my age. 
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14. By the time of referral I was well into puberty, so there wasn't really any 
point in the blockers. 
15. As I was pretty much all the way through puberty by the time they decided 
to give me medical assistance it was no longer an option 
16. Reaching [service] at 17 I had pretty much developed my female body, my 
boobs only got partially (minutely!) bigger since. So to take hormone 
blockers would visibly be a bit redundant seeming as there was no growth 
to stop, my hips and breasts had already developed etc etc. But I 
remember going to my GP (think I asked 2 or 3 different ones) for 
something to stop my periods and I mentioned hormone blockers, 
contraception, if they knew anything else.  And they were all written off 
quickly, even contraception just because I didn't have sex, but it's often 
used on biological women for period control. My doc said it was because 
she wasn't sure about how it would affect my hormones and didn't want to 
skupper when I can go on to testosterone (3 years later...!). When 
mentioning wanting to stop my periods at [service] the focus was around 
that I wasn't dysphoric about them so just live with them and I put a brave 
face on like yeah it's fine. But surely now you'd think it would be fine to 
prescribe contraception for it. Anyway, what surprised me was the lack of 
knowledge my doc had on what could be done pre-testosterone to stop 
periods. 
17. I was pressured at the child services to take hormone blockers but I didn't 
want to due to my own research on the side effects. 
18. When this conversation about hormone blockers came up I had already 
finished puberty so all that it would do is stop periods. I'd already gone on 
a contraceptive to stop periods so I didn't see the point in changing 
medicine. 
19. I asked for blockers and was turned down - I'm still angry about this! 
20. My family are not supportive of my transition so they stopped me talking 
blockers 
21. I was told i had to go on them for 12+ months before receiving HRT. i was 
17, i should not have to go along with the protocol in place to protect much 
younger children. 
22. When I was referred to [service], I was told I was already too old to start 
taking hormone blockers. 
23. No comment 
24. No comment 
25. Started T privately as I am still waiting for my first appointment with 
[service] 
26. No comment 
27. I went to the [service] hoping to be put on blockers until I could start HRT, 
however they explained to me that there was no point taking hormone 
blockers as I was 17 and there would be no point. 
28. I was too close to adulthood anyway 
29. No comment 
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Appendix N. Comments on reflections on previous decisions about 
interventions (full quotes) 
 
Current Reflections on Previous Decisions about Interventions (28) 
 
1. I've somewhat de-transitioned now, medically speaking (not socially). I 
would now put more emphasis on the emotional support I could get from 
therapy. I would consider hormone blockers as a longer term treatment 
rather than a precursor to hormones. I would not be on cross-sex 
hormones. But I would still have wanted top surgery. 
2. I'd like to have started therapy when I was younger so I could have started 
hormone blockers. 
3. I just want to go back in time so I can start physical transition sooner. 
4. I would have applied to an adult’s clinic first so I could actually have 
access to the hormones and surgery I need, instead of having to sit and 
wait in a clinic that couldn't even give me anything physically. 
5. I would have chosen to take blockers sooner. I did not realise that the clinic 
would use my decision to hold off against me. My whole experience with 
the clinic was a waste of time. 
6. No comments. 
7. I would have been happy to take hormone blockers if i was given the 
option and I would have had speech therapy if the option was closer to 
home. 
8. I would have taken birth control instead of hormone blockers to stop my 
menses. Some aspects of hormone blockers are wonderful - there's no 
fluctuations in my masculinity and femininity like I used to have due to my 
cycle, and it feels great to feel simply neutral, but the cost has been quite 
high. I know depression is a common side effect and it's difficult to tell 
whether I've experienced it as a result or whether my mental health has 
struggled because I've been so tired that I've felt like I have no future. 
9. Although I was too old to be put on hormone blockers by the time I 
reached the children's services (due to the lengthy waiting process, as I 
was put through CAMHS first), this is something I wish I had had access to 
sooner 
10. The criteria that you must be on hormone blockers for 12 months before 
you are able to receive cross sex hormones from the NHS just seems 
rather long especially for those who are certain. 
11. The wait is so long that I would have preferred to have something between 
like blockers. Therapy was a waste of time. They don't help or offer any 
advice whatsoever. 
12. Would seek counselling sooner. Would want blockers & T much sooner to 
help prevent the last stages of puberty that i had to go through while 
waiting. Would have had chest surgery 2 years ago. 
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13. If I'd been confident enough to come out earlier in life, I have jumped at the 
chance to prevent female puberty 
14. I think the mandatory hormone blockers are unnecessary, and I now no 
longer want bottom surgery. 
15. As said in my previous comment, it's to do with not knowing the gender 
binary was so large when I was at [service]. I saw transitioning as going 
from one extreme to the other. Like I knew I was never gonna be a 'manly 
man' but I never thought about potentially being gender queer, or 
transmasculine.  Without being graphic or tmi, I didn't have sex til I was 20, 
and I think that helped me come to realise I'm more transmasculine than 
just a man. Now I'm here I think I could reconsider chest surgery, but I 
don't regret it. I can't wait to have my first summer where I can take my top 
off, and where a binder won't rub me and suffocate me. 
16. No comment. 
17. I would have liked to have been offered genital and chest surgery at a 
younger age, as I was much more confident. 16 onwards my life 
completely fell apart, due to not feeling at home in my body. The 
counselling/therapy from such a young age was probably detrimental to  
my mental health. 
18. No comment. 
19. I’d try to come out and seek therapy and counselling sooner possibly, but I 
am quite happy with things and how they turned out, so really, I have 
nothing to complain about 
20. I’d have preferred to be started on blockers at an earlier age 
21. I would have definitely started cross-sex hormones, had I had the 
confidence to ask during my earlier sessions. And I would've started 
hormone blockers a lot earlier than I did. 
22. Which I’d have come out earlier so I could have had more time for fantasy 
to get use to ur so I can start blocker 
23. I’d ask them to talk to me like an adult and not a scared child, and I would 
take the blockers because menstruating is causing me so much stress on 
top of all the other stresses of this process. 
24. Send the patients waiting for counselling, updated statistics and 
information leaflets about their condition and options. Don't let people have 
surgeries and drugs based on the whim that they aren't happy being the 
sex they are. 
25. No comment 
26. I would have paid for the hormones myself earlier. As far as the surgeries 
go, I would pay for them now if I had the money, I've known exactly what 
I've wanted for years now. 
27. I initially waited to request hormone blockers because of my family and felt 
it would have benefitted my mental health had I just requested it when I 
wanted 
28. Counselling/therapy should’ve continued between child and adult services 
  
148 
 
Appendix O.  Comments on the timings and length of process of 
interventions (full quotes) 
1 - LENGTH OF PROCESS 
Reason for the wait 
Wait too long (initially, between clinics, for interventions) 
Not enough services 
Appointments rescheduled & referral problems due to admin errors/staff leaving 
Waiting for signatures  
Other mental health issues  
Not offered services  
Steps or processes seen as unnecessary   
Impact of the wait 
Privately 
Delays treatment  
Process caused distress 
Made surgery necessary  
 
Other comments 
Hormones & surgeries too easily obtainable 
Unsupportive clinicians 
More therapy should be offered 
 
1. The services in the NHS take far too long and are so difficult to come by. 
The only reason I have had counselling and am on Estrogen is because I 
paid to go privately. I was never offered any support or services from 
Tavistock. I am currently looking into private Speech and Language 
therapy and laser hair removal as the waiting times for these are 
ridiculously long and I was never referred to them in the first place. 
2. Ridiculously too long, for everything. I am desperate to begin hormone 
therapy, and it's not even within the foreseeable future that I get to, after 3 
years. 
3. I didn't need counseling or therapy, so I feel that should have been 
omitted.  Being treated by the NHS was a process of relieving dysphoria at 
the cost of profound trauma. The denial & gatekeeping of treatment, the 
requirement to fulfill gatekeepers' fantasies of a trans woman, was like no 
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abuse I have ever experienced. The genital examination required to obtain 
estrogen, something that could be easily self-performed & reported, was 
akin to sexual assault in the pain and psychosis it left me with. I began 
healing only in the aftermath of my surgery. 
4. I was offered genital surgery when I was 21. Many years after I first 
attended the [service]. I turned it down, due to other mental issues I 
currently face. 
5. Waiting times for appointments, surgery and hormones are too long and 
cause much stress for the patient. 
6. I feel like a lot of people who say they are trans and want hormones, 
decide so even before they have been to an identity clinic, and that they 
should need answers and someone to talk to about issues concerning 
them wanting to transition very quickly, so that they are not in turmoil for 
very long about their condition. Therefore, I think the waiting time for 
therapy is too long, but the surgeries and drugs people often strive for as 
an ultimate solution to their problems, which far more often than not can  
be treated otherwise, are far too easily attainable, considering their 
irreversible effects. 
7. I waited around two years to get into the children's clinic. I was there for 
around a year before being kicked out because I was over 18. I'll now have 
to wait another year and a half to get my first adult clinic appointment and 
my second appointment will likely be 6 months after the first. Once I'm on 
hormones, I'll likely have to wait another year before I can get top surgery. 
8. The waiting list is a joke and not helped by unsympathetic clinicians. More 
therapy should be offered. 
9. The only reason it took such a long time to get on testosterone (it took 7 
months longer than I was told to expect) was because an endocrinologist 
had left the clinic, so there was more time pressure on fewer staff and my 
appointment was set back. 
10. I do think there does need to be a strict process to determine whether or 
not a patient should receive hormones/surgery due to aspects of them 
being irreversible (especially if they are adolescents).  However, the wait 
for me personally was far too long because of the referral error where I 
was meant to be referred to adult services from the children's services but 
for some reason wasn't. 
11. The wait time is over a year for initial assessment and +7 for any other 
help so it makes it very difficult to keep any therapy questions in mind and 
it made me incredibly depressed and anxious to wait that long to be seen. 
12. It took too long to get blockers and then to get T afterwards. the waiting list 
for charring cross was over 1 year. then it took another year to be referred 
through to even see a surgeon. 
13. Aside from empty promises that were later redacted, I was never promised 
hormone blockers or cross-sex hormones. As I'm still on a waiting list to 
begin attending adult services (after 2 years) I've still never been offered 
any sort of surgery. I was never offered speech and language therapy. 
14. I’m still waiting to get the signatures for the reassignment surgery’s 
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15. I have put 'not sure' for Counselling/Therapy because the [service] length 
was good, but the [service] length abysmal.  I do feel that, in general, 
people should be able to have hormone blockers sooner. If I had had 
hormone blockers before I hit puberty, I would not have needed top 
surgery. However, specifically for me, this would not have been possible, 
as I hit puberty around age 8-9, before I had words to describe my gender 
identity. 
16. Due to the backlog of paperwork in [service] I felt delayed a couple of 
months starting hormones (also just the wait for my first appointment to 
[service] was over a year, so that ontop of 6 months between 
appointments there etc) With Chest Surgery it would have been 'About 
Right' if they hadn't made a mess of the paperwork. After a backlog of 
letters they sent my referal to the Private Hospital that [name of worker] 
worked at. So I had to do a lot of chasing up on it. So quite late, it got 
sorted. But I know that on the surgeon's side of it it was all fine, it's 
[service’s] fault. ## the counselling one was a local nhs service and late 
because of my deteriorating mental health not to do with [service] In 
regards to the below question 'the timings of when you had the 
treatments/interventions' I'm assuming this is their timing in relation to each 
other. Hormones just late as explained above Chest surgery late becuase 
the guide line is the surgery to be had '6 months or more' after starting 
hormones. So when talking about chest surgery at [service] I had been on 
hormones for 4/5 months (despite there being 6+months between 
appointments, their fault) the doc didn't want to start the referral yet. not 
accounting for the waiting time of the referral, and the time between 
consultation and actual surgery. 
17. Having to wait until I was 18 made it a lot harder for me. 
18. I am still yet to receive top surgery, I was on a waiting list from nearly a 
year but have been taken of it due to the surgeon being unable to now do 
the surgery as he has moved. I'm now unaware of when I will be getting 
surgery. 
19. At the start when I was referred by [service] I felt the process was too long 
and it would take 12 months from being referred to receive the blockers. 
Then after being on blockers for another 12 months, I would then have the 
decision to go on hormones. But the process of upping my dosage of my 
hormones has not felt dragged out or long, it has come steady and regular 
which is how I am happy with it. 
20. Would have liked to have received hormones earlier rather than having to 
attend appointments at adult services to assess whether I was "ready" to 
take them, and being required to change my legal name before I could 
even get a recommendation 
21. I desperately needed counselling and asked for it and was not offered it 
22. I have received no treatment other than some patronising counselling 
sessions. I am diagnosed, why am i being forced to wait and beg? what if I 
was less stable? this process would have killed me a long, long time ago. 
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23. Still waiting for an appointment with the adult clinic, still waiting to 
medically transition 
24. As a Welsh individual they appear to make the waiting time longer which 
appears very unfair.. I've seen people who've been in the system less time 
than me get the help quicker. Where is the logic. It's not like this was 
greatly impeding my well-being or life, or anything....   I have a lot of 
grievance toward the service as a whole.    Very disrespectful and very 
uneducated and very lengthy process'. 
25. The length of time I had to wait in between appointments at the adult clinic 
were inexcusable, as I had 2 cancelled appointments which led to a year 
and 1/2 wait before I was seen again after the first meeting. With no 
contact or apology from the clinic, at one stage I had to get my GP to 
contact them to issue me with another appointment letter, it was as if I'd 
been forgotten about. By the time I was seen again, I was told that my first 
appointment (1 and 1/2 years previously) was no longer valid as a doctors' 
approval for surgery, as that doctor had now left the clinic. As a result I  
had to wait another 6 months and come back again causing me to wait 
even longer for my chest surgery referral. Hence, when I waited around 2 
years longer than I should have to even get referred. On the other hand, I 
had no issues at all with cancelled appointments or long waits at the 
[clinic], and they were much better at keeping in contact/returning calls 
when needed. 
26. I was supposed to have top surgery a few years ago but my name was 
dropped of the list by accident several times and now finally is getting 
sorted 
27. As of now I am still waiting for chest surgery which I thought would take 
place in May, but has been moved back again. I made the decision that I 
wanted bottom surgery a long time ago, but I have absolutely no clue  
when that will happen. The fact that I transitioned ten years ago but still 
have not had access to these surgeries is appalling. 
 
2 – TIMINGS 
1. I've been in the NHS system for 5 years without the offer of any 
psychological or medical interventions. The system let me down and the 
only reason i'm in a good place now is because I had the chance to go 
privately, I worry about those who don't have that chance. From the first 
appointment it felt that I had to fit into a box before I could get any 
treatment and that I had to be completely sure and totally confident 
about my decision, which was an impossible task at the time. 
2. If you aren't like most people involved in trans care, my gratitude is utter, 
and I hope you can forgive me if my tone is harsh. 
3. If it wasn't clear by my answers so far, I no longer think 
transgenderism is real, and is rather people trying to find happiness 
by transitioning and labelling their emotional dissatisfaction and 
mental issues with fancy words and terms (genderfluid, transgender 
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umbrella, bigender, transgender, gender dysphoria) that allow them 
to express themselves, but don't actually help them dissolve the 
issues and dissatisfaction. 
4. The immense wait for treatment is somewhat understandable due to the 
failing budget of the NHS, but given the importance of getting treatment  
as soon as possible where trans persons are concerned, improving this 
should be a priority. It can mean the difference between life and death, as 
someone that struggles greatly with the physical side of the problem, I 
would be much happier in my general life if I had gotten the treatment I 
needed when I asked for it. A potentially more troubling issue is the 
barriers one faces when trying to get treatment, it is categorically 
insufficient to truthfully explain your struggles. My experience was being 
interrogated about the way I present, being told I have to 'be a woman all 
of the time, not just some of the time'. The criteria for being judged as 
correctly transgender seem very specific, and god help me if I didn't figure 
out the rough criteria and start lying. This is criticism given because 
otherwise I am greatly in the debt of the [service], and would very much 
like to see it improve so that better treatment is available to those that 
follow. Thank you. 
5. I can't speak for trans feminine people, but the fact that trans masculine 
people are denied referrals for top surgery until they've been on HRT for a 
certain amount of time is cruel and ridiculous. Binding is painful, 
unpleasant, and can be traumatising. Many people can't pass as 
masculine because of their chest, meaning that physical changes they 
may experience from HRT (esp. facial hair) make it even more dangerous 
to exist as a trans person due to how visible discrepancies from gender 
norms are received. 
6. I wish I'd been offered physical transition options at [service]. 
7. Without a doubt, there needs to be more clinics, especially children's 
ones. There were people there travelling 4+ hours for their appointment 
because there are just no clinics near them. The lack of clinics also lead to 
being able to help less people, and in the meantime people are suffering 
because they're not being seen. 
8. I was due to start testosterone treatment mid 2015, however due to my 
GP repeatedly refusing the first injection due to supposed complications 
despite telling him I wasn't allergic to anything, I wasn't able to start the 
treatment until June 2016. The injection was done by a local hospital and 
only then was I allowed to have the continuing injections done at the 
surgery. The year wait before I was able to start testosterone caused me 
to become suicidal and depressed. 
9. The [service] treated me awfully. I filed a complaint but the reply 
confirmed that they don't actually care about their patients. The 
clinic acts dangerously and recklessly, I was lied to many times by 
my clinicians and blamed for their incompetency. I hope 
improvements are made because many trans young people are not in 
a place where their futures should depend on the whims of careless 
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clinicians who simply don't understand our experiences. The 
discharge experience was horrible - I was left alone with no support 
and I have realised how little dignity the clinic affords its patients. I 
wonder if this is because of our vulnerability. I hope that change will 
come soon. 
10. Overall I feel that the counselling sessions for me didn’t give me anything. 
I always dreaded going because I found them pointless and just made me 
feel like something was wrong with me. Still to this day me and my  
parents joke that it was pointless. But as I’ve said before, I can 100% see 
how they can help a lot of people. Unfortunately I wasn’t one of them. 
Maybe it was because I was already so sure of what I needed. 
11. Offered group therapy and speech therapy, but never received a letter or 
confirmation despite requesting this twice. 
12. The overall factor in me having a negative experience with these services 
is due to the error of not being correctly referred to the adult services, 
meaning I wasted approximately 2 years and subsequently had to pay for 
expensive private services which I struggled and still struggle to afford 
13. I understand why the process is long and that a lot of it can't be helped by 
people involved in the services however it is my life and a lot has to be put 
on hold because I couldn't/can't get access to treatment for example I am 
currently waiting for top surgery which would ease a lot of dysphoria and 
allow my life to really begin but currently I am just waiting with no sense of 
when it could happen. 
14. Overall the 'treatment' I received from [service] was extremely poor. I 
felt constantly lied to and manipulated, and as though they weren't 
taking my personal situation into account. If I hadn't have been able to 
scrape together the money to start taking hormones from a private clinic, I 
wouldn't have been able to start transitioning at all. 
15. My waiting for hormones was very long , and resulted in multiple suicide 
attempts 
16. When I first got referred to [service] I knew there was cisgender, 
transgender, but I saw it as male or female, not a large binary scale which 
I've come to learn. And I wish I had known more about this back then, 
because I think I identify as transmasculine now, and I wasn't very 
dysphoric about my breasts, but I hated having to wear binders due to the 
discomfort of them, and passing was difficult. If I started my transition now 
I might rethink top surgery. But I would defo have HRT and a 
hysterectomy.   I'd also like to apologise if a lot of my comments are 
negative about my experience with [services] but that's because there's 
not a lot of positive things I have to say about them. 
17. Had I not gone private I'd be waiting for testosterone still now. [service] did 
not listen to me or my needs - I asked for counselling directly. I am happy 
that I transitioned but I can't see how [service] impacted that apart from 
making it harder. I saw them perhaps three times and we never discussed 
medical transition. 
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18. I am an 18 yr old trans man who’s been seeing [service] since I was 15, I 
feel the support and talking side has always been very good and helpful, 
but whereas I could’ve started blockers at a younger age and then 
smoothly moved to hormone therapy, I had to wait til I was 17 to even be 
introduced to the idea of blockers, which I am currently still on. I also think 
that if [service] are going to send a referral to an adult service with a very 
long waiting list, they should have th authority to send said referral before 
a patient is 18 because this way the wait will eat away less at adulthood 
19. this whole process is upsetting and horrible. the waits are too long and 
[service] protocols need to be addressed and fixed to suit older teens. i 
feel completely hung out to dry by this whole thing and its not fair to myself 
or my family who have to watch me suffer. 
20. I waited months to attend the [service], where I was falsely told that I 
would be able to skip the waiting list for the adult clinic, influencing my 
decision to stop attending [service] when it would have probably been 
more beneficial for me to stay. 
21. I haven't actually even made it to adult services yet. The [service] said 
they would send off my referral when I was 17 and half (the age 
requirement) and they didn't send it until 3 months after my 18th birthday. 
Now I'm still being seen in a paediatrics ward covered in Winnie the Pooh 
acrylics and walking around London with Finding Nemo plasters on my 
arm. The state of the service is shocking and it's a shame it's so under-
funded. 14 months waiting periods for an appointment. That's just to be 
seen. Let alone the years long waiting lists for surgery that you can't get 
onto until you've been seen. I'm going to have tits well into my 20's unless 
I can magically find the money to go private. So fantastic. By the time I'll 
actually transfer into adult services I'll have been in the GIDS programme 
6 years. 
22. Since 15 when i first started identifying as male, I feel like I've been 
waiting an extremely long time for counselling, and physical treatment. 
However I was unlucky with my timing, I was first referred to the [service] 
when I was 16, and by the time I was being seen at the [service] (10 
months after) I was nearly 18 so I didn't have many sessions there, I was 
referred to the [service] back in June and I'm currently waiting for my 
appointment there. I feel like the system is a waiting game, however in 
some ways I'm quite grateful for it, as it's meant that I've had to learn to 
cope with my body and learn how to deal with my mental health regarding 
the wait, and has also certified my feeling that I am Trans and I do feel  
like I'm in the wrong body. Just excited to start with sessions at [service]! 
23. I'll reiterate how imperative, I believe it is for the service to be 
understanding and caring toward transgender individuals in relation to 
their body or their identity. It comes across as very disrespectful when 
doctors, psychiatrists or other staff are referring to body-parts or other 
such things with the incorrect terms, or just not taking their time to use 
gender neutral one. By doing so they're impacting mental health of the 
individual. I know I dread going to the [service], I always have and always 
155 
 
will. However, if I thought i wouldn't have to encounter words that make 
me want to cut myself up I could deal with the process that bit easier. 
24. Overall my experiences at the [service] were good from start to finish, 
whereas my experiences at [service] have been awful. Some of the 
doctors were rude and insensitive in the manner with which they spoke to 
me and asked me personal questions. The number of cancellations I had 
meant my transition was made much longer than it should have been and 
every single call I made and message I left was neglected over the course 
of a 2 year period. 
25. The [service] once cancelled my appointments consecutively for a year 
and a half. That's a year and a half delay in my treatment- plus no reason 
was given. At this stage in my life I thought I would have finished my 
transition and enjoying my twenties, but the clinics had other ideas. Every 
time I think I'm getting close to progress, things get messed up by the 
services. 
